Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,solute:sodium symporter activity (GO:0015370),0.8610840507348234,2.0462110312219397,0.0,0.0020533179654649847,0.002,3/27,0.63%,SLC4A10;SLC4A4;SLC5A6
prerank,glutamate receptor activity (GO:0008066),-0.757281778095537,-1.9857945699597455,0.0,0.038698368465998466,0.037,11/19,10.73%,GRM7;GRM3;GRM5;GRIA4;GRID2;GRIK2;GRM1;GRIK1;GRM8;GRIA2;GRIA1
prerank,outward rectifier potassium channel activity (GO:0015271),-0.8191584785984765,-1.8780728636506479,0.002386634844868735,0.11137579217043461,0.186,6/11,10.58%,KCNK2;KCNT2;KCND2;KCND3;KCNQ1;KCNT1
prerank,sulfate transmembrane transporter activity (GO:0015116),0.8937226241249847,1.8367409970068538,0.0,0.264878017544983,0.341,3/14,3.83%,SLC26A7;SLC26A2;SLC26A6
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.8515086934743168,1.82349554312565,0.006299212598425197,0.22586497620114832,0.403,3/15,3.83%,SLC26A7;SLC26A2;SLC26A6
prerank,gap junction channel activity (GO:0005243),-0.658933108631182,-1.8151633401110723,0.0026595744680851063,0.17524383118342396,0.366,5/22,4.99%,GJB6;GJB2;GJC1;GJD3;GJA1
prerank,cell adhesion mediator activity (GO:0098631),-0.6546888809415239,-1.8115168703313838,0.0030303030303030303,0.13780394624477504,0.381,14/24,13.34%,BSG;LRRC4C;ESAM;CNTN4;CD47;SIRPA;JAM3;ROBO4;PALLD;CNTN2;NINJ1;DSCAML1;BCAM;NEXN
prerank,anion:anion antiporter activity (GO:0015301),0.8538365734894598,1.809168733012487,0.0,0.22073168128748585,0.49,4/17,6.07%,SLC26A7;SLC26A2;SLC26A6;SLC4A2
prerank,metalloendopeptidase activity (GO:0004222),0.6572770502600453,1.8046571652529522,0.0,0.19075323899169708,0.521,13/76,6.51%,ADAMTSL3;ADAMTS17;ADAMTSL1;THSD4;TRABD2B;ADAMTS2;MMP28;ADAM9;ADAMTSL5;PHEX;MMP16;ADAMTS5;IDE
prerank,symporter activity (GO:0015293),0.9033870907489853,1.8023459345513453,0.001718213058419244,0.16529209621993127,0.537,2/10,0.63%,SLC4A4;SLC5A6
prerank,wide pore channel activity (GO:0022829),-0.6500616084708608,-1.7953709574778716,0.0027247956403269754,0.1310081351970875,0.437,5/23,4.99%,GJB6;GJB2;GJC1;GJD3;GJA1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7237804480599108,-1.7942672815973462,0.007444168734491315,0.11121848172951594,0.443,4/14,4.97%,SLC7A11;SLC1A3;SLC1A1;SLC1A2
prerank,chloride transmembrane transporter activity (GO:0015108),0.8452566340946971,1.7927434911121805,0.0016366612111292963,0.1660254240647402,0.595,3/16,3.83%,SLC26A7;SLC26A2;SLC26A6
prerank,organic anion transmembrane transporter activity (GO:0008514),0.614852545377498,1.7925472426492588,0.0,0.14565724317517234,0.596,15/134,3.83%,SLC26A7;SLC38A2;SLC26A2;SLC23A1;SLC23A2;SLC38A1;SLCO3A1;SLC5A6;SLCO2A1;SLCO4A1;SLC16A1;SLC6A7;ABCG2;SLC38A6;SLC26A6
prerank,carbohydrate:cation symporter activity (GO:0005402),0.8926407459057821,1.7916236118520752,0.0017793594306049821,0.13175456945066985,0.602,2/11,0.16%,SLC23A1;SLC23A2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.7628126287205109,1.7765481351107597,0.005856515373352855,0.15584683357879234,0.704,8/27,8.86%,SLC9A2;SLC23A1;SLC9B2;CNNM4;SLC9A8;SLC9C1;SLC4A8;SLC9A1
prerank,cAMP binding (GO:0030552),-0.7496373035220278,-1.7498147008842722,0.009433962264150943,0.164097262798328,0.635,7/11,8.32%,RAPGEF4;PDE4B;RAPGEF2;HCN1;PDE4D;PDE2A;PDE4A
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.7174003694940906,1.7161049281292322,0.013215859030837005,0.33413083256202936,0.943,4/31,2.62%,KCNK5;SLC12A7;SLC12A2;SLC12A8
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.7259385802450038,1.7091945898635648,0.01023391812865497,0.334263053794654,0.957,3/29,3.83%,SLC26A7;SLC26A2;SLC26A6
prerank,metal ion:proton antiporter activity (GO:0051139),0.8278700805735747,1.6997949419396463,0.013223140495867768,0.34432562805489747,0.966,5/13,8.86%,SLC9A2;SLC9B2;SLC9A8;SLC9C1;SLC9A1
prerank,cation:chloride symporter activity (GO:0015377),0.849526453519301,1.6936259982029676,0.005154639175257732,0.3418774412499199,0.969,3/10,2.62%,SLC12A7;SLC12A2;SLC12A8
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.491330553733907,-1.6776776804684088,0.00411522633744856,0.28764214121983006,0.864,29/57,27.98%,COX4I1;UQCRH;UQCR10;COX5B;NDUFB9;CYB5A;COX6B1;NDUFA8;NDUFC1;COX8A;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFA4L2;NDUFS4;COX6A1;UQCR11;COX4I2;NDUFA13;COX10;NDUFB7;UQCRC1;NDUFA2;NDUFA6;NDUFA10;NDUFS6;NDUFV3
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6662311136695724,-1.6761272078126201,0.015113350125944584,0.2588281121248895,0.866,8/15,17.02%,ALDH1A2;ALDH1A1;ALDH7A1;ALDH1L1;ALDH4A1;ALDH9A1;ALDH1A3;ALDH3B1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.8304148190778872,1.6728874410215377,0.020100502512562814,0.4006023350622185,0.991,5/12,8.86%,SLC9A2;SLC9B2;SLC9A8;SLC9C1;SLC9A1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.7239220038173378,1.6662508453382345,0.01762114537444934,0.404503639196602,0.992,9/27,8.09%,SLC23A1;SLC9B2;SLC12A2;CNNM2;CNNM4;ATP2B4;ITPR2;CLDN16;SLC4A8
prerank,sodium:proton antiporter activity (GO:0015385),0.8351800496465857,1.6659715136468294,0.01867572156196944,0.3817359664618873,0.992,5/11,8.86%,SLC9A2;SLC9B2;SLC9A8;SLC9C1;SLC9A1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6986999111139225,-1.6578345711813913,0.014457831325301205,0.277306845251472,0.908,7/13,13.36%,ALDH1A2;ALDH1A1;ALDH7A1;ALDH1L1;ALDH4A1;ALDH9A1;ALDH1A3
prerank,retinoid binding (GO:0005501),-0.6171837966687006,-1.6493003313982526,0.0110803324099723,0.2732053330282464,0.926,6/22,2.25%,ALDH1A2;PTGDS;NR2F2;CYP26B1;ABCA4;RBP4
prerank,ligand-gated channel activity (GO:0022834),-0.5493758523979398,-1.6482210939447939,0.012269938650306749,0.25303384421771763,0.929,11/29,10.73%,GRIA4;GRID2;GRIK2;GRIN2A;GRIN2B;GABRB1;GRIK1;GRIA3;GRIN1;GRIA2;GRIA1
prerank,adenylate cyclase binding (GO:0008179),-0.7447421111594936,-1.6432281943855869,0.029850746268656716,0.2447508444631911,0.935,6/10,13.41%,ADCY5;CAP2;CALM1;AKAP6;ADCY2;CALM3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.7072163938537968,1.6428181052724558,0.013493253373313344,0.45583658833322654,0.995,4/27,4.23%,SLC26A7;SLC26A2;SLC26A6;SLC39A14
prerank,metallopeptidase activity (GO:0008237),0.5763537249238341,1.6356333464196795,0.004624277456647399,0.4639958255117848,0.998,16/113,6.54%,ADAMTSL3;ADAMTS17;ADAMTSL1;THSD4;TRABD2B;ADAMTS2;MMP28;BMP1;ADAM9;ADAMTSL5;PHEX;ADAM12;MMP16;ADAMTS5;IDE;MYSM1
prerank,ligand-gated ion channel activity (GO:0015276),-0.5452708219527989,-1.6352955029232845,0.012539184952978056,0.24412333138568024,0.947,11/30,10.73%,GRIA4;GRID2;GRIK2;GRIN2A;GRIN2B;GABRB1;GRIK1;GRIA3;GRIN1;GRIA2;GRIA1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.7799358153015875,1.6337583163619036,0.024958402662229616,0.44880397430150903,0.998,3/13,3.11%,BMP4;BMP5;BMP6
prerank,MAP kinase kinase kinase activity (GO:0004709),0.8162346950043146,1.6329843602003296,0.02910958904109589,0.4311967727476468,0.998,2/11,0.87%,EGFR;MAP3K5
prerank,nucleotidase activity (GO:0008252),0.7846970156639118,1.6291157669623912,0.022913256955810146,0.4269034715471291,0.998,4/15,6.35%,NT5E;NT5C1A;ACP3;NT5DC3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6164892448429813,1.6235784951093704,0.02056555269922879,0.42967910294708567,0.998,7/55,3.56%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC38A6
prerank,solute:anion antiporter activity (GO:0140323),0.781999813334084,1.6199394970441297,0.027868852459016394,0.4239246049532916,1.0,4/14,6.07%,SLC26A7;SLC26A2;SLC26A6;SLC4A2
prerank,5'-nucleotidase activity (GO:0008253),0.796381124998466,1.6193518188621687,0.03156146179401993,0.40897987236131567,1.0,4/13,6.35%,NT5E;NT5C1A;ACP3;NT5DC3
prerank,chemoattractant activity (GO:0042056),0.6821875257437985,1.6170144284462151,0.03177004538577912,0.401660583552112,1.0,7/26,10.91%,BMP4;PGF;FGF2;DEFB130A;GDNF;VEGFA;CCL3
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.619690153324685,1.6166194281300157,0.015789473684210527,0.38788697343904277,1.0,5/53,3.56%,SLC47A1;SLC38A2;SLC38A1;SLC6A7;SLC38A6
prerank,BMP receptor binding (GO:0070700),0.7799377579227067,1.6124234964621524,0.02905982905982906,0.38815042825736296,1.0,3/12,3.11%,BMP4;BMP5;BMP6
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.6356814388773923,1.6059492089128173,0.016861219195849545,0.3960071510636434,1.0,9/48,7.48%,PIEZO2;SLC12A7;SLC12A2;TRPM6;NALCN;TRPM4;CALHM5;TRPM7;CALHM2
prerank,anion channel activity (GO:0005253),0.5991532532138069,1.5885743610960539,0.02216427640156454,0.4446802273875335,1.0,7/61,4.00%,SLC26A7;CLIC4;LRRC8D;ANO6;GLRB;ANO9;GABRA3
prerank,gated channel activity (GO:0022836),0.7650447982257034,1.5884844089326287,0.04201680672268908,0.43070000227213107,1.0,3/14,5.07%,PIEZO2;TMC6;TMC1
prerank,endopeptidase activity (GO:0004175),0.5172044090180685,1.5806945567872597,0.0010438413361169101,0.44463958880280036,1.0,48/257,14.28%,ADAMTSL3;F3;ADAMTS17;ADAMTSL1;THSD4;TRABD2B;HTRA3;PCSK5;ADAMTS2;MMP28;ADAM9;USP46;USP2;USP13;ADAMTSL5;USP24;DDI2;PRSS12;CASP6;PHEX;HTRA4;MMP16;TASP1;ADAMTS5;IDE;PSMB2;PGC;ASPRV1;NLN;USP34;USP49;BACE2;MMP14;USP15;USP25;USP1;USP10;USP7;USP47;ADAMTS3;USP33;PMPCB;CLPP;OMA1;PREP;PITRM1;ECE1;PCSK7
prerank,mechanosensitive ion channel activity (GO:0008381),0.7696817273565709,1.5755979107810298,0.043478260869565216,0.449645523558567,1.0,3/12,5.07%,PIEZO2;TMC6;TMC1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.6322035688197786,-1.5744533603306128,0.0199501246882793,0.3747763944446942,0.991,10/15,21.55%,COX4I1;COX5B;CYB5A;COX6B1;COX8A;NDUFA4;NDUFA4L2;COX6A1;COX4I2;COX10
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5559136530053269,-1.5716708859566133,0.02830188679245283,0.35843183963324193,0.991,15/29,15.60%,GRIA4;GRID2;GABRG3;GRIK2;GABRA2;GABRB1;GRIK1;GABRB2;GABRB3;GABRA1;GRIA2;GLRA3;GABRG1;GABRA4;GABRA5
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.6243462547566325,-1.5681986031318669,0.04488778054862843,0.34711936822011824,0.992,4/15,4.97%,SLC1A3;SLC1A1;SLC1A5;SLC1A2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.6106871414709579,1.5654158679523404,0.0228494623655914,0.4721121527947799,1.0,3/47,0.29%,SLC47A1;SLC38A2;SLC38A1
prerank,potassium ion antiporter activity (GO:0022821),0.7403462069364228,1.5545883437815042,0.04669887278582931,0.4983402702183517,1.0,5/15,8.86%,SLC9A2;SLC24A3;SLC9A8;SLC9C1;SLC9A1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6432154001598652,-1.5499989854558225,0.03768844221105527,0.3789608521731314,0.996,8/12,12.34%,PDE8B;PDE4B;PDE7B;PDE4D;PDE2A;PDE4A;PDE8A;PDE4C
prerank,R-SMAD binding (GO:0070412),0.6982434465891374,1.5480670816995001,0.04953560371517028,0.5089091540794812,1.0,9/18,13.40%,DDX5;SMAD6;PMEPA1;LDLRAD4;JUN;SMAD2;PPM1A;SMURF1;PAX6
prerank,potassium:proton antiporter activity (GO:0015386),0.7913498894881544,1.5479087924802977,0.04529616724738676,0.4955988132590553,1.0,4/10,8.86%,SLC9A2;SLC9A8;SLC9C1;SLC9A1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7123651265375259,1.5430422175827594,0.036753445635528334,0.5000369592740255,1.0,6/18,6.45%,BAIAP2L1;STXBP6;ANXA1;ANXA2;TMOD3;PDLIM5
prerank,secondary active transmembrane transporter activity (GO:0015291),0.598141685013144,1.5429292101540493,0.027925531914893616,0.4877419905658364,1.0,5/51,1.49%,SLC4A4;SLCO3A1;SLC5A6;SLCO2A1;SLCO4A1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6263715879227366,1.5392438785763884,0.0450070323488045,0.4891773387974643,1.0,6/32,7.03%,SLC38A2;SLC38A1;SLC6A7;SLC38A6;SFXN3;SLC6A19
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6702758867618784,-1.5386700987681416,0.045563549160671464,0.38738110051072666,0.998,3/10,2.89%,SLC6A13;SLC6A12;SLC6A1
prerank,chloride channel activity (GO:0005254),0.5819069560599636,1.5363036276784745,0.030026109660574413,0.487988542816849,1.0,7/59,5.97%,SLC26A7;CLIC4;ANO6;GLRB;ANO9;GABRA3;CLIC1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.6553231973981594,-1.5351593462856497,0.04018912529550828,0.3791496247022338,0.998,2/11,4.69%,ITPR1;RYR2
prerank,leucine zipper domain binding (GO:0043522),0.7810119197487644,1.5316455468475654,0.06506849315068493,0.49245409205068547,1.0,5/10,12.04%,PAWR;ERC1;MRTFA;DDIT3;AATF
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.755223807624371,1.5302439051623555,0.04310344827586207,0.4857768293645416,1.0,3/12,10.95%,AOX1;FDX1;CISD2
prerank,I-SMAD binding (GO:0070411),0.7372916582152008,1.528195932381232,0.07094594594594594,0.48236638977338214,1.0,6/13,13.35%,SMAD9;SMAD6;TGFBR1;TGFB1I1;SMAD2;SMURF1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5841370033206713,-1.5258769314556464,0.03768115942028986,0.38563530945211016,0.998,7/18,17.02%,ALDH1A2;ALDH1A1;FAR2;ALDH9A1;HSD17B12;ALDH1A3;ALDH3B1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.6803008990414742,-1.5222209384188807,0.05783132530120482,0.3779740866800959,0.998,4/10,6.79%,PRKAR2B;PRKAG2;PRKAR1B;PRKAR1A
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.734676479153208,1.5210495816153558,0.0594679186228482,0.4964922840494333,1.0,5/14,11.55%,CAPN5;CAPN2;CAPN6;CAPN10;CAPN12
prerank,insulin-like growth factor I binding (GO:0031994),-0.6292481907038147,-1.513281954080395,0.043478260869565216,0.3853832219132467,0.998,6/13,3.90%,IGF1R;IGFBP2;ITGA6;IGFBP3;IGFBP4;INSR
prerank,calcium activated cation channel activity (GO:0005227),0.7021523183985855,1.507337158818598,0.0636215334420881,0.5345322312270259,1.0,4/17,4.96%,KCNMB3;KCNMB2;ANO6;TRPM4
prerank,retinoic acid binding (GO:0001972),-0.64215489951331,-1.5044262089385405,0.05069124423963134,0.39319744707627313,0.998,2/12,1.99%,NR2F2;CYP26B1
prerank,histone deacetylase activity (GO:0004407),0.664121709855382,1.496730712305676,0.07462686567164178,0.5628712482351247,1.0,6/19,17.32%,HDAC4;HDAC9;HDAC8;MIER1;HDAC10;SIRT6
prerank,delayed rectifier potassium channel activity (GO:0005251),0.6129920377283133,1.4929468525781309,0.052039381153305204,0.5654110460111132,1.0,4/32,3.00%,KCNB2;KCNQ5;KCNS3;KCNB1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.647121051835577,-1.4878438276843635,0.050119331742243436,0.42013214077037175,0.998,6/11,13.73%,ITPR1;TRPC3;TRPC4;TRPC6;RPH3A;TRPC1
prerank,receptor antagonist activity (GO:0048019),0.6776048068497671,1.4858144141902383,0.0880503144654088,0.579789946330072,1.0,6/17,10.13%,ADH7;ESR2;LRPAP1;IGSF1;DKK3;IL18BP
prerank,calcium-activated potassium channel activity (GO:0015269),0.7542229850308135,1.4852253136788485,0.07017543859649122,0.5704938635247913,1.0,2/11,0.90%,KCNMB3;KCNMB2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.7146741954013104,1.4813676469434582,0.08600337268128162,0.5734796294133969,1.0,8/14,18.54%,USP13;MINDY3;USP15;DESI2;USP7;OTUD7B;OTUD5;USP9X
prerank,GABA-A receptor activity (GO:0004890),-0.5739346874280845,-1.4745675326887688,0.05670103092783505,0.4407475530447349,0.999,9/18,15.60%,GABRG3;GABRA2;GABRB1;GABRB2;GABRB3;GABRA1;GABRG1;GABRA4;GABRA5
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.637156962315651,-1.4679472610816908,0.08312342569269521,0.44256670711792295,0.999,6/11,31.96%,PPP1R1A;PPP1R14A;PABIR1;PPP1R2;PPP1R8;PPP1R11
prerank,phospholipase inhibitor activity (GO:0004859),0.7318689115551161,1.4679029991517527,0.08304498269896193,0.6136261766024205,1.0,3/10,2.53%,ANXA1;ANXA2;ANXA4
prerank,ATPase binding (GO:0051117),0.5452318314413628,1.4659106210972772,0.05157232704402516,0.610125999606138,1.0,12/71,7.43%,EGFR;SLC2A13;PTPN3;ANK2;ATP1B1;PPP3CA;EZR;ATP6V0A4;SNTA1;ESR1;TOR1AIP1;RDX
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.5819781691036631,-1.4624714434579653,0.05454545454545454,0.44085127421457143,1.0,9/16,27.92%,SLC44A1;SLC22A4;SLC22A2;SLC44A2;SLC22A3;SLC5A7;SLC29A4;SLC7A8;SLC25A42
prerank,Notch binding (GO:0005112),0.6284783218549354,1.460254023233932,0.06134969325153374,0.6191514154012286,1.0,8/22,13.96%,CCN3;SNED1;TCIM;JAG1;AAK1;GALNT11;NCOR2;CUL3
prerank,SUMO transferase activity (GO:0019789),0.6807852343354479,1.4590065453785572,0.0946372239747634,0.6129527457452154,1.0,5/16,9.73%,HDAC4;PIAS2;PIAS3;EGR2;RANBP2
prerank,histone acetyltransferase activity (GO:0004402),0.6201166344812554,1.4589152467295794,0.076163610719323,0.6022088261570876,1.0,22/30,28.11%,KAT6B;NAA40;CREBBP;TADA3;SRCAP;BRCA2;KAT2A;BAZ1A;EP300;ATF2;EPC1;KAT2B;USP22;KAT5;NAA50;HAT1;TAF1;KAT14;KAT6A;NAA60;TAF9;TADA2A
prerank,hexose transmembrane transporter activity (GO:0015149),-0.6055127765419595,-1.4579576236388907,0.07788944723618091,0.4377569855909835,1.0,9/12,35.60%,SLC2A1;SLC5A3;MFSD4A;SLC2A4;SLC2A8;PPBP;SLC2A5;SLC2A3;SLC2A6
prerank,cation transmembrane transporter activity (GO:0008324),0.5642958196908231,1.4493665389857027,0.07549668874172186,0.627450742499458,1.0,6/48,6.91%,SLC38A2;SLC38A1;SLC6A7;SLC38A6;SFXN3;SLC7A2
prerank,mRNA methyltransferase activity (GO:0008174),0.7044073502710253,1.4418683547646056,0.08585858585858586,0.6440338004782586,1.0,1/12,0.75%,RNMT
prerank,enoyl-CoA hydratase activity (GO:0004300),0.7070756009221644,1.4316403227846495,0.11347517730496454,0.6722876236927091,1.0,3/10,5.69%,EHHADH;AUH;ECHDC1
prerank,MHC class I protein binding (GO:0042288),-0.6120043713716559,-1.4308161479948578,0.08418367346938775,0.49911456694682904,1.0,6/13,22.00%,ATP5F1B;TAP2;ATP5F1A;ABCB9;TUBB4B;TAPBP
prerank,insulin-like growth factor binding (GO:0005520),-0.5722165466687079,-1.4283120083473764,0.07253886010362694,0.49062589257364225,1.0,6/15,3.90%,IGF1R;IGFBP2;ITGA6;IGFBP3;IGFBP4;INSR
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6909090714957339,1.4272167067927755,0.11073825503355705,0.6778858153152191,1.0,5/12,9.28%,DDI2;SPPL2A;PGC;ASPRV1;BACE2
prerank,GABA receptor binding (GO:0050811),-0.5988509459894565,-1.4268023550260573,0.09523809523809523,0.47942323250483165,1.0,6/11,25.35%,PLCL2;JAKMIP1;GABARAPL1;GABARAP;TRAK2;GABARAPL2
prerank,sequence-specific DNA binding (GO:0043565),0.4550697743437645,1.4252705847988272,0.0,0.6736397669486559,1.0,92/590,10.53%,FOXP2;FOXP1;KLF12;VSX1;NR3C2;TBX15;TCF7L1;KLF5;TFCP2L1;SIX1;TCF7L2;SLTM;PRRX2;RARB;NFIB;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;PBX1;KLF3;CUX1;NFAT5;GLI3;FOXO3;MEOX2;HES1;GRHL1;HOXB6;KLF4;NFE2L2;ZNF148;ZIC1;ELF1;ZNF423;ABL1;NR2F1;FOXC2;MEF2A;JDP2;HOXA6;GLIS1;FOXL1;NR4A2;SMG6;TELO2;FOXK1;KLF10;ZBTB7B;NFATC4;BHLHE40;GLIS2;ISL1;ESR1;KDM1A;MBD1;GATA4;HOXB5;E2F3;HOXC4;DMRT3;MYOG;DMBX1;NOBOX;PITX3;BARHL2;PHOX2A;SOX14;SP8;MBNL2;NFIX;SIX4;TEAD1;PITX2;STN1;RXRA;GRHL2;FOXC1;RORA;GLI2;EGR2;GATA1;CTCFL;RARG;HOXB4;ATF7;RARA;JUN;LBX1;ELF3;FOXE1
prerank,double-stranded DNA binding (GO:0003690),0.4554726185961207,1.4249706211549247,0.0,0.66385094544751,1.0,120/531,17.24%,EGFR;FOXP1;KLF12;VSX1;NR3C2;TBX15;TCF7L1;KLF5;TFCP2L1;SIX1;PRRX2;RARB;NFIB;SOX9;ZIC4;HOXA5;PBX1;KLF3;CUX1;NFAT5;GLI3;FOXO3;MEOX2;HES1;GRHL1;HOXB6;KLF4;ZIC1;ELF1;ABL1;NR2F1;FOXC2;JDP2;HOXA6;GLIS1;NR4A2;FOXK1;HDGFL3;KLF10;ZBTB7B;NFATC4;BHLHE40;GLIS2;ISL1;ESR1;MBD1;GATA4;HOXB5;E2F3;HOXC4;DMRT3;MYOG;DMBX1;PITX3;BARHL2;PHOX2A;SOX14;SP8;MBNL2;NFIX;SIX4;TEAD1;PITX2;ERCC5;CAMTA2;RXRA;GLI2;EGR2;GATA1;RARG;HOXB4;ATF7;RARA;TOP1;JUN;LBX1;APEX1;ELF3;FOXE1;ZBTB32;SMAD2;ATF6;DDX11;NFKB2;ATOH7;BCL11B;NR4A1;NR6A1;NFATC3;HNF4A;PRKDC;RFX2;XRCC5;PAX6;SP3;E2F2;NFATC1;POLG2;ETV3;DHX9;FOXD2;CREB3L1;ATF2;RFX7;HOXD3;KIN;TFAP2A;ZBTB7A;HSF2;BCL6;ZFP1;RBBP8;POU6F1;XPA;YY1;ZNF76;ZBTB37;POU3F4;HOXA2;SREBF1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4552420996770767,1.4235006658330578,0.0,0.6592291401345637,1.0,145/597,17.24%,BNC2;FOXP1;KLF12;VSX1;NR3C2;TBX15;TCF7L1;KLF5;TFCP2L1;SIX1;TCF7L2;PRRX2;RARB;NFIB;SOX9;ZIC4;HDAC4;HOXA5;PBX1;KLF3;CUX1;NFAT5;SMAD6;GLI3;FOXO3;MEOX2;HES1;GRHL1;HOXB6;KLF4;NFE2L2;ZIC1;ELF1;CRY2;ABL1;NR2F1;FOXC2;JDP2;HOXA6;GLIS1;NR4A2;FOXK1;ARID4A;KLF10;ZBTB7B;NFATC4;BHLHE40;ARID4B;GLIS2;ISL1;ESR1;STAT3;GATA4;DDIT3;HOXB5;TBL1X;E2F3;HOXC4;DMRT3;MYOG;DMBX1;PITX3;BARHL2;PHOX2A;SOX14;SP8;MBNL2;IRF1;NFIX;SIX4;TEAD1;GABPB1;GABPB2;PITX2;MCM7;RXRA;FOXC1;NFYA;GLI2;PER3;EGR2;NFKB1;GATA1;CTCFL;MCM2;RARG;HOXB4;ATF7;RARA;JUN;LBX1;ELF3;FOXE1;NCOR1;ZBTB32;PER1;ATF6;DDX11;ZBED4;NFKB2;FOXK2;ATOH7;NKX2-1;BCL11B;NR4A1;CDC45;NR6A1;KMT2D;NFATC3;HNF4A;HNF1A;RFX2;XRCC5;PAX6;CHD3;MLH3;SP3;E2F2;NFATC1;REST;ETV3;DHX9;FOXD2;CREB3L1;ATF2;RFX7;MCM9;HOXD3;HINFP;TFAP2A;ZBTB7A;HSF2;BCL6;ZFP1;CALCOCO1;POU6F1;XPA;PRDM5;YY1;ZNF76;ZBTB37;CREB3L3;POU3F4;HOXA2;SREBF1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.5460461083728307,-1.419177791987354,0.08951406649616368,0.48554582637013305,1.0,4/17,11.33%,SLC2A1;SLC5A3;SLC5A11;MFSD4A
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.6984209301519693,1.4187821884244547,0.12060301507537688,0.6671037571236472,1.0,6/11,22.08%,UBE4B;UBR5;UBE4A;UBE2K;PPIL2;ANAPC11
prerank,cholesterol transfer activity (GO:0120020),-0.5572342478345182,-1.4137352393622458,0.07532467532467532,0.486422390431295,1.0,5/16,9.41%,PLTP;GRAMD1B;ABCA1;ABCG1;NPC2
prerank,cation channel activity (GO:0005261),0.5105566327195571,1.4137294380587109,0.05338078291814947,0.6759838637382339,1.0,12/94,5.98%,PIEZO2;KCNK5;SLC24A3;PKD1;ANXA2;ANO6;TRPM6;NALCN;TRPM4;PKD2L2;CALHM5;TRPM7
prerank,phosphatase binding (GO:0019902),0.5006661809032499,1.411907423471811,0.054696789536266346,0.6719794150766808,1.0,25/105,11.40%,EGFR;MET;MAP3K5;WNK1;PPP1R3C;CRY2;SHOC2;ANAPC5;SFI1;VCP;AP3B1;STAT3;DLG1;FCRL6;VRK3;JUP;IKBKE;STYXL1;CNST;CDKN1B;IQGAP1;PPP6R3;SMAD2;ERBB2;MAST2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.7181420222906129,1.4109325761742855,0.11724137931034483,0.6652903440790541,1.0,5/10,19.12%,DSE;GLCE;RENBP;GALE;GNE
prerank,manganese ion binding (GO:0030145),0.5583003505924433,1.410795111380067,0.06891891891891892,0.6560350899660625,1.0,11/48,13.91%,ME1;MPPED2;LARGE1;ABL1;XPNPEP1;B4GALT1;XPNPEP3;WRN;DYRK2;LARGE2;MGAT1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6141922189413378,-1.4094065172778008,0.09466019417475728,0.4851184322890917,1.0,9/12,15.60%,GABRG3;GABRA2;GABRB1;GABRB2;GABRB3;GABRA1;GABRG1;GABRA4;GABRA5
prerank,mannose binding (GO:0005537),0.6914459928866581,1.4021361051918666,0.1281198003327787,0.6774907747936025,1.0,2/12,5.88%,COLEC11;LMAN2L
prerank,thiol-dependent deubiquitinase (GO:0004843),0.511615109796133,1.399522022222496,0.06715506715506715,0.677110932225871,1.0,37/83,20.82%,TANK;USP46;USP2;USP13;OTUD1;MINDY3;USP24;MYSM1;USP34;USP49;USP15;USP25;USP1;USP10;USP32;DESI2;USP7;OTUD7B;USP47;COPS5;USP4;USP33;ZC3H12A;ZRANB1;JOSD1;BAP1;OTUD3;OTUD5;VCPIP1;USP28;USP22;USP9X;UFD1;USP40;PSMD14;USP21;USP36
prerank,cytokine activity (GO:0005125),0.4781320189673624,1.3979552040191405,0.040955631399317405,0.672938813216968,1.0,25/131,11.38%,BMP4;TNFRSF11B;WNT9A;BMP5;TGFB3;WNT11;BMP6;INHBA;FGF2;FAM3C;CLCF1;WNT16;SLURP1;GDF6;IL10;GDF5;CXCL2;GDF10;CTF1;IL33;VEGFA;CCL3;TIMP1;CCL1;INHBB
prerank,sterol transfer activity (GO:0120015),-0.5433339201975166,-1.397344352473804,0.08222811671087533,0.5064085277240925,1.0,5/17,9.41%,PLTP;GRAMD1B;ABCA1;ABCG1;NPC2
prerank,GTPase regulator activity (GO:0030695),-0.3421811994488948,-1.393870156952635,0.013888888888888888,0.502594103834609,1.0,57/212,11.05%,RANBP3L;PLCB1;ASAP1;PREX2;ARHGAP28;ARHGAP29;TBC1D4;CHN2;ERRFI1;ARHGAP24;RASGRP3;ARHGAP32;ALDH1A1;RGS3;RAPGEF2;CPEB2;RGS5;RGS7;RIMS1;RALGAPA2;USP6NL;ARHGAP26;RABGAP1L;ARAP3;RGS12;RALGAPA1;CHN1;IQGAP2;TNK2;SIRPA;TBC1D12;ARHGAP25;CCDC88A;OPHN1;VAV3;TBC1D8;ADGRB3;TBC1D9;RHOH;ARL2BP;ARHGAP39;GMIP;ARHGAP15;ACAP2;ABR;HACD3;GARNL3;TBC1D1;SYDE2;TBC1D16;TBC1D30;SMAP2;RGS16;SIPA1;ELMOD1;RP2;RGS20
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4447007764525832,1.3925085927063572,0.001002004008016032,0.6840115472455229,1.0,130/732,11.53%,FOXP2;ZBTB7C;FOXP1;KLF12;NR3C2;PBX3;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;TCF7L2;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;FOXN3;PBX1;KLF3;FOXP4;NFIA;NFAT5;GLI3;FOXO3;MEOX2;HOXA3;ZBTB16;HES1;GRHL1;SKIL;HOXB6;ESR2;KLF4;NFE2L2;ZNF148;ZIC1;ELF1;PRRX1;ZNF423;NR2F1;FOXC2;MEF2A;KLF7;JDP2;HOXA6;GLIS1;EHF;NR4A3;FOXL1;NR4A2;FOXK1;KLF10;ZBTB7B;HOXC6;FOXO6;NFATC4;BHLHE40;KLF9;GLIS2;ISL1;SKI;ESR1;STAT3;ATF1;HOXB3;E2F5;GATA4;DDIT3;HOXB5;NFIL3;HIF3A;E2F3;HOXC4;DMRT3;MYOG;NOBOX;PITX3;SOX14;SP8;IRF1;NFIX;REL;SIX4;TEAD1;PITX2;MLXIP;HIVEP3;RXRA;ZNF8;GRHL2;ATOH8;FOXC1;NFYA;RORA;GLI2;EGR2;NFKB1;GATA1;CTCFL;RARG;HOXB4;ATF7;RARA;RBMX;TOP1;JUN;NFE2L1;NRF1;CARF;FOXE1;PRDM15;ZBTB32;MYNN;PER1;SMAD2;ATF6;MXD1;GTF2IRD1;NFKB2;BPTF;FOXK2
prerank,transcription corepressor binding (GO:0001222),0.5916939800518306,1.3915151894497058,0.10309278350515463,0.6783121835091895,1.0,13/27,18.96%,ZBTB16;ESR1;LCOR;EHMT1;RORA;PER3;PER1;EED;SUZ12;ZBTB7A;EHMT2;PER2;NEK6
prerank,cyclic nucleotide binding (GO:0030551),-0.5163533090867379,-1.3897066523164032,0.08708708708708708,0.5008930028788994,1.0,7/21,8.32%,RAPGEF4;PDE4B;RAPGEF2;HCN1;PDE4D;PDE2A;PDE4A
prerank,calcium channel regulator activity (GO:0005246),-0.45204159823869805,-1.388609590146893,0.06688963210702341,0.491195801367045,1.0,9/37,9.55%,ITPR1;PRKG1;NRXN1;CALM1;SGK1;REM1;CACNG4;CACNG7;SLC30A1
prerank,cholesterol binding (GO:0015485),-0.4316174983161996,-1.3883114335853264,0.058823529411764705,0.4799069621106567,1.0,14/47,10.47%,OSBPL8;APOD;SIDT1;PROM1;OSBPL10;PTCH1;GRAMD1B;NR1H3;ABCA1;ABCG1;CD81;NPC2;OSBPL1A;SYP
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.5951824800003462,-1.3880073674315558,0.11722488038277512,0.4691227558596769,1.0,4/11,10.72%,KCNJ3;KCND3;KCNQ1;KCNJ8
prerank,mRNA 5'-UTR binding (GO:0048027),-0.48528021294099283,-1.385257918423503,0.08333333333333333,0.46411074655040674,1.0,11/24,24.45%,RPS14;RPS13;RPL41;RPS7;RPL26;MYH10;MRPS11;DDX3X;RPL5;IGF2BP1;SHMT2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.5501899559802641,-1.3823966860585677,0.11195928753180662,0.46005621365789107,1.0,6/14,5.98%,COL4A3;TIMP3;SPOCK2;SPOCK3;SPOCK1;BST2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.44089559363332925,1.3816185505478764,0.001002004008016032,0.7046904014855606,1.0,181/731,17.24%,FOXP2;ZBTB7C;FOXP1;KLF12;NR3C2;PBX3;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;TCF7L2;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;PBX1;KLF3;FOXP4;NFIA;NFAT5;GLI3;FOXO3;MEOX2;HOXA3;ZBTB16;HES1;GRHL1;SKIL;HOXB6;ESR2;KLF4;NFE2L2;ZNF148;ZIC1;ELF1;PRRX1;ZNF423;NR2F1;FOXC2;MEF2A;KLF7;JDP2;HOXA6;GLIS1;EHF;NR4A3;FOXL1;NR4A2;FOXK1;KLF10;ZBTB7B;HOXC6;FOXO6;NFATC4;BHLHE40;KLF9;GLIS2;SKI;ESR1;STAT3;ATF1;HOXB3;E2F5;GATA4;DDIT3;HOXB5;NFIL3;HIF3A;E2F3;HOXC4;DMRT3;MYOG;NOBOX;PITX3;SOX14;SP8;IRF1;NFIX;REL;SIX4;TEAD1;PITX2;MLXIP;HIVEP3;RXRA;ZNF8;GRHL2;ATOH8;FOXC1;NFYA;RORA;GLI2;EGR2;NFKB1;GATA1;CTCFL;RARG;HOXB4;ATF7;RARA;RBMX;TOP1;JUN;NFE2L1;NRF1;CARF;FOXE1;PRDM15;ZBTB32;MYNN;PER1;SMAD2;ATF6;MXD1;GTF2IRD1;NFKB2;BPTF;FOXK2;MTA1;ATOH7;NKX2-1;BCL11B;NR4A1;NR6A1;NFATC3;MXD4;TCF3;HNF4A;HNF1A;RFX2;PAX6;CC2D1B;SP3;E2F2;EBF4;NFATC1;REST;ZNF691;DHX9;FOXD2;DNMT3A;STAT5A;CREB3L1;ATF2;RFX7;ZBTB1;HOXD3;TWIST1;ZNF585B;ZNF585A;HINFP;TFAP2A;THRAP3;ZNF219;ZBTB7A;HSF2;BCL6;ZFP1;CALCOCO1;POU6F1;PRDM5;NSD1;YY1;ZNF76;ZBTB37;ZKSCAN1;POU6F2;CREB3L3;POU3F4;HOXA2;SREBF1
prerank,androgen receptor binding (GO:0050681),0.6079720203640329,1.3769725783414783,0.11678832116788321,0.7127887985315148,1.0,11/25,20.23%,FOXP1;DDX5;KDM1A;TGFB1I1;SMARCA4;EP300;ZBTB7A;NSD1;RNF14;SNW1;TMF1
prerank,aspartic-type peptidase activity (GO:0070001),0.6939217507737977,1.3769658648342669,0.1357142857142857,0.7034370158924879,1.0,4/10,9.28%,DDI2;PGC;ASPRV1;BACE2
prerank,monocarboxylic acid binding (GO:0033293),-0.544099354893467,-1.376185372820106,0.10209424083769633,0.4657533127127266,1.0,5/18,15.34%,NR2F2;CYP26B1;NAPEPLD;NR1H4;PSAP
prerank,microtubule plus-end binding (GO:0051010),0.6121933690393824,1.3746698929776333,0.1332312404287902,0.7024614091592384,1.0,5/20,9.48%,CLIP4;MAPRE2;CLIP1;PAFAH1B1;FBXW11
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6797567615423249,1.3705299811161542,0.15437392795883362,0.7091975980590951,1.0,3/10,1.49%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,serine-type peptidase activity (GO:0008236),0.4896529322956251,1.368822287371529,0.07515151515151515,0.7060164880368115,1.0,5/96,4.72%,F3;HTRA3;PCSK5;HTRA1;PRSS12
prerank,potassium channel activity (GO:0005267),0.49050100135759006,1.366674679049056,0.08732057416267942,0.7049297240186976,1.0,7/89,3.00%,KCNB2;KCNK5;KCNMB3;KCNMB2;KCNQ5;KCNS3;KCNB1
prerank,amino acid:sodium symporter activity (GO:0005283),0.6660661364957723,1.3665766162351018,0.14285714285714285,0.6966578311964038,1.0,2/11,0.29%,SLC38A2;SLC38A1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4607132926070736,1.365873926305194,0.030601092896174863,0.6906034491285554,1.0,46/188,13.50%,BNC2;VSX1;SIX1;TCF7L2;HDAC4;PBX1;SMAD6;FOXO3;GRHL1;KLF4;NFE2L2;CRY2;FOXC2;FOXK1;ARID4A;ARID4B;GLIS2;STAT3;GATA4;DDIT3;TBL1X;IRF1;GABPB1;GABPB2;PITX2;RXRA;FOXC1;NFYA;PER3;EGR2;NFKB1;GATA1;CTCFL;JUN;NCOR1;PER1;ATF6;ZBED4;FOXK2;NKX2-1;KMT2D;HNF4A;HNF1A;XRCC5;PAX6;CHD3
prerank,sterol binding (GO:0032934),-0.4056361486844249,-1.3616741383092534,0.059574468085106386,0.49177341303729005,1.0,15/56,10.47%,OSBPL8;APOD;SIDT1;PROM1;OSBPL10;PTCH1;GRAMD1B;NR1H3;ABCA1;INSIG2;ABCG1;CD81;NPC2;OSBPL1A;SYP
prerank,transforming growth factor beta binding (GO:0050431),0.6013614041001968,1.3609996344772244,0.14622641509433962,0.6995876957275217,1.0,9/23,6.98%,THBS1;CD109;TGFB3;TGFBR1;LTBP3;TGFBR2;TSKU;ITGAV;LTBP4
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5407717649629828,1.3607321383146216,0.12043301759133965,0.6921514863229021,1.0,7/46,6.14%,EXT1;MGAT4C;B3GNT2;LARGE1;HEXA;GCNT2;MGAT3
prerank,H4 histone acetyltransferase activity (GO:0010485),0.6979728603771413,1.3605823605798872,0.13097345132743363,0.6844916612992126,1.0,8/10,27.52%,NAA40;BRCA2;EP300;ATF2;USP22;NAA50;HAT1;NAA60
prerank,acetylation-dependent protein binding (GO:0140033),0.6094851117167677,1.3573650092256062,0.12345679012345678,0.680025868263708,1.0,7/20,17.73%,MLLT3;BRD3;ZMYND8;BRD9;SMARCA4;BAZ2A;CARM1
prerank,lysine-acetylated histone binding (GO:0070577),0.6094851117167677,1.3573650092256062,0.12345679012345678,0.680025868263708,1.0,7/20,17.73%,MLLT3;BRD3;ZMYND8;BRD9;SMARCA4;BAZ2A;CARM1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5872259262760278,-1.3572155850176726,0.11435523114355231,0.4929835635016327,1.0,3/11,5.71%,SASH1;ROR2;DAB2IP
prerank,deubiquitinase activity (GO:0101005),0.495387562100905,1.3568869056618893,0.08484848484848485,0.6738732897910397,1.0,37/88,20.82%,TANK;USP46;USP2;USP13;OTUD1;MINDY3;USP24;MYSM1;USP34;USP49;USP15;USP25;USP1;USP10;USP32;DESI2;USP7;OTUD7B;USP47;COPS5;USP4;USP33;ZC3H12A;ZRANB1;JOSD1;BAP1;OTUD3;OTUD5;VCPIP1;USP28;USP22;USP9X;UFD1;USP40;PSMD14;USP21;USP36
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5161608070887069,-1.3554799702095373,0.12137203166226913,0.47653265315295074,1.0,8/17,14.30%,EPHA7;EPHB1;EPHA4;EPHB4;EPHA8;EPHA6;EFNB3;EPHA5
prerank,ephrin receptor activity (GO:0005003),-0.5161608070887069,-1.3554799702095373,0.12137203166226913,0.47653265315295074,1.0,8/17,14.30%,EPHA7;EPHB1;EPHA4;EPHB4;EPHA8;EPHA6;EFNB3;EPHA5
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5730776617714055,-1.346596704709358,0.12903225806451613,0.49003807554753664,1.0,3/12,4.13%,CDK8;CDK19;CDK6
prerank,histone methyltransferase activity (GO:0042054),0.5613652859735353,1.3465008231060893,0.12769010043041606,0.7004928845666358,1.0,13/32,22.25%,SMYD2;KMT2C;SETD2;EHMT1;PRMT8;EED;PRMT6;SUZ12;KMT5A;CARM1;EHMT2;KMT5B;PRMT5
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.5254687654295338,-1.3429175551354007,0.116751269035533,0.4886754460874646,1.0,3/16,4.69%,SLC13A3;SLC1A1;SLC1A5
prerank,RNA polymerase core enzyme binding (GO:0043175),0.5703768404600701,1.3406084583879818,0.12393162393162394,0.7132770319144142,1.0,14/33,16.97%,ELOF1;SMYD2;SCAF8;ERCC5;WDR43;UVSSA;WAC;ERBB2;CTR9;DHX9;ELP4;URI1;AGO2;RECQL5
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6286216262066053,1.3325976344947754,0.16803953871499178,0.7331247694057452,1.0,1/14,0.28%,KCNJ2
prerank,lipid phosphatase activity (GO:0042577),0.6331149165991868,1.3307085422125637,0.18074324324324326,0.7314833658601319,1.0,2/14,2.22%,PLPPR2;PLPP3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.4385734476241443,-1.329986284986558,0.1040268456375839,0.5015540888613835,1.0,16/34,27.98%,NDUFB9;NDUFA8;NDUFC1;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFS4;NDUFA13;NDUFB7;NDUFA2;NDUFA6;NDUFA10;NDUFS6;NDUFV3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.4385734476241443,-1.329986284986558,0.1040268456375839,0.5015540888613835,1.0,16/34,27.98%,NDUFB9;NDUFA8;NDUFC1;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFS4;NDUFA13;NDUFB7;NDUFA2;NDUFA6;NDUFA10;NDUFS6;NDUFV3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.43740370809675544,1.3280896029040794,0.04397905759162304,0.7326591759783876,1.0,67/254,15.72%,KLF5;TFCP2L1;SIX1;PLAGL1;NFIB;SOX9;HOXA5;NFIA;NFAT5;FOXO3;MEOX2;ZBTB16;GRHL1;KLF4;ELF1;PRRX1;FOXC2;MEF2A;KLF7;EHF;NR4A3;NR4A2;KLF10;GLIS2;ESR1;STAT3;ATF1;HOXB3;GATA4;DDIT3;E2F3;PLSCR1;HOXC4;MYOG;IRF1;REL;MLXIP;MDM4;GRHL2;FOXC1;EGR2;NFKB1;GATA1;CTCFL;JUN;NRF1;ELF3;PRDM15;SMAD2;ATF6;NFKB2;FOXK2;NR4A1;NFATC3;TCF3;HNF4A;HNF1A;E2F2;NFATC1;FOXD2;CREB3L1;ATF2;HOXD3;ZNF585B;ZNF585A;HINFP;TFAP2A
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.4227093111429182,1.326421739969421,0.001001001001001001,0.7306972261996723,1.0,137/831,11.53%,FOXP2;ZBTB7C;FOXP1;KLF12;NR3C2;PBX3;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;TCF7L2;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;PBX1;KLF3;FOXP4;CUX1;NFIA;NFAT5;GLI3;FOXO3;MEOX2;HOXA3;ZBTB16;HES1;GRHL1;TWIST2;SKIL;PURG;HOXB6;ESR2;KLF4;NFE2L2;ZNF148;ZIC1;ELF1;PRRX1;ZNF423;NR2F1;FOXC2;MEF2A;KLF7;JDP2;HOXA6;GLIS1;EHF;NR4A3;FOXL1;NR4A2;FOXK1;KLF10;ZBTB7B;HOXC6;FOXO6;NFATC4;BHLHE40;KLF9;GLIS2;SKI;ESR1;STAT3;ATF1;HOXB3;E2F5;GATA4;DDIT3;HOXB5;NFIL3;HIF3A;E2F3;HOXC4;DMRT3;MYOG;DMBX1;NOBOX;PITX3;BARHL2;PHOX2A;LHX2;SOX14;SP8;IRF1;NFIX;REL;SIX4;TEAD1;PITX2;MLXIP;HIVEP3;RXRA;ZNF8;GRHL2;ATOH8;FOXC1;NFYA;RORA;GLI2;EGR2;NFKB1;GATA1;CTCFL;RARG;HOXB4;ATF7;RARA;RBMX;TOP1;JUN;NFE2L1;NRF1;CARF;FOXE1;ZNF25;PRDM15;ZBTB32;MYNN;PER1;SMAD2;ATF6;MXD1;GTF2IRD1;RB1;NFKB2;BPTF;FOXK2
prerank,omega peptidase activity (GO:0008242),0.48099639042509473,1.326417538230278,0.10462287104622871,0.7230272903235229,1.0,37/89,20.82%,TANK;USP46;USP2;USP13;OTUD1;MINDY3;USP24;MYSM1;USP34;USP49;USP15;USP25;USP1;USP10;USP32;DESI2;USP7;OTUD7B;USP47;COPS5;USP4;USP33;ZC3H12A;ZRANB1;JOSD1;BAP1;OTUD3;OTUD5;VCPIP1;USP28;USP22;USP9X;UFD1;USP40;PSMD14;USP21;USP36
prerank,UDP-glycosyltransferase activity (GO:0008194),0.48832250107787073,1.3213458730000496,0.12189054726368159,0.733440899518331,1.0,14/70,13.84%,EXT1;MGAT4C;B3GNT2;GXYLT2;LARGE1;HEXA;GCNT2;B4GALT1;POGLUT3;HAS1;B3GALT6;B4GAT1;B4GALNT3;LARGE2
prerank,copper ion binding (GO:0005507),-0.4179573710598809,-1.3210835062977144,0.09608540925266904,0.5147435076581776,1.0,7/42,8.56%,PAM;MOXD1;LOXL3;SOD3;SNCA;ATOX1;LACC1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6468455167278331,1.3197390028188898,0.19210977701543738,0.7311399574038953,1.0,5/10,20.81%,SMYD2;SETD2;SETD5;NSD1;ASH1L
prerank,GTPase inhibitor activity (GO:0005095),0.6456506637158697,1.3183115752375496,0.17420435510887772,0.728215502119398,1.0,2/13,4.13%,SLIT2;PDE6D
prerank,protein kinase C binding (GO:0005080),0.5226512884964497,1.3160966356632562,0.14486638537271448,0.7284093631023258,1.0,12/43,12.68%,GRK5;ADAM9;HDAC9;DSP;ABL1;IRS1;NELL1;ITGAV;PDLIM5;DACT1;PRKCSH;CAVIN2
prerank,phospholipid transfer activity (GO:0120014),0.5814465698391243,1.313295360765396,0.16377952755905512,0.7305397323429597,1.0,3/21,2.58%,TNFAIP8L3;PITPNC1;PITPNA
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5234706350340571,1.3132825856934853,0.15384615384615385,0.7233778202690603,1.0,12/42,13.02%,PTPN3;NEDD4;VAV2;SHC1;ABL1;IRS1;NCK2;CBLC;BCAR3;PLCG2;PIK3R3;YES1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.47629822390596166,-1.313020662011274,0.14084507042253522,0.5158295163418989,1.0,5/21,7.04%,CDK8;CDK14;CDK19;CDK6;CDK15
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.47629822390596166,-1.313020662011274,0.14084507042253522,0.5158295163418989,1.0,5/21,7.04%,CDK8;CDK14;CDK19;CDK6;CDK15
prerank,NAD binding (GO:0051287),0.5565013615805403,1.3113939946193627,0.16272189349112426,0.7222445290681638,1.0,2/26,1.78%,ME1;BDH2
prerank,inward rectifier potassium channel activity (GO:0005242),0.5589907599218538,1.309045607277474,0.1639871382636656,0.7231566587983015,1.0,2/24,2.72%,KCNJ2;KCNJ15
prerank,ligand-gated calcium channel activity (GO:0099604),-0.4984846182615287,-1.308927856581613,0.14361702127659576,0.5172872938109578,1.0,5/19,7.93%,ITPR1;GRIN2A;RYR2;GRIN2B;GRIN1
prerank,protein phosphatase binding (GO:0019903),0.45552030702156654,1.3078244964416943,0.11200923787528869,0.7203296087596849,1.0,24/117,11.11%,EGFR;MET;MAP3K5;PPP1R3B;PPP1R3C;STRN;SHOC2;ANAPC5;VCP;AP3B1;ATP2B4;STAT3;FCRL6;VRK3;JUP;IKBKE;STYXL1;STRN3;CDKN1B;SLC9A1;IQGAP1;BOD1L1;PPP6R3;ERBB2
prerank,death receptor binding (GO:0005123),0.6269150707240564,1.302332065997907,0.19626168224299065,0.731988299279072,1.0,5/15,15.33%,NGF;EDA;FEM1B;MYD88;PIDD1
prerank,ligand-gated anion channel activity (GO:0099095),-0.5178542809510194,-1.2989272130481568,0.1769436997319035,0.5353191509494218,1.0,11/17,15.60%,GABRG3;GABRA2;GABRB1;GABRB2;GABRB3;GLRA1;GABRA1;GLRA3;GABRG1;GABRA4;GABRA5
prerank,proton transmembrane transporter activity (GO:0015078),-0.41184375773729487,-1.2981345651711915,0.10740740740740741,0.5285142610051439,1.0,15/39,21.55%,COX4I1;SLC33A1;UQCRH;UQCR10;COX5B;CYB5A;COX6B1;COX8A;NDUFA4;NDUFA4L2;ATP6V1F;COX6A1;UQCR11;COX4I2;COX10
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4365326359038501,1.296701530738987,0.06739130434782609,0.7446376972682969,1.0,48/181,15.25%,ZFPM2;TCF7L2;HDAC4;TACC2;HES1;ANXA4;WWP2;KLF4;NFE2L2;GSK3B;PRRX1;MDFIC;MEF2A;BCAS3;BHLHE40;CREBBP;ISL1;STAT3;KDM1A;GATA4;TADA3;ID2;JUP;PITX2;PIAS2;RXRA;PIAS3;EGR2;DACT1;GATA1;JUN;MTDH;NCOR1;TCERG1;MIER1;RB1;MTA1;HIRA;DDRGK1;SMARCA4;TCF3;HNF4A;EP300;NCOR2;NFATC1;DHX9;ATF2;BAZ2A
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5649962512366835,-1.2956865733941463,0.18138424821002386,0.5256835005343984,1.0,4/10,11.53%,DPP10;DPP4;PRCP;DPP6
prerank,ion channel inhibitor activity (GO:0008200),0.5244088194494948,1.2911508344658802,0.15977175463623394,0.7562350876920011,1.0,8/35,10.07%,KCNMB2;NEDD4;CAMK2D;WNK1;STX8;TNNI3;COMMD1;MCUB
prerank,DNA-binding transcription factor binding (GO:0140297),0.43192483623819883,1.2897714619674874,0.0832443970117396,0.7534251018002698,1.0,55/189,16.55%,ZFPM2;TCF7L2;HDAC4;HDAC9;HES1;WWP2;KLF4;NFE2L2;GSK3B;PRRX1;MEF2A;TXLNG;TLE2;BHLHE40;TLE6;CREBBP;ISL1;SKI;ZMYND8;STAT3;KDM1A;GATA4;DDIT3;ID2;PITX2;PIAS2;PIAS3;EGR2;DACT1;GATA1;CBX5;JUN;MTDH;NCOR1;TCERG1;MIER1;SMAD2;RB1;MTA1;HIRA;DDRGK1;TCF3;HNF4A;EP300;HCFC1;TLE3;CRTC1;NFATC1;DHX9;TLE4;ATF2;TWIST1;ZBTB7A;RBBP8;PRDM5
prerank,poly-purine tract binding (GO:0070717),-0.4506861049655897,-1.28737407849819,0.16346153846153846,0.5375297766191739,1.0,5/27,6.82%,RBPMS;RBMS1;ATXN1;KHDRBS2;ELAVL4
prerank,RNA polymerase II complex binding (GO:0000993),0.5516808876270886,1.286583251988191,0.18571428571428572,0.7569867503048411,1.0,13/32,16.97%,ELOF1;SMYD2;SCAF8;ERCC5;WDR43;UVSSA;WAC;CTR9;DHX9;ELP4;URI1;AGO2;RECQL5
prerank,O-acyltransferase activity (GO:0008374),0.5420257546300948,1.2846319205000876,0.19236417033773862,0.7564983380581766,1.0,11/30,20.47%,SOAT1;MOGAT3;PLA2G15;MBOAT1;MBOAT4;DGAT2L6;LCAT;MOGAT1;LPCAT1;GPAT3;PLA2G4A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5161141738749001,-1.2836809699425338,0.20347394540942929,0.529659180042887,1.0,4/16,4.40%,PTPRG;PTPRM;PTPRB;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5161141738749001,-1.2836809699425338,0.20347394540942929,0.529659180042887,1.0,4/16,4.40%,PTPRG;PTPRM;PTPRB;PTPRT
prerank,sodium channel activity (GO:0005272),-0.4273274070920564,-1.2811697846191021,0.15328467153284672,0.5274843813205088,1.0,11/37,16.15%,SCN7A;SHROOM2;GRIK2;HCN1;GRIK1;SCN1A;SCN3A;CACNA1I;HCN2;SCN2A;SCN9A
prerank,nuclear receptor binding (GO:0016922),0.45471463268883916,1.2807752667193646,0.12149532710280374,0.762197178288617,1.0,37/111,17.78%,FOXP1;TCF7L2;DDX5;TACC2;JMJD1C;STRN;NR4A3;NR4A2;BCAS3;ISL1;ESR1;KDM1A;TADA3;TGFB1I1;TRIP12;LCOR;JUP;RXRA;MED13;NCOR1;DCAF1;NR4A1;SMARCA4;TRIP6;EP300;NCOR2;MED14;DNAAF4;BAZ2A;THRAP3;ZBTB7A;MED24;NSD1;RNF14;BRD8;GAS2L1;NCOA6
prerank,glucuronosyltransferase activity (GO:0015020),0.5891211419581421,1.2804519871966218,0.2,0.7564460051165244,1.0,4/19,13.84%,EXT1;LARGE1;B4GAT1;LARGE2
prerank,GTPase activator activity (GO:0005096),-0.3078430353845829,-1.278877533486408,0.0,0.524359943143512,1.0,81/313,11.92%,RANBP3L;PLCB1;ASAP1;PREX2;ARHGAP28;ARHGAP29;TBC1D4;RAPGEF5;DOCK10;CHN2;RAPGEF4;ERRFI1;ARHGAP24;DENND2A;RASGRP3;ELMO1;ARHGAP32;DOCK11;RAPGEF3;ALDH1A1;RGS3;FGD5;DOCK4;SBF2;RAPGEF2;RGS5;RALGPS1;RGS7;RALGAPA2;USP6NL;ARHGAP26;RABGAP1L;RASGRF2;ARAP3;RASGRP2;RASGRF1;RALGAPA1;CHN1;IQGAP2;ARHGEF15;EEF1B2;EPS8L2;RGL1;RAB3IP;TBC1D12;ARHGAP25;CCDC88A;OPHN1;VAV3;DENND5A;TBC1D8;CYTH1;ADGRB3;SPATA13;TBC1D9;ARHGAP39;GMIP;ARHGAP15;ACAP2;ABR;DENND5B;HACD3;GARNL3;RAPGEF1;TBC1D1;SYDE2;TBC1D16;DOCK2;TBC1D30;SMAP2;RGS16;SIPA1;DENND1A;ELMOD1;RP2;RGS20;ARHGEF11;ARHGEF4;ARHGEF7;VAV1;ARHGAP22
prerank,protease binding (GO:0002020),0.4588605900191733,1.2771497351237195,0.12215568862275449,0.7609541867146894,1.0,19/99,11.25%,F3;SLC2A13;FN1;ANXA2;COL3A1;CRADD;ITGB1;GSK3B;SERPINB9;VCP;LDLR;ITGAV;TIMP2;RIPK2;LCOR;BRCA2;ITGB3;LONP2;TIMP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6419088700956969,1.2762628087503616,0.21617161716171618,0.757350121156769,1.0,1/10,0.87%,DPYSL3
prerank,sodium channel regulator activity (GO:0017080),0.5263897208557177,1.2758182954175075,0.17563739376770537,0.7519071840144472,1.0,8/37,5.73%,PTPN3;NEDD4;FXYD5;CAMK2D;FGF13;SGK3;ATP2B4;SNTA1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.42678838036512495,1.268006737104797,0.11245865490628446,0.7707642312864186,1.0,18/173,6.37%,FOXP2;FOXP1;KLF12;ZFHX3;PLAGL1;FOXP4;FOXO3;ZBTB16;HES1;SKIL;ZNF148;NR2F1;JDP2;FOXK1;NFATC4;BHLHE40;SKI;NFIL3
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6594630309244724,1.267082211885369,0.24424778761061947,0.760954417701411,1.0,3/10,11.50%,DUSP16;DUSP5;DUSP10
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6594630309244724,1.267082211885369,0.24424778761061947,0.760954417701411,1.0,3/10,11.50%,DUSP16;DUSP5;DUSP10
prerank,phosphatase activator activity (GO:0019211),-0.5226096804905315,-1.2669006362653363,0.2016348773841962,0.5453638365769248,1.0,5/14,13.41%,CALM1;FRS2;BMP2;PPP2R5A;CALM3
prerank,FAD binding (GO:0071949),0.5624283162386339,1.265634561372692,0.19631901840490798,0.7592531409695209,1.0,4/24,6.74%,MICAL2;CRY2;MMACHC;AGPS
prerank,flavin adenine dinucleotide binding (GO:0050660),0.48883263862402465,1.2645511432302345,0.15796344647519583,0.756570670850142,1.0,8/53,7.46%,MICAL2;AOX1;CRY2;KDM1A;MMACHC;ACOX3;AGPS;GSR
prerank,tau-protein kinase activity (GO:0050321),0.5736457286599832,1.264370501138769,0.2302839116719243,0.7508525621316461,1.0,5/20,9.89%,MARK1;GSK3B;MARK2;SIK3;MARK3
prerank,protein phosphatase 1 binding (GO:0008157),0.5622858417534015,1.2604916008976732,0.205607476635514,0.7573040588037906,1.0,3/21,4.51%,PPP1R3B;PPP1R3C;SHOC2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4599642041200154,1.260355197946183,0.1592356687898089,0.7515477626441757,1.0,15/71,8.91%,EYA2;PTP4A2;PTPN3;PTPRU;UBASH3B;EYA4;PTPRF;PTPDC1;PTPN2;PTPRA;CDC25B;EYA3;PTPN21;DUSP11;CDC14A
prerank,E-box binding (GO:0070888),-0.415671877643108,-1.2601948780049683,0.14102564102564102,0.5532036169143455,1.0,6/34,8.96%,TCF4;ZEB1;AHR;MITF;TAL1;CIART
prerank,clathrin adaptor activity (GO:0035615),0.5858841931567569,1.2585199921497991,0.24126455906821964,0.7513901827413054,1.0,4/15,8.98%,STON1;AP2A2;STON2;AP2A1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.48745568638541664,-1.2578621922818094,0.18733509234828497,0.5506100223857119,1.0,9/17,10.73%,GRIA4;GRIK2;GRIN2A;GRIN2B;GRIK1;GRIA3;GRIN1;GRIA2;GRIA1
prerank,voltage-gated potassium channel activity (GO:0005249),0.4520569395869973,1.254101864039578,0.1681087762669963,0.759160931463576,1.0,6/80,3.00%,KCNB2;KCNJ2;KCNQ5;KCNJ15;KCNS3;KCNB1
prerank,SUMO binding (GO:0032183),0.5969827586318092,1.2533766150726389,0.22388059701492538,0.7555069380708107,1.0,7/13,22.15%,HERC2;USP25;SERBP1;RNF111;PML;TDG;CASP8AP2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.5062178368746815,-1.252735638243812,0.2064676616915423,0.5545748255704817,1.0,6/14,16.76%,CTSH;NOD1;MAL;ATP2A3;RACK1;CASP1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6237696362820624,1.2520009610502598,0.24162257495590828,0.754044645136525,1.0,5/10,12.24%,CXADR;DSP;DSG2;JUP;DSC2
prerank,cadherin binding (GO:0045296),0.4101966023874464,1.2518172631353153,0.08169596690796277,0.7486990839309726,1.0,79/315,13.86%,EGFR;CDH1;CDH11;FMNL2;BAIAP2L1;TES;STXBP6;CTNND2;FXYD5;EZR;AHNAK;ABI1;NDRG1;ANXA1;ANXA2;CALD1;MPP7;PHLDB2;PARVA;SPTAN1;CTNNA1;GIPC1;PLCB3;ITGB1;PAICS;FLNB;ERC1;CAST;PDXDC1;HDLBP;TMOD3;SNX2;ESYT2;STX5;VCL;CLINT1;SHTN1;CLIC1;PFKP;PDLIM5;DLG1;BZW1;PKP1;RDX;JUP;KTN1;MARK2;SH3GLB2;UNC45A;TXNDC9;P2RX4;CD46;IQGAP1;NIBAN2;ACVR1;EHD1;CCS;CTTN;EMD;SERBP1;KRT18;CAPZA1;PLEC;GAPVD1;EIF3E;GOLGA3;ADD1;LYPLA2;LIMA1;PCMT1;NOP56;EPS15L1;PKN2;PAK2;SH3GLB1;HCFC1;ARGLU1;TBC1D10A;BAG3
prerank,peptidoglycan binding (GO:0042834),-0.5627037239234021,-1.2515274099253981,0.21026894865525672,0.5496290014011377,1.0,2/10,5.37%,NOD1;PGLYRP1
prerank,CoA hydrolase activity (GO:0016289),0.5736658291915224,1.2512567564277275,0.22012578616352202,0.7444710172228336,1.0,9/16,25.07%,ACOT8;HIBCH;ACOT12;ACOT9;ACOT13;ABCD1;ACOT11;NUDT7;ACOT6
prerank,diacylglycerol kinase activity (GO:0004143),-0.5426634769820406,-1.249111985861271,0.22037914691943128,0.5472515618679492,1.0,4/11,8.86%,DGKB;DGKI;DGKD;DGKG
prerank,transcription cis-regulatory region binding (GO:0000976),0.40415872363034394,1.2465455939345091,0.059003051881993895,0.7533939510362639,1.0,79/406,13.96%,BNC2;FOXP1;VSX1;SIX1;TCF7L2;PLAGL1;SOX9;HDAC4;FOXN3;PBX1;CUX1;SMAD6;GLI3;FOXO3;GRHL1;TWIST2;PURG;KLF4;NFE2L2;CRY2;FOXC2;MEF2A;FOXK1;ARID4A;KLF10;ZBTB7B;ARID4B;GLIS2;ISL1;STAT3;ATF1;GATA4;DDIT3;TBL1X;NFIL3;HIF3A;E2F3;MYOG;DMBX1;BARHL2;PHOX2A;LHX2;IRF1;TEAD1;GABPB1;GABPB2;PITX2;MLXIP;RXRA;GRHL2;FOXC1;NFYA;RORA;PER3;EGR2;NFKB1;GATA1;CTCFL;RARA;JUN;ZNF25;NCOR1;PER1;SMAD2;ATF6;ZBED4;RB1;FOXK2;NKX2-1;KMT2D;TCF3;HNF4A;HNF1A;XRCC5;PAX6;CHD3;SP3;E2F2;PRDX5
prerank,calcium channel inhibitor activity (GO:0019855),-0.5387990395448732,-1.2452030682345288,0.24096385542168675,0.5492350028075323,1.0,3/11,9.55%,ITPR1;CALM1;SLC30A1
prerank,triglyceride lipase activity (GO:0004806),0.5589491140755642,1.2450329782726393,0.22826086956521738,0.7522040394096535,1.0,4/20,12.80%,PNPLA3;PLA2G15;DAGLB;LCAT
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.4503430373640439,-1.2448947621116284,0.19318181818181818,0.5423277450671941,1.0,9/24,18.22%,OSBPL8;CERT1;DAB2IP;PLEKHA5;GSDMD;JPH2;RUBCNL;LANCL2;SNX3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6223967690887853,1.244417889394836,0.2313915857605178,0.74848884244895,1.0,3/12,16.06%,CYFIP2;EIF4E3;AGO2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.5665317605098459,1.24419111412731,0.23420647149460708,0.7435095229910595,1.0,11/21,28.48%,REV3L;POLB;POLE2;REV1;POLA1;POLD3;POLK;POLQ;POLM;POLI;PRIMPOL
prerank,potassium ion leak channel activity (GO:0022841),0.5711034445880506,1.2431626577252102,0.2296416938110749,0.7409719667016776,1.0,1/15,0.19%,KCNK5
prerank,filamin binding (GO:0031005),0.6177383340945996,1.2409574429006043,0.24190800681431004,0.742327678685067,1.0,2/11,5.92%,DPYSL3;NEBL
prerank,DNA polymerase activity (GO:0034061),0.5583718983355526,1.238656500482138,0.23206106870229007,0.744282468702407,1.0,11/22,28.48%,REV3L;POLB;POLE2;REV1;POLA1;POLD3;POLK;POLQ;POLM;POLI;PRIMPOL
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5990441835926891,1.2360653287590337,0.25254237288135595,0.7467557735059134,1.0,4/12,11.16%,SULF1;ARSI;ARSB;SGSH
prerank,receptor ligand activity (GO:0048018),0.406708942932752,1.2357008971740406,0.10531914893617021,0.7424157961146638,1.0,40/245,11.82%,BMP4;TNFRSF11B;WNT9A;OSGIN2;BMP5;NGF;EDA;PGF;TGFB3;SEMA3E;WNT11;SEMA3D;SEMA3C;BMP6;INHBA;FGF2;LRPAP1;FAM3C;CLCF1;DEFB130A;WNT16;GDNF;PTHLH;SLURP1;JAG1;GDF6;IL10;GDF5;NBL1;PDGFA;GDF10;CTF1;IL33;C1QTNF12;VEGFA;CCL3;TIMP1;ERFE;INHBB;FGF22
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5222355736429727,1.2331695466767052,0.23738872403560832,0.7446453620224778,1.0,2/25,1.98%,MICAL2;FMO1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5514983900923021,1.2325439179463484,0.22641509433962265,0.7411451196345862,1.0,8/23,9.84%,PLCE1;EDNRA;PLCB3;PLCZ1;CHRM5;CASR;PLCD3;PLCG2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5247657974792866,1.232299105673973,0.2267605633802817,0.7367115547084457,1.0,13/33,16.97%,ELOF1;SMYD2;SCAF8;ERCC5;WDR43;UVSSA;WAC;CTR9;DHX9;ELP4;URI1;AGO2;RECQL5
prerank,iron ion binding (GO:0005506),0.47716639348799594,1.2311051154798158,0.19319727891156463,0.7351095216149729,1.0,8/48,11.91%,AOX1;EGLN3;FDX1;FTO;TYW5;SCD;CDO1;ALKBH8
prerank,metalloaminopeptidase activity (GO:0070006),0.5646592346080987,1.2285610962033684,0.26174496644295303,0.7375073007076592,1.0,6/16,11.30%,NPEPPS;MMP16;XPNPEP1;XPNPEP3;MMP14;ERAP1
prerank,lysine N-methyltransferase activity (GO:0016278),0.551848457260058,1.2274121482413394,0.25878594249201275,0.73553699494141,1.0,11/20,26.77%,SMYD2;SETD2;EHMT1;ETFBKMT;KMT5A;EHMT2;EEF1AKMT1;METTL21A;SETD6;METTL21C;EEF1AKMT4
prerank,fibroblast growth factor binding (GO:0017134),0.5508649222711525,1.2269671317378517,0.24887556221889057,0.7316255127222839,1.0,3/21,5.85%,THBS1;FGFR1;ITGAV
prerank,leak channel activity (GO:0022840),0.5527272548035403,1.2266692799430645,0.23714759535655058,0.7274722721960585,1.0,2/18,4.49%,KCNK5;NALCN
prerank,endodeoxyribonuclease activity (GO:0004520),0.548246614499864,1.2257679721315848,0.2572347266881029,0.7252402862918875,1.0,9/20,22.87%,EXO1;ERCC5;APLF;APEX1;RBBP8;ERCC1;RAD50;MBD4;EXOG
prerank,acid-thiol ligase activity (GO:0016878),-0.508631765158085,-1.2229377785809117,0.22194513715710723,0.5856990956034964,1.0,4/13,11.16%,ACSS3;ACSL1;ACSS1;ACSS2
prerank,RNA cap binding (GO:0000339),0.5769207869709468,1.2227274564510602,0.25274725274725274,0.7293440908411774,1.0,1/16,0.98%,CYFIP2
prerank,serine-type endopeptidase activity (GO:0004252),0.4461924014340123,1.2222872752529874,0.18932655654383734,0.725806558819413,1.0,3/80,4.72%,F3;PCSK5;PRSS12
prerank,translation initiation factor activity (GO:0003743),0.5023538026689192,1.2217695832843931,0.2103825136612022,0.7224462373624184,1.0,14/36,20.87%,EIF4G3;EIF4G1;EIF2D;MTIF3;EIF3E;COPS5;EIF4E3;EIF3A;EIF2B2;EIF2S2;AGO2;EIF2S1;EIF4G2;EIF2B3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.4675497459146669,-1.2190612078678549,0.20754716981132076,0.5874141929245529,1.0,9/19,15.60%,GRID2;GABRG3;GRIK2;GABRA2;GRIK1;GABRA1;GABRG1;GABRA4;GABRA5
prerank,CoA-ligase activity (GO:0016405),-0.4922506476874838,-1.2189992997657493,0.21374045801526717,0.5797581913793879,1.0,5/14,15.19%,ACSS3;ACSL1;ACSS1;ACSS2;ACSBG1
prerank,chloride channel inhibitor activity (GO:0019869),0.6087071546487668,1.2189590338345349,0.2699490662139219,0.7255759381474396,1.0,2/10,9.29%,WNK1;STX8
prerank,phosphotyrosine residue binding (GO:0001784),0.5001700971922122,1.2187443327814962,0.2253922967189729,0.721531880463148,1.0,11/37,13.02%,PTPN3;VAV2;SHC1;ABL1;IRS1;NCK2;CBLC;BCAR3;PLCG2;PIK3R3;YES1
prerank,SH3 domain binding (GO:0017124),0.45588196555925187,1.2173156907280551,0.2002534854245881,0.7206609243627726,1.0,11/62,9.17%,AFAP1L1;DPYSL3;ABI1;ADAM9;ABL1;ADAM12;PLSCR1;CBLC;SHANK1;RUFY1;AFAP1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4402962411568553,1.2129657382475163,0.19306930693069307,0.7283612153145353,1.0,4/75,2.10%,ME1;EHHADH;BDH2;ADH7
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5564360891972757,1.2126618865207266,0.25903614457831325,0.7245496739491909,1.0,11/20,20.57%,USP25;DESI2;USP7;USP47;COPS5;SENP5;OTUD5;USP9X;SENP3;SENP1;USP21
prerank,protein serine/threonine kinase activity (GO:0004674),0.3918523243016353,1.208588654117086,0.12215320910973085,0.7309614522635589,1.0,78/334,15.46%,STK39;EGFR;MAP3K5;GRK5;MARK1;PTK2B;CIT;CAMK2D;WNK1;PRKCD;ULK2;CLK1;LIMK2;HIPK1;ALPK1;BMPR1A;GSK3B;TLK1;PRKCE;NEK7;BCR;TGFBR1;CLK2;MKNK2;STK16;TGFBR2;SGK3;STK35;GAK;TRIO;IRAK4;CDK12;RIPK2;VRK3;FAM20A;MARK2;IKBKE;CHEK2;PLK3;CSNK1A1;CSNK1G3;NLK;RIPK3;CHUK;AAK1;AURKA;SIK3;MARK3;SIK2;IRAK3;ACVR1;PIM2;ATM;TOP1;MAPK12;MAST2;HTATIP2;CDKL2;CPNE3;PDK3;MTOR;CSNK1G1;CHEK1;SMG1;PKN2;PAK2;PRKDC;CSNK1E;ERN2;CDC42BPG;DYRK2;EIF2AK4;CDK11B;MAPKAPK2;PRKCA;CDK16;SQSTM1;CLK4
prerank,DNA binding (GO:0003677),0.3877789826514234,1.2061228981252146,0.05805805805805806,0.733492259714256,1.0,163/694,19.08%,FOXP2;EGFR;KLF12;TCF7L1;SIX1;TCF7L2;SLTM;PLAGL1;RARB;NFIB;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;PBX1;CUX1;FOXO3;MEOX2;ZBTB16;HES1;GRHL1;COLEC11;ESR2;MPG;NFE2L2;ZNF148;CRY2;ZNF423;ABL1;NR2F1;FOXC2;MEF2A;EHF;NR4A3;FOXL1;NR4A2;HDGFL3;RNF138;ARID4A;RBM6;CREBBP;STAT3;C1D;MBD1;GATA4;DDIT3;CEBPZ;E2F3;EXO1;SLPI;MYOG;DMBX1;NOBOX;SOX14;CCDC25;IRF1;TEAD1;STN1;ERCC5;MCM7;CAMTA2;RXRA;ZNF8;GRHL2;FOXC1;NFYA;RORA;GLI2;WRN;EGR2;BCLAF1;GATA1;CTCFL;MCM2;RARG;RAD23B;TOP1;CHTF18;JUN;APEX1;CARF;FOXE1;CLSPN;BRCA2;TRIM26;ZBTB32;IGHMBP2;NABP1;SMAD2;ATF6;DDX11;BPTF;FOXK2;ZMYM4;CBFB;SMC1A;NKX2-1;RAD52;NR4A1;CDC45;NR6A1;ZC3H12A;SMARCA4;KMT2D;TCF3;HNF4A;HNF1A;PRKDC;RFX2;XRCC5;PAX6;EP300;CHD3;E2F2;POLG2;DHX9;FOXD2;DNMT3A;TLR8;MCM9;KIN;HINFP;ERCC3;TFAP2A;THRAP3;ZNF219;ZBTB7A;TRIM16;BCL6;CALCOCO1;TAF12;RBBP8;POU6F1;XPA;PRDM5;YY1;RPA1;ZNF76;TOP3A;TAF4;SREBF1;NBN;TSG101;TSHZ2;RAD51;ERCC1;POLR3F;KHDRBS1;EZH1;NEIL3;SMARCA5;AIFM2;DHX36;QRICH1;INO80;WDR48;PPARG;RFX5;CIITA;RFC1;CCNT1;AIFM1
prerank,poly(A) binding (GO:0008143),-0.43828909596613397,-1.2050105274852032,0.2155688622754491,0.6070154542723387,1.0,4/21,6.82%,RBPMS;RBMS1;KHDRBS2;ELAVL4
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.5911176787925353,1.2046037940545833,0.26352530541012215,0.7332229510792226,1.0,5/13,21.66%,PNPLA3;LCLAT1;LPCAT1;GPAT3;ABHD5
prerank,NF-kappaB binding (GO:0051059),0.52068490291102,1.2044578063334936,0.25370919881305637,0.7289924474874112,1.0,6/24,17.17%,ANXA4;GSK3B;MTDH;EP300;CPNE1;BCL10
prerank,RNA polymerase binding (GO:0070063),0.5553617224569338,1.2038824412125282,0.26537216828478966,0.7259313168342191,1.0,7/18,14.40%,NEDD4;STOM;SCAF8;TCERG1;PKN2;PHRF1;DHX9
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.44419446923830225,1.2035674271740824,0.22860635696821516,0.722206768623299,1.0,10/72,4.52%,KCNJ2;VILL;MARK1;STXBP6;ANXA2;GSN;PLEKHA4;FZD7;SNX18;PLCZ1
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3441579937763304,-1.2035451930324195,0.16203703703703703,0.6024295269654613,1.0,28/60,14.46%,FLT1;IGF1R;TEK;PDGFRB;MERTK;KIT;EPHA7;TIE1;KDR;EPHB1;INSR;ROR2;ERBB4;EPHA4;EPHB4;EPHA8;EPHA6;NTRK2;PDGFRA;FGFR4;AXL;FLT4;LMTK2;TYRO3;MUSK;EPHA5;CSF1R;ACVRL1
prerank,single-stranded DNA helicase activity (GO:0017116),0.540811258885446,1.2023714490374526,0.2667706708268331,0.7209174027143049,1.0,11/19,28.33%,MCM7;MCM2;CHTF18;DHX9;CHTF8;RAD51;HELB;DSCC1;RFC5;POLQ;MCM6
prerank,myosin II binding (GO:0045159),0.5979909658612936,1.1996280692809966,0.2842465753424658,0.7243803453134876,1.0,6/10,24.12%,GSN;SHROOM4;TRIOBP;LLGL1;MYL4;STXBP5
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.41207909988935265,-1.1957115133011436,0.2088607594936709,0.6150475215826468,1.0,9/28,15.60%,GRID2;GABRG3;GRIK2;GABRA2;GRIK1;GABRA1;GABRG1;GABRA4;GABRA5
prerank,damaged DNA binding (GO:0003684),0.4728381380899018,1.1949681237308087,0.236986301369863,0.7330219934395028,1.0,15/44,20.67%,MPG;CRY2;CREBBP;ERCC5;APEX1;EP300;ERCC3;RBBP8;XPA;RPA1;NBN;ERCC1;NEIL3;SMC6;TDG
prerank,MHC protein binding (GO:0042287),-0.45264353464162005,-1.1875768726812561,0.20481927710843373,0.6279315070909175,1.0,8/20,22.00%,ATP5F1B;CD81;TAP2;ATP5F1A;CD74;ABCB9;TUBB4B;TAPBP
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4382137297873757,1.1860370069528363,0.221001221001221,0.7533001397725737,1.0,19/78,12.29%,CAPN5;USP46;USP2;USP13;CAPN2;USP24;CASP6;CAPN6;USP34;USP49;USP15;USP25;USP1;USP10;USP7;CAPN10;USP47;CAPN12;USP33
prerank,tropomyosin binding (GO:0005523),0.5474739243840324,1.1845225642325634,0.29193548387096774,0.7529739628296114,1.0,3/16,5.92%,CALD1;TMOD3;NEBL
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5645322709719184,1.1794525292359896,0.31069609507640067,0.762942872658985,1.0,2/13,11.68%,EHHADH;EBP
prerank,calcium ion binding (GO:0005509),0.38417042042737526,1.1788300464039476,0.140641158221303,0.7601493107328094,1.0,32/323,7.51%,SLIT3;SLIT2;SMOC2;THBS1;CDH1;ACER3;CDH11;ESYT3;PPP3CA;ANXA1;ANXA3;ANXA2;DSPP;GSN;ANXA4;COLEC11;DSG2;GLCE;ESYT2;PLA2G4F;TRPM4;STIM2;ITPR2;LRP1;CASR;PLSCR1;CRACR2A;LTBP4;OC90;TGM3;S100G;SYT8
prerank,death receptor activity (GO:0005035),-0.5255264958735099,-1.178734687687567,0.2688679245283019,0.6423929165355746,1.0,3/11,7.12%,TNFRSF19;FAS;TNFRSF11A
prerank,endopeptidase inhibitor activity (GO:0004866),-0.3239255628245482,-1.1778997174685795,0.1722488038277512,0.6366994438368432,1.0,15/82,8.94%,COL4A3;TIMP3;SPOCK2;PROS1;SPOCK3;SERPINI1;CST3;ITIH2;SPOCK1;APP;TFPI;BST2;SERPIND1;GAPDH;A2M
prerank,amyloid-beta binding (GO:0001540),0.43058451464738606,1.177017871967878,0.25274725274725274,0.7608818792144655,1.0,9/79,8.77%,COL25A1;ADRB2;LRPAP1;ITM2C;LDLR;LRP1;CLU;TLR4;ATP1A3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5148432839058564,1.175574346499584,0.2701062215477997,0.7604402693394704,1.0,10/22,16.38%,TAB3;IKBKE;OTUD7B;WDR81;UIMC1;ZRANB1;RNF168;ZBTB1;SQSTM1;IKBKG
prerank,histone acetyltransferase binding (GO:0035035),0.5171243284587139,1.1729392606058884,0.28858024691358025,0.763540094321665,1.0,7/21,16.02%,GLI3;MEF2A;BCAS3;KANSL1L;KANSL1;PAX6;ZBTB7A
prerank,phospholipase C activity (GO:0004629),0.515012816585936,1.1702450345760176,0.2901849217638691,0.7665979058797484,1.0,8/25,9.84%,PLCE1;EDNRA;PLCB3;PLCZ1;CHRM5;CASR;PLCD3;PLCG2
prerank,magnesium ion binding (GO:0000287),0.40297941995115427,1.1689598358836406,0.208955223880597,0.7657095677688325,1.0,35/135,20.67%,EYA2;MAP3K5;MARK1;GCLC;ABL1;PLSCR1;DXO;MARK2;NLK;WRN;SIK3;SIK2;IRAK3;NUDT5;MAPK12;HACL1;MAST2;FOXK2;ERN2;CDC42BPG;DYRK2;PLSCR3;CLYBL;NUDT12;DIS3L2;CDC42BPA;SRPK1;DHX36;RHEB;NEK6;DYRK3;RAN;EXD2;PDXP;TDG
prerank,estrogen receptor binding (GO:0030331),-0.39204802517391224,-1.1668422577759276,0.25245901639344265,0.6561111543516892,1.0,5/32,5.36%,LEF1;TACC1;NCOA1;PPARGC1B;RERG
prerank,protein tyrosine kinase binding (GO:1990782),-0.3305615088743743,-1.1655311362363734,0.16279069767441862,0.6515267777027477,1.0,27/71,21.08%,NRG3;DOCK4;GRM5;GRB14;CBLB;NEDD9;EPHA4;SIRPA;ANGPT2;SOCS5;GAS6;BLNK;SHC3;DUSP3;SHC4;NOX4;SH2B3;RACK1;ARHGEF16;FLT3LG;CDH5;TJP2;HYAL2;TREM2;NRG1;ANGPT4;PHYHIP
prerank,phosphatidate phosphatase activity (GO:0008195),0.5604313849519647,1.16442465897921,0.309328968903437,0.7735344404381019,1.0,2/13,2.22%,PLPPR2;PLPP3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.4681785620580562,-1.1634044266917563,0.2736077481840194,0.6489729875500022,1.0,6/14,22.82%,ALDH1L1;BLVRB;ALDH4A1;QDPR;AASS;PYCR2
prerank,rRNA binding (GO:0019843),-0.3756776751546718,-1.160991305817403,0.23773584905660378,0.6477451729489494,1.0,16/42,27.27%,RPS14;RPS9;RPS13;RPS3;RPS5;RPL23;RPL11;FASTKD2;MRPS11;RPL12;RPL5;EMG1;RCC1L;RPLP0;RRS1;DDX28
prerank,chloride channel regulator activity (GO:0017081),0.5455012173208568,1.1605044084294571,0.31511254019292606,0.7796272316187793,1.0,3/14,9.29%,WNK1;SGK3;STX8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5333985923753262,-1.1603918817553598,0.30275229357798167,0.6416400214485731,1.0,4/10,9.80%,APOBEC1;ADARB2;LACC1;GDA
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4975091185562298,1.1583129969635955,0.2962962962962963,0.7811941532246327,1.0,4/24,4.74%,PTK2B;CAMK2D;PHKA2;MKNK2
prerank,protein tyrosine kinase activity (GO:0004713),-0.30646373461133597,-1.1574636497963846,0.12244897959183673,0.641490280074579,1.0,40/108,15.83%,FLT1;IGF1R;LYN;TEK;PEAK1;PDGFRB;MERTK;KIT;EPHA7;TIE1;KDR;EPHB1;TEC;INSR;ROR2;ERBB4;EPHA4;TNK2;EPHB4;EPHA8;PTK2;EPHA6;NTRK2;BMX;AATK;PDGFRA;FGFR4;AXL;FLT4;FES;LMTK2;TYRO3;MUSK;EPHA5;CSF1R;TTBK1;JAK3;HCK;FLT3;HIPK3
prerank,neurexin family protein binding (GO:0042043),0.5879208154064359,1.1572269375282453,0.3205574912891986,0.7798142012175394,1.0,2/10,4.45%,SYTL5;SYTL4
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.41827786299932657,1.15689254946848,0.2637231503579952,0.7763041523702083,1.0,17/91,9.74%,KCNJ2;VILL;MARK1;STXBP6;ANXA2;GSN;PLEKHA4;FZD7;SNX18;PLCZ1;WIPI2;RLBP1;GBF1;SLC9A1;PARD3;FCHO2;COMMD1
prerank,ion channel activity (GO:0005216),0.4285519390548764,1.156478477373679,0.24548736462093862,0.7731200981979123,1.0,12/80,7.58%,PIEZO2;TMEM120A;TMC6;TRPM6;NALCN;TRPM4;TMC1;CALHM5;TRPM7;P2RX2;CALHM2;GRIK4
prerank,pre-mRNA binding (GO:0036002),0.4938663316634439,1.1562386272215686,0.27994227994227994,0.7694752038969878,1.0,11/28,25.76%,DDX5;SRSF6;CELF1;CELF3;U2AF2;RNPC3;U2AF1L4;TRA2B;RBM4;CELF4;ERI1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.3907182251517256,-1.1532973081412594,0.23404255319148937,0.6448405239867777,1.0,6/28,8.87%,TNK2;MAP2K6;PRKAA2;SGK1;RPS6KA1;PAK3
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5088544301861099,-1.1515314253778506,0.2974828375286041,0.6415296533968703,1.0,2/10,4.04%,MECOM;PRDM16
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4165052835154444,-1.1488443091500617,0.2818991097922849,0.6405576280581898,1.0,13/23,17.93%,PDE8B;PDE4B;PDE7B;PDE1C;PDE4D;PDE2A;PDE4A;PDE8A;PDE4C;PDE1A;PDE9A;PDE3B;CNP
prerank,fatty acid synthase activity (GO:0004312),-0.5139640438861901,-1.1466861406797717,0.32754342431761785,0.639254313936322,1.0,3/10,11.39%,ELOVL7;ELOVL6;ELOVL4
prerank,growth factor activity (GO:0008083),0.42087889813232965,1.146202881546561,0.2682926829268293,0.7935109671179268,1.0,10/74,7.96%,OSGIN2;NGF;PGF;INHBA;FGF2;CLCF1;GDNF;JAG1;IL10;PDGFA
prerank,voltage-gated ion channel activity (GO:0005244),-0.45890227465866734,-1.1431059675217372,0.30310880829015546,0.6406980675242854,1.0,3/14,3.92%,CACNA1E;KCND2;HCN1
prerank,WW domain binding (GO:0050699),-0.40114392163163237,-1.142249426816105,0.27300613496932513,0.6357168644041995,1.0,7/26,15.88%,RAPGEF2;TNK2;LITAF;TCEAL9;NDFIP2;ENAH;DAZAP2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5453095243877681,1.1416634524274973,0.3194888178913738,0.8018545114146062,1.0,3/13,3.24%,SOX9;EZR;GSK3B
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5103724015731481,1.139788532329451,0.32605304212168484,0.8028753752886869,1.0,7/18,11.05%,TGFB3;SMAD6;TGFBR1;TGFBR2;BAMBI;USP15;SMAD2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5422631601413382,1.1394887732441805,0.3288135593220339,0.7992986554043207,1.0,5/12,16.68%,JMJD1C;KDM1A;KDM3B;KDM4D;HR
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.43934641156857346,1.1378914120959795,0.2900552486187845,0.7991735501910312,1.0,5/54,5.36%,ACER3;HDAC4;HDAC9;VNN1;HDAC8
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.423197515086283,-1.1326834028611803,0.28273809523809523,0.6519379785656156,1.0,10/21,12.83%,PDE8B;PDE4B;PDE7B;PDE1C;PDE4D;PDE2A;PDE4A;PDE8A;PDE4C;PDE1A
prerank,N-methyltransferase activity (GO:0008170),0.4995328691437326,1.132405248061594,0.31655844155844154,0.8099511422966837,1.0,4/20,17.46%,RNMT;NNMT;GNMT;METTL15
prerank,BMP binding (GO:0036122),-0.4888535418930605,-1.1288271762604811,0.3475,0.654235908887685,1.0,2/11,2.03%,ENG;GREM2
prerank,pseudouridine synthase activity (GO:0009982),0.5432390564171751,1.1281346150764269,0.32554257095158595,0.8177311346689362,1.0,8/13,30.74%,PUS10;RPUSD4;PUS7L;RPUSD1;PUSL1;TRUB2;PUS7;RPUSD2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.5372212649960898,1.1280846708387813,0.34775374376039936,0.8135507904869987,1.0,10/15,35.23%,PNPLA3;LCLAT1;LPCAT1;GPAT3;ABHD5;ABHD4;LPCAT2;GPAT4;AGPAT5;AGPAT2
prerank,snoRNA binding (GO:0030515),0.47726267121954125,1.1278308892336935,0.3177004538577912,0.8099796167948395,1.0,16/30,27.92%,BMS1;NUDT4;NUDT5;UTP6;NOP56;PRKDC;XRCC5;DDX21;WDR3;BYSL;NUDT1;NOP58;NUDT7;IMP4;TSR1;NUDT16L1
prerank,ubiquitin binding (GO:0043130),0.4154415489922972,1.1253946381659998,0.29949238578680204,0.8126816368577202,1.0,25/73,24.74%,NEDD4;USP13;DDI2;RNF185;USP25;RAD23B;MVB12B;USP33;RNF168;NPLOC4;CXCR4;SQSTM1;IKBKG;TSG101;NBR1;WDR48;UBE2N;RNF31;TOM1L1;RBCK1;FAF2;UBAP1;ADRM1;BUB3;ASCC2
prerank,CARD domain binding (GO:0050700),0.5386318986548778,1.124322783571823,0.35604770017035775,0.8114314836351534,1.0,3/14,6.35%,CARD14;MAVS;RIPK2
prerank,sialyltransferase activity (GO:0008373),-0.42509169641673245,-1.1217244403120736,0.3029411764705882,0.6644891343431166,1.0,9/20,9.30%,ST6GALNAC3;ST6GAL1;ST3GAL1;ST3GAL6;ST8SIA4;ST3GAL3;ST8SIA6;ST8SIA1;ST6GALNAC2
prerank,small GTPase binding (GO:0031267),0.3794629987832734,1.1211892933959755,0.2681318681318681,0.8159104906156397,1.0,30/169,10.18%,PLCE1;CDC42EP5;EXOC4;NDRG1;AKAP13;SGSM2;ARHGDIB;YBX3;DOCK7;UNC13B;ERC1;MLPH;SRGAP2;PDE6D;HPS4;RAB11FIP3;ANKRD27;RAPGEF6;OCRL;MYCBP2;RGP1;EXOC5;FGD6;RAB3GAP2;STRN3;PIH1D2;IQGAP1;RANBP2;EHD1;NCKAP1
prerank,telomeric DNA binding (GO:0042162),0.4618160343147448,1.1201804535161848,0.3192090395480226,0.8144437834727511,1.0,12/32,21.97%,SMG6;TELO2;KDM1A;STN1;WRN;APEX1;SMG1;XRCC5;RPA1;UPF2;RAD50;TEN1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.4117836346885519,-1.1200498597486157,0.2934472934472934,0.661579600704862,1.0,8/22,16.15%,SCN7A;HCN1;SCN1A;SCN3A;CACNA1I;HCN2;SCN2A;SCN9A
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4717007527333606,-1.1184880706912181,0.33171912832929784,0.6585175577714567,1.0,3/12,1.09%,LTBP1;ENG;TGFBR3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5604906526735618,1.1179762827756987,0.36300174520069806,0.8160827580834789,1.0,4/10,21.34%,EXO1;APEX1;EXD2;TATDN1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.514421935206188,-1.116542185945874,0.35294117647058826,0.6565565765979268,1.0,6/10,15.60%,GABRG3;GABRA2;GABRA1;GABRG1;GABRA4;GABRA5
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.46215933048661806,1.1160129492237094,0.3465909090909091,0.8171047220621402,1.0,12/34,26.77%,SMYD2;SETD2;EHMT1;ETFBKMT;KMT5A;EHMT2;KMT5B;EEF1AKMT1;METTL21A;SETD6;METTL21C;EEF1AKMT4
prerank,3'-5' exonuclease activity (GO:0008408),0.43980257759905667,1.1139399711330227,0.324468085106383,0.8185248262076169,1.0,25/45,32.48%,REV3L;ERI3;WRN;APLF;APEX1;EXOSC7;ANGEL1;ANGEL2;CNOT7;DIS3L2;PNLDC1;EXD2;TATDN1;RAD50;ERI2;ERI1;PARN;EXOSC4;CNOT8;REXO2;EXOSC2;REXO4;DIS3;EXD1;EXOSC3
prerank,vinculin binding (GO:0017166),0.5558206359280006,1.113784415418662,0.3625632377740304,0.8147972181384618,1.0,3/11,5.27%,SORBS3;CTNNA1;DMD
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.47933475342240167,1.113765699050858,0.3318112633181126,0.8107235618441355,1.0,5/26,3.83%,SLC5A6;SLC16A9;SLC16A1;ABCG2;SLC26A6
prerank,acetyltransferase activity (GO:0016407),0.47476409709300543,1.113124676830646,0.33472803347280333,0.8083572330071522,1.0,16/31,28.62%,KAT6B;CREBBP;ELP3;PAFAH1B2;LCAT;EP300;KAT2B;NAA15;SAT1;GTF2B;NAT10;ESCO1;NAA50;NAA80;KAT6A;PAFAH1B3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5203922989199439,1.111380325059447,0.36757624398073835,0.8092382766643188,1.0,4/17,9.95%,BDH2;DECR1;PECR;LBR
prerank,protein phosphatase activator activity (GO:0072542),-0.4746851986747337,-1.1105473052615285,0.3324324324324324,0.6638563530945211,1.0,4/13,13.41%,IGFBP3;CALM1;PPP2R5A;CALM3
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.46810567734696895,-1.110461279461254,0.33649289099526064,0.6575078021083604,1.0,5/12,16.76%,CTSH;NOD1;ATP2A3;RACK1;CASP1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.4285397154489286,1.110057298984414,0.32858990944372574,0.8089919551248049,1.0,8/55,5.98%,SLC24A3;PKD1;ATP2C2;ANXA2;PKD2L2;ATP2B4;ITPR2;TRPM7
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5257637311489233,1.1093327637441255,0.362876254180602,0.8069742903085851,1.0,1/14,2.10%,ADH7
prerank,potassium channel regulator activity (GO:0015459),0.4322804837928042,1.1093185995939512,0.3364737550471063,0.803039506966483,1.0,7/49,6.71%,KCNMB3;KCNMB2;WNK1;ADRB2;KCNS3;SGK3;DLG1
prerank,chemorepellent activity (GO:0045499),-0.3910661422289059,-1.1090656604832148,0.3162393162393162,0.6541430811166662,1.0,10/25,12.22%,SEMA6A;NRG3;EPHA7;SEMA7A;SEMA6D;DPP4;SEMA5B;SEMA3G;SEMA6B;SEMA3B
prerank,mitogen-activated protein kinase binding (GO:0051019),0.4712240860443628,1.1083237734715217,0.3431952662721893,0.8017753717354266,1.0,9/29,17.63%,ABL1;DUSP16;DUSP5;ATF7;DUSP10;NFATC1;TNIP1;MAPKAPK2;NBR1
prerank,low-density lipoprotein particle binding (GO:0030169),0.5128766388909038,1.108309440355841,0.3520900321543408,0.7979143532870944,1.0,2/16,5.59%,THBS1;LDLR
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.4182040556507129,-1.1072350595287754,0.3179347826086957,0.6519799951737768,1.0,3/18,1.09%,LTBP1;ENG;TGFBR3
prerank,single-stranded RNA binding (GO:0003727),0.4488295974494986,1.107209782344664,0.3506139154160982,0.7967471759780489,1.0,12/43,20.06%,STRBP;ZFR;L1TD1;U2AF2;DDX11;IFIH1;DHX9;TLR8;AGO2;JMJD6;EIF4B;FMR1
prerank,calcium channel activity (GO:0005262),0.4064422138353612,1.1067175185385345,0.30713422007255137,0.7943364703211135,1.0,17/84,11.95%,SLC24A3;PKD1;CACNA1C;ANXA2;CACHD1;TRPM4;TMC1;PKD2L2;STIM2;ITGAV;TRPM7;CACNG6;CACNA1F;P2RX4;MCU;SEC61A1;ORAI3
prerank,endopeptidase regulator activity (GO:0061135),-0.3507762427838089,-1.1037887262315684,0.3049645390070922,0.653779167257301,1.0,14/40,22.24%,PROS1;CST3;ITIH2;TFPI;SERPIND1;A2M;APH1B;PSME2;VSIR;ABCA2;UCHL5;HRG;ITIH3;AHSG
prerank,alkali metal ion binding (GO:0031420),-0.4726007975850563,-1.1007294323946517,0.3262411347517731,0.6546900984313901,1.0,1/13,0.02%,ATP1A2
prerank,ankyrin binding (GO:0030506),0.5105650039668593,1.0992751926947555,0.35248447204968947,0.8103547683080403,1.0,1/19,0.33%,CDH1
prerank,Wnt-activated receptor activity (GO:0042813),0.5157825623857581,1.0978127106870867,0.35784313725490197,0.8102844618166989,1.0,5/15,10.84%,PKD1;FZD7;FZD1;ROR1;LRP5
prerank,frizzled binding (GO:0005109),0.4484165956160295,1.096085768045903,0.33516483516483514,0.8108210425960314,1.0,7/34,8.01%,WNT9A;LRP6;WNT11;FZD7;WNT16;BAMBI;FZD1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.41934899624420585,1.0950940906052016,0.3368146214099217,0.8097565934801272,1.0,9/60,4.26%,EGFR;CRIM1;MET;NTRK3;DDR2;FGFR1;NRP1;IGF2R;EFEMP1
prerank,MAP kinase phosphatase activity (GO:0033549),0.5500343118919802,1.0949054165477632,0.3865979381443299,0.8064067318190183,1.0,3/12,11.50%,DUSP16;DUSP5;DUSP10
prerank,calcium-dependent phospholipid binding (GO:0005544),0.42441445966208746,1.0926026581986723,0.34285714285714286,0.8089590784409629,1.0,10/49,9.65%,ESYT3;ANXA1;ANXA3;ANXA2;ANXA4;ESYT2;PLA2G4F;SYT8;C2CD5;PCLO
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4496800705196588,1.092231174829664,0.3561643835616438,0.8061911623985124,1.0,12/34,13.38%,CYTH3;ARAP1;GAB2;ZFYVE1;ARAP2;GBF1;IQGAP1;PARD3;COMMD1;KIF16B;FCHSD2;DAPP1
prerank,nucleotidyltransferase activity (GO:0016779),0.488389662768954,1.0904169834233903,0.3678343949044586,0.8071210909598118,1.0,7/19,21.53%,PAPSS2;NUDT5;TUT7;TUT4;REV1;MOCS3;TENT2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4472563930027479,1.0896230013015649,0.36923076923076925,0.8052666273774146,1.0,13/35,25.70%,FOXP1;KLF10;TAF1C;SMARCA4;BAZ2A;AGO2;TAF4;POU2F1;NR3C1;UBTF;GTF2B;RRN3;ZBTB17
prerank,transition metal ion binding (GO:0046914),0.35324134380800454,1.089592588567295,0.28353658536585363,0.8016361507660278,1.0,80/397,14.42%,ME1;AOX1;ACER3;ZFPM2;TES;HDAC4;MPPED2;ADH7;KLF4;NPEPPS;LARGE1;ABL1;HHIP;EEA1;KLF7;SEC24B;FDX1;CLIP1;TAB3;ZFYVE1;PHEX;MMP16;SKI;ARIH1;MNAT1;TIMP2;ZMYND8;MBD1;PLA2G15;XPNPEP1;ADA;B4GALT1;IDE;PLSCR1;CBLC;TNP2;MYCBP2;XPNPEP3;ZMYM2;MDM4;RXRA;ZNF8;P2RX4;TYW5;GLI2;WRN;SCD;COMMD1;LIMS1;CCS;SEC23A;SCO2;ZBTB32;CUTC;ZDHHC15;TIMP1;ERAP1;ADAMTS3;SMPDL3A;MSRB2;ALKBH8;CZIB;USP33;CHORDC1;IFIH1;ARIH2;CHD3;UBA5;TK1;DYRK2;PLSCR3;LARGE2;PITRM1;MGAT1;RNF2;NFU1;ECE1;HDAC10;S100B;SEC24D
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.45463887906959943,1.0870122313550972,0.36444444444444446,0.8044296979747819,1.0,16/29,28.43%,ACER3;GANC;IDUA;NEU3;HPSE;GALC;GANAB;ENGASE;MGAM;HEXD;HYAL3;GAA;HPSE2;GBA2;NEU1;MOGS
prerank,protein kinase binding (GO:0019901),0.3492901836705334,1.0863583446307108,0.27586206896551724,0.8024769771925356,1.0,67/479,10.08%,SLC12A7;SLC12A2;TCF7L2;GRK5;PKD1;SOX9;ANK2;CCNA2;EZR;CIT;WNK1;ADAM9;PRKCD;FOXO3;HDAC9;UNC5C;DSP;SHC1;ITGB1;CNTLN;GSK3B;RHOBTB1;ABL1;IRS1;AP2A2;NELL1;SPRED2;NR4A3;ACSL3;TELO2;PTPN2;RNF138;BECN1;DNAJC3;SKI;IRAK4;ESR1;ITGAV;STAT3;MAVS;PFKFB2;PDLIM5;CDC25B;NBEA;DLG1;NSF;CHEK2;DUSP16;CDKN1B;IBTK;DUSP5;AP2A1;RHOA;IQGAP1;RND3;TNNI3;AURKA;DACT1;PPEF2;PLCG2;ATF7;RARA;IRAK3;ACVR1;RB1CC1;LIMS1;PPP1R12A
prerank,protein phosphatase 2A binding (GO:0051721),-0.3993952169097585,-1.0854232769882421,0.3681159420289855,0.6849860540689978,1.0,8/23,14.75%,MFHAS1;FOXO1;DAB2IP;CTTNBP2NL;MAPT;SPHK1;GRIN3A;SMG7
prerank,histone deacetylase binding (GO:0042826),0.38989491734640974,1.0850935106335482,0.34143377885783716,0.801979330993226,1.0,30/88,24.18%,HDAC4;GLI3;HDAC9;HES1;MEF2A;LCOR;CAMTA2;DACT1;NCOR1;MIER1;MTA1;NIPBL;KAT2A;PKN2;NCOR2;HDAC10;CCND1;KAT2B;DHX36;BRMS1L;MAPK8;SATB2;MIER2;THAP7;BEX4;MEF2D;AKAP8L;BRMS1;NUDT21;CIR1
prerank,metal ion binding (GO:0046872),0.34875289662851533,1.0818846396493909,0.29441624365482233,0.8064243716312163,1.0,57/477,11.60%,SLIT3;SLIT2;SMOC2;THBS1;CDH1;EYA2;ACER3;CDH11;MAP3K5;ESYT3;MARK1;PPP3CA;ANXA1;ANXA3;ANXA2;DSPP;GSN;ANXA4;GCLC;COLEC11;DSG2;GLCE;ABL1;ESYT2;PLA2G4F;TRPM4;STIM2;ITPR2;LRP1;CASR;PLSCR1;CRACR2A;LTBP4;OC90;TGM3;S100G;SYT8;DXO;MARK2;NLK;S100A10;IQGAP1;WRN;C2CD5;SIK3;PCLO;S100A2;SIK2;IRAK3;APEX1;NUDT5;MAPK12;TRIM26;HACL1;MAST2;FOXK2;DSG3
prerank,kinase binding (GO:0019900),0.3472248893270883,1.0813137273162972,0.30284552845528456,0.804257824450563,1.0,70/434,13.57%,SLC12A7;EGFR;SLC12A2;TCF7L2;PKD1;ANK2;CCNA2;CIT;WNK1;PRKCD;FOXO3;UNC5C;GSN;SHC1;TAX1BP1;CNTLN;GSK3B;RHOBTB1;TTC28;AP2A2;SPRED2;NR4A3;ACSL3;TELO2;PTPN2;RNF138;DLG2;BECN1;DNAJC3;SKI;IRAK4;ESR1;STAT3;MAVS;PIP5K1A;PFKFB2;CDC25B;NBEA;DLG1;NSF;CHEK2;BCAR3;CDKN1B;IBTK;ATP1A4;AP2A1;RHOA;IQGAP1;RND3;TNNI3;AURKA;PLCG2;IRAK3;RB1CC1;LIMS1;PPP1R12A;CAB39;STRADA;SMCR8;PER1;RB1;TIAM1;CHP1;CARD16;TRIP6;FAM83H;NISCH;PAK2;PAX6;PRAM1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.47607052498284125,1.0792093142684391,0.37181409295352325,0.8059549245566495,1.0,8/20,23.87%,MAGI3;DLG2;DLG1;AK4;AK3;AK9;CASK;AK1
prerank,ADP binding (GO:0043531),0.4663225846477629,1.0764685549172255,0.3738601823708207,0.8092410266437368,1.0,2/25,2.63%,ME1;GCLC
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.46422482891968064,-1.07636803548435,0.37349397590361444,0.6997286027346393,1.0,9/12,46.04%,ELOVL4;GPR88;RRH;GPR52;OPN3;OPN5;OPN1SW;GNAT2;OPN4
prerank,store-operated calcium channel activity (GO:0015279),-0.47313600365874553,-1.0759975175134806,0.3891625615763547,0.6941235810847929,1.0,6/10,14.87%,TRPC3;TRPC4;TRPC6;ORAI2;TRPC1;ORAI1
prerank,voltage-gated cation channel activity (GO:0022843),0.3854634195348377,1.0758093401803355,0.35842293906810035,0.8072551137293404,1.0,11/97,7.26%,KCNB2;CACNA1C;PTK2B;KCNQ5;KCNS3;CACHD1;KCNB1;TMC1;ITGAV;CACNG6;CACNA1F
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.4271263227801748,-1.0730334019723693,0.35309278350515466,0.6950812344519349,1.0,4/15,12.92%,PIK3R1;PIK3R6;SOCS5;PIK3R5
prerank,actin binding (GO:0003779),0.3640383494109175,1.06957671435323,0.35838779956427014,0.819491919685888,1.0,35/170,13.17%,MICAL2;COBL;FXYD5;EZR;PHACTR1;PAWR;CALD1;GSN;PARVA;PDLIM7;SORBS1;GIPC1;ITGB1;FLNB;PRKCE;MLPH;ABL1;VCL;DMD;MRTFA;PDLIM5;DMTN;RDX;NCALD;MAP1B;TNNI3;MYOZ3;EMD;SYNE2;CAPZA1;MSRB2;ADD1;LIMA1;SSH3;PHACTR2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.39566237274292415,-1.0677949700996903,0.3819241982507289,0.701993552314915,1.0,6/21,19.92%,GRM5;GRM1;GRIA1;ANXA9;CHRNA7;CHRFAM7A
prerank,exopeptidase activity (GO:0008238),-0.33270534785686323,-1.0672612896224747,0.3441295546558704,0.6968512402015031,1.0,15/50,14.56%,CTSH;ACE;DPP10;DPP4;ENPEP;CTSA;CTSZ;PRCP;ACE2;DPP6;TRHDE;MME;LTA4H;ZMPSTE24;RNPEP
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.45915433014974694,1.066308177981588,0.38088235294117645,0.8243393222322487,1.0,9/28,22.15%,EDA;FEM1B;MYD88;TRAF5;TNFSF11;PIDD1;TRAP1;TRAF3;CASP8AP2
prerank,carboxy-lyase activity (GO:0016831),0.4720273228528985,1.0643191009638755,0.4071207430340557,0.8256949897528821,1.0,9/23,23.43%,CSAD;ECHDC1;MVD;PPCDC;AZIN1;ACOD1;UMPS;ODC1;GGCX
prerank,nucleoside-diphosphatase activity (GO:0017110),0.5165344117135151,1.061793683790045,0.40439932318104904,0.8285137990651213,1.0,5/12,14.68%,ENTPD6;NUDT5;ENTPD2;ENTPD7;NUDT15
prerank,GTPase binding (GO:0051020),0.3551923842621378,1.058534350712189,0.3783783783783784,0.8330489535279745,1.0,32/194,10.18%,PLCE1;CDC42EP5;EXOC4;NDRG1;AKAP13;SGSM2;ARHGDIB;YBX3;DOCK7;UNC13B;ERC1;MLPH;SRGAP2;PDE6D;HPS4;RAB11FIP3;BECN1;ANKRD27;RRAGB;RAPGEF6;OCRL;MYCBP2;RGP1;EXOC5;FGD6;RAB3GAP2;STRN3;PIH1D2;IQGAP1;RANBP2;EHD1;NCKAP1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3590580017234011,-1.055946708122292,0.3856655290102389,0.717377747314486,1.0,11/30,18.52%,SLC30A10;SLC39A10;SLC40A1;SLC39A8;SLC30A1;SLC31A1;SLC30A4;TTYH1;SLC39A1;SLC39A7;ATP7A
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4225875026915833,1.0553155367956,0.3827683615819209,0.8373848437817188,1.0,5/37,8.81%,WARS2;EARS2;YARS1;CARS2;NARS2
prerank,vitamin D receptor binding (GO:0042809),0.507569748934688,1.0546730247735487,0.4208754208754209,0.8353552421138474,1.0,6/14,19.81%,RXRA;MED13;MED14;THRAP3;MED24;SNW1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.48961711732233126,1.0521016751164847,0.4056291390728477,0.8384763568331821,1.0,3/15,2.80%,HS3ST4;HS3ST1;HS6ST2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.45129641948430776,-1.0512351452514688,0.3768844221105528,0.722247037452613,1.0,3/12,3.90%,IGF1;PIK3R1;INSR
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.5096589314625717,1.045450510589909,0.43686006825938567,0.8519953327214644,1.0,4/12,10.86%,PGF;ITGA5;VEGFA;ITGB3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5108457632797396,1.04521686174848,0.4096774193548387,0.8488765970162538,1.0,4/12,20.30%,B3GNT2;B4GAT1;B3GNT9;B3GNT6
prerank,PDZ domain binding (GO:0030165),0.388914990681078,1.0444717129460492,0.3959731543624161,0.8472372747502087,1.0,11/61,8.01%,CRIM1;CIT;CXADR;FZD7;ERC1;SLC26A6;KIDINS220;ATP2B4;SNTG2;NSF;FZD1
prerank,sulfotransferase activity (GO:0008146),0.42797287049940747,1.0429606362559258,0.3930635838150289,0.8474355139873809,1.0,5/33,4.55%,UST;HS3ST1;CHST13;CHST5;SULT1A1
prerank,"DNA binding, bending (GO:0008301)",0.4913423705658282,1.0415947260647505,0.43456375838926176,0.8473732657563249,1.0,3/14,8.69%,FOXD1;FOXL1;FOXC1
prerank,N-acyltransferase activity (GO:0016410),-0.3465803016171453,-1.0412148402800872,0.3651315789473684,0.7398144446468322,1.0,5/32,12.05%,CERS4;TGM2;NMT2;CERS1;CERS2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.36644828612393154,-1.0395534274574083,0.3791208791208791,0.7374439886892815,1.0,6/25,12.02%,PARP14;ART3;PARP16;PARP8;TIPARP;PARP11
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.44241452966104416,1.0367192097338715,0.43213728549141966,0.8562164090217816,1.0,10/24,24.98%,IP6K2;PPIP5K2;IP6K1;IP6K3;AK4;AK3;AK9;PPIP5K1;AK1;NME6
prerank,phospholipase activity (GO:0004620),0.3815229980536222,1.0361761903882727,0.4253164556962025,0.8540134415487396,1.0,8/67,8.10%,PLCE1;MGLL;PLCB3;PNPLA3;PLA2G4F;PLA2G15;ABHD6;DDHD1
prerank,cysteine-type peptidase activity (GO:0008234),0.3841832791310074,1.0342831575897327,0.4177831912302071,0.8549726328483226,1.0,25/73,20.82%,USP46;USP2;USP13;CAPN2;USP24;CASP6;USP34;USP49;USP15;USP25;USP1;USP10;USP7;OTUD7B;USP47;USP33;CASP2;USP28;USP9X;ATG4A;USP40;ATG4B;TINAGL1;USP21;USP36
prerank,phosphatidylglycerol binding (GO:1901611),0.5008443763888931,1.0314441328321424,0.4492512479201331,0.8582911519568542,1.0,2/13,2.58%,PITPNC1;PITPNA
prerank,lipoprotein particle binding (GO:0071813),0.4667034352526671,1.0312768424820329,0.4276629570747218,0.8551435586048864,1.0,2/20,5.59%,THBS1;LDLR
prerank,calcium:sodium antiporter activity (GO:0005432),0.5242269868905544,1.028701456125891,0.4527363184079602,0.8580975667191875,1.0,1/10,0.69%,SLC24A3
prerank,protein kinase regulator activity (GO:0019887),0.36663061152222043,1.028680995059461,0.4424019607843137,0.8546244607851465,1.0,16/95,11.55%,CCNA2;WNK1;WNT11;PARVA;FGF13;KIDINS220;DNAJC3;CCNL2;ELP3;MARK2;CDKN1B;CCNL1;CAB39;STRADA;SMCR8;CCNYL1
prerank,MAP kinase activity (GO:0004707),-0.42804587499728264,-1.0262316249304897,0.43209876543209874,0.7644229651545749,1.0,1/14,0.31%,MAPK4
prerank,nuclear localization sequence binding (GO:0008139),0.4611691896532794,1.0242462507517887,0.4358974358974359,0.8620471524238839,1.0,5/18,15.98%,KPNA1;TNPO2;KPNA4;NUP153;NUP214
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.44004923126535833,-1.020740603019405,0.43686868686868685,0.7721683832520274,1.0,8/13,15.60%,GABRG3;GABRA2;GLRA1;GABRA1;GLRA3;GABRG1;GABRA4;GABRA5
prerank,myosin binding (GO:0017022),0.3923485678970968,1.0198633739659082,0.42649006622516555,0.8692850458733118,1.0,10/55,9.21%,CALD1;GSN;GIPC1;MLPH;RAB6A;DMD;NPHS1;SHROOM4;RHOA;RAB25
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.34738822804017727,1.0177951976971555,0.46258503401360546,0.8705943980952656,1.0,29/147,11.72%,PLCE1;DOCK5;ARHGEF28;CYTH3;AKAP13;VAV2;DNMBP;RASGEF1B;BCR;RAP1A;HERC2;HPS4;ANKRD27;DENND2C;ARHGEF6;RAPGEF6;WDR41;MYCBP2;RGP1;FGD6;RAB3GAP2;DENND6A;ARHGEF10;SMCR8;ARHGEF5;GAPVD1;RANGRF;TIAM1;FARP1
prerank,kinase activator activity (GO:0019209),0.42079704741602886,1.0154342362101885,0.4410029498525074,0.872936384928414,1.0,6/30,10.52%,WNK1;WNT11;FGF13;MARK2;CAB39;STRADA
prerank,phosphatidylcholine transporter activity (GO:0008525),0.46976077600911864,1.0152590610985672,0.45187601957585644,0.8698388764380696,1.0,3/17,2.58%,PITPNC1;ATP10A;PITPNA
prerank,NADP binding (GO:0050661),0.41958328014762336,1.0147132808626398,0.45294117647058824,0.8676086459055882,1.0,4/32,9.95%,ME1;GMDS;DECR1;LBR
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4982391870281343,1.014284713555359,0.4596375617792422,0.8652698202643774,1.0,3/12,3.62%,SHC1;GAB2;IRS1
prerank,hexosyltransferase activity (GO:0016758),0.361005786127782,1.0079864506680065,0.4567307692307692,0.8768885094728449,1.0,23/101,20.30%,TMTC1;EXT1;MGAT4C;B3GNT2;LARGE1;HEXA;GCNT2;B4GALT1;POGLUT3;HAS1;PIGB;B4GAT1;A4GALT;B4GALNT3;LARGE2;POMGNT2;B3GNT9;ALG12;POGLUT2;POFUT1;CHPF2;B4GALT7;B3GNT6
prerank,acylglycerol lipase activity (GO:0047372),0.5043523736269167,1.0054616440905078,0.49466192170818507,0.8796406080122997,1.0,2/11,6.81%,MGLL;ABHD6
prerank,Hsp90 protein binding (GO:0051879),0.4136403538781669,1.0024972649569732,0.4670487106017192,0.8830354302187033,1.0,7/33,12.35%,SLC12A2;TELO2;HDAC8;UNC45A;PPEF2;PPP5C;CHORDC1
prerank,GDP binding (GO:0019003),0.3761757869891923,1.002400809800198,0.46797385620915033,0.8798026339485816,1.0,24/63,28.41%,NRAS;KRAS;MRAS;RAP1A;ARL3;RAP2C;MIEF1;RIT1;RAB27B;RAB5B;RAB21;RHEB;RAN;RAB5A;RAB18;RAB11B;RAB35;RAB7A;RAB8A;RAB42;DIRAS2;RAP2B;RALB;RAB17
prerank,nuclease activity (GO:0004518),0.38941274020810285,1.0013201358872055,0.449868073878628,0.878927948333931,1.0,20/52,26.53%,N4BP2;STK31;EXO1;PLSCR1;ERCC5;WRN;APEX1;ZC3H12A;ERN2;RNASEH2A;DFFB;DIS3L2;RNASE6;REXO1;DDX1;RNASE3;EXOG;MAP1S;PARN;RNASE12
prerank,calcium-release channel activity (GO:0015278),-0.38647926867454585,-1.0011074569161433,0.4810126582278481,0.8150093967277905,1.0,2/17,4.69%,ITPR1;RYR2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.45154910013948407,1.0006908698260217,0.4604200323101777,0.8769179845920905,1.0,8/20,21.66%,PNPLA3;MOGAT3;PLA2G15;MOGAT1;LCLAT1;LPCAT1;GPAT3;ABHD5
prerank,galactosyltransferase activity (GO:0008378),0.5039493855155366,1.0002462678496395,0.4833040421792619,0.8746738139451209,1.0,6/11,20.30%,B4GALT1;B3GALT6;A4GALT;A3GALT2;B4GALT7;B3GNT6
prerank,zinc ion binding (GO:0008270),0.3276788947198614,0.9993976943802143,0.4859228362877998,0.8734261808712728,1.0,66/293,16.23%,ACER3;ZFPM2;TES;HDAC4;ADH7;KLF4;NPEPPS;HHIP;EEA1;KLF7;SEC24B;CLIP1;TAB3;ZFYVE1;PHEX;MMP16;SKI;ARIH1;MNAT1;TIMP2;ZMYND8;MBD1;PLA2G15;ADA;IDE;PLSCR1;CBLC;TNP2;MYCBP2;ZMYM2;MDM4;RXRA;ZNF8;P2RX4;GLI2;LIMS1;SEC23A;ZBTB32;ZDHHC15;TIMP1;ERAP1;ADAMTS3;SMPDL3A;MSRB2;ALKBH8;CZIB;USP33;CHORDC1;IFIH1;ARIH2;CHD3;UBA5;TK1;PITRM1;RNF2;ECE1;HDAC10;S100B;SEC24D;DPP3;KDM2A;ZDHHC20;NUDT12;DPEP1;CAD;SORD
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4236368730101168,0.9992800607899431,0.46307692307692305,0.8703314682046966,1.0,12/27,30.77%,POLR1A;POLR1F;POLR3K;PRIM1;POLR3F;POLR3A;POLR3B;CRCP;POLR1D;POLR1H;PRIMPOL;POLR1C
prerank,active ion transmembrane transporter activity (GO:0022853),0.403100926808463,0.9985283370933582,0.48450704225352115,0.8686828114009639,1.0,3/37,1.49%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,ubiquitin protein ligase activity (GO:0061630),0.33661801468860847,0.9982803016633851,0.5069222577209798,0.8659185381242193,1.0,52/228,16.81%,WWP1;NEDD4;TRAF3IP2;UBE4B;WWP2;RNF144A;RNF115;HERC2;RNF138;RNF185;UBR4;ARIH1;MKRN3;UBR5;RNF19A;TRIM44;RNF114;TRIP12;CBLC;BIRC7;MYCBP2;RNF126;UBE2D3;LRSAM1;UBE4A;KCMF1;TRIM41;TRIM7;TRIM26;TRIM55;FBXO17;RNF111;RNFT2;COP1;RNF122;ARIH2;ANKIB1;SMURF1;CUL3;RNF2;RNF135;FANCL;ASB1;TRIM39;UBE2K;SH3RF3;NSMCE1;MKRN1;BFAR;UHRF2;RNF14;UBE3C
prerank,four-way junction DNA binding (GO:0000400),0.4570013691151387,0.9973493234213744,0.4552980132450331,0.8647851942618863,1.0,5/17,20.60%,ABL1;WRN;YY1;FANCM;RAD51C
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.39646927579819624,0.9963461420828554,0.46131805157593125,0.8638463648104812,1.0,17/42,28.21%,CCNA2;CCNL2;CDKN1B;CCNL1;CCNYL1;CCND1;KAT2B;CDKN1A;CCNT1;CCNG1;CCNB1;CCND3;CCNF;HEXIM1;CDKN2C;CCNE2;CCNT2
prerank,actinin binding (GO:0042805),0.4414711986800824,0.9951942888270447,0.46476761619190404,0.8632426619471776,1.0,6/21,9.89%,CACNA1C;CSRP3;PDLIM5;CSRP2;NFKB1;RARA
prerank,sequence-specific mRNA binding (GO:1990825),0.5112206116998692,0.9945796765850025,0.4928571428571429,0.8614437898071479,1.0,4/10,21.69%,ETF1;DHX9;FMR1;SSB
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5029419606784132,0.9933759998614505,0.4797297297297297,0.8609340041802894,1.0,9/11,32.25%,PRMT8;PRMT6;CARM1;NDUFAF7;PRMT5;FBXO11;PRMT2;PRMT9;PRMT3
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3679553044146089,-0.992288538017675,0.465564738292011,0.8308370766167944,1.0,5/22,12.19%,APOE;PICALM;HSPG2;SYT1;HSP90B1
prerank,ribosome binding (GO:0043022),0.39138885275286195,0.9910155776099425,0.4568062827225131,0.8632446419754027,1.0,11/46,17.64%,RPSA;ETF1;MRPS27;IGHMBP2;MTIF3;SERBP1;SEC61A1;EIF6;ZC3H12A;NAA15;EIF2S1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.4952250855760712,0.9909457691760551,0.46880570409982175,0.8602375616315553,1.0,4/11,18.11%,APEX2;APLF;APEX1;NEIL3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.40246381286598154,0.988724284573423,0.47076023391812866,0.862086684323333,1.0,6/32,11.00%,EGLN3;FTO;RIOX2;TMLHE;TYW5;JMJD4
prerank,beta-tubulin binding (GO:0048487),-0.32779022892197185,-0.9866997879700494,0.49174917491749176,0.8384331880084499,1.0,9/31,18.69%,GJB6;TTLL7;EML4;PDCD5;GABARAPL1;GABARAP;TRPV4;PACRG;DLEC1
prerank,hormone receptor binding (GO:0051427),0.46225088574501716,0.9863235620666396,0.4867109634551495,0.8640203470451381,1.0,3/14,17.78%,PTHLH;SOCS2;NCOA6
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2922811093813168,-0.9836605097175083,0.5,0.8391094928957714,1.0,20/56,20.36%,PIK3R1;NRG3;DOCK4;GRB14;CBLB;ANGPT2;SOCS5;FRS2;GAS6;BLNK;SHC3;DUSP3;SHC4;SH2B3;RACK1;ARHGEF16;FLT3LG;HYAL2;NRG1;ANGPT4
prerank,ligand-gated cation channel activity (GO:0099094),0.3548506232284141,0.982102335473811,0.48064918851435706,0.8702044272064122,1.0,7/75,8.66%,KCNJ2;PTK2B;KCNJ15;TRPM4;P2RX2;GRIK4;P2RX4
prerank,thyroid hormone receptor binding (GO:0046966),0.41510456146291486,0.98125190214853,0.4773060029282577,0.8688457599780138,1.0,11/28,17.78%,JMJD1C;TRIP12;MED13;NCOR1;TRIP6;THRAP3;MED24;NSD1;BRD8;GAS2L1;NCOA6
prerank,5'-3' RNA polymerase activity (GO:0034062),0.41242440653316265,0.9811990604397479,0.4848024316109423,0.8658057866233573,1.0,10/27,26.93%,POLR1A;POLR1F;POLR3K;POLR3F;POLR3A;TENT2;POLR3B;CRCP;POLR1D;POLR1H
prerank,methylation-dependent protein binding (GO:0140034),0.3765069512001121,0.9809575747031565,0.4961340206185567,0.8631449408377282,1.0,23/57,30.22%,TDRD3;ZMYND8;MBTD1;SGF29;CBX5;MORC3;BPTF;ZCWPW2;ATRX;PYGO1;SUZ12;FMR1;MORC4;CHD1;ING1;THAP7;SPIN4;CBX2;ING3;NCAPD3;MPHOSPH8;CBX8;CHD8
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4349084178862045,-0.9809268993907401,0.5095693779904307,0.8388695310675225,1.0,3/11,8.83%,LEF1;GATA2;MBD2
prerank,methylated histone binding (GO:0035064),0.37291136379405393,0.980059732049491,0.4929757343550447,0.8619561961813499,1.0,24/62,30.22%,TDRD3;ZMYND8;MBTD1;SGF29;CBX5;MORC3;BPTF;ZCWPW2;ATRX;PYGO1;SUZ12;FMR1;MORC4;CHD1;ING1;THAP7;SPIN4;CBX2;ING3;TAF1;NCAPD3;MPHOSPH8;CBX8;CHD8
prerank,cardiolipin binding (GO:1901612),-0.44148395190608875,-0.9791078192869992,0.5062034739454094,0.836630640565923,1.0,2/10,12.82%,GSDMD;MME
prerank,ubiquitin protein ligase binding (GO:0031625),0.3247631563366429,0.9782506814316809,0.524416135881104,0.8629807353451298,1.0,52/254,17.26%,EGFR;SNCAIP;TANK;SMAD6;FHIT;USP2;USP13;MID1;GSK3B;HERC2;VCP;UBE2B;VCL;BECN1;SKI;ARIH1;CLU;IKBKE;CHEK2;GPI;NLK;HSPA1L;EGR2;USP25;JUN;SLC22A18;USP7;PER1;SMAD2;RB1;TRAF5;TNFRSF1B;CKB;XRCC5;TRIOBP;FATE1;CUL3;NPLOC4;CXCR4;PSMD1;FANCL;SPOP;CASC3;SQSTM1;PML;UBE2K;IKBKG;CUL1;AMBRA1;BCL10;PRKAR2A;TSG101
prerank,N-acetyltransferase activity (GO:0008080),0.44552232613743337,0.977368728741108,0.48604992657856094,0.861933572832779,1.0,9/19,26.46%,ATAT1;EP300;KAT2B;NAT1;SAT1;NAT10;ESCO1;NAA50;NAA80
prerank,solute:proton symporter activity (GO:0015295),0.4554130613728589,0.9770878088656669,0.49411764705882355,0.8595335669005388,1.0,1/16,1.19%,SLC2A13
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.32676145695664893,0.9748861014618337,0.5411392405063291,0.861677441720861,1.0,52/232,16.81%,WWP1;NEDD4;TRAF3IP2;WWP2;RNF144A;RNF115;HERC2;RNF138;RNF185;UBR4;ARIH1;MKRN3;UBR5;RNF19A;TRIM44;RNF114;TRIP12;CBLC;BIRC7;MYCBP2;PIAS2;PIAS3;RNF126;UBE2D3;LRSAM1;EGR2;KCMF1;TRIM41;TRIM7;TRIM26;TRIM55;FBXO17;RNF111;RNFT2;COP1;RNF122;ARIH2;ANKIB1;SMURF1;CUL3;RNF2;RNF135;FANCL;ASB1;TRIM39;SH3RF3;NSMCE1;MKRN1;BFAR;UHRF2;RNF14;UBE3C
prerank,protein homodimerization activity (GO:0042803),0.31352753884053086,0.9744402628257234,0.555667001003009,0.8595356472632191,1.0,114/589,17.26%,SLIT2;FOXP2;AOX1;EXT1;MAP3K5;ABCD3;LRP6;PDGFC;CAMK2D;MGLL;NECTIN3;ZBTB16;HES1;ABCG2;GRHL1;ADRB2;PRPS2;FGFR1;MID1;CPQ;BMPR1A;GLCE;SRGAP2;EEA1;NR4A3;MYOM3;SNX2;NPR3;ZBTB7B;HPS4;ACP3;RAB11FIP3;BHLHE40;PDCD6IP;NOG;PNPO;SPPL2A;PON3;STAT3;GDNF;DDIT3;CASR;RIPK2;XPNPEP1;IDE;MMACHC;CLTRN;JUP;NFS1;XPNPEP3;CHEK2;PDGFA;ERCC5;RABEP1;PAFAH1B2;TYW5;S100A10;PRMT8;CHUK;WRN;COMMD1;IRAK3;ACVR1;NRF1;VEGFA;HSPB8;SRM;NUDT5;CEP131;MVD;CISD2;SLC39A13;MKLN1;INHBB;SLC8B1;GLB1;CCDC66;ADD1;DGCR8;NAGA;NR6A1;ZDHHC2;FBXO4;TCF3;HNF4A;GALE;SH3GLB1;UBA5;ECE1;GSTM4;S100B;CEACAM5;ST3GAL2;ZBTB1;CARNMT1;ADAM10;PML;KYAT1;CEP43;TMEM192;SDCBP2;XDH;IKBKG;XPA;MAD2L1;KNSTRN;CEP57;SCARB2;STARD3NL;ABCD1;CREB3L3;PSMD7;BARD1;TSG101
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.4085140243906107,-0.9732343857111428,0.4905149051490515,0.8445515492541165,1.0,5/12,25.23%,TBPL1;STAT1;RUVBL2;GTF2A1;RELA
prerank,anion transmembrane transporter activity (GO:0008509),-0.4088707632306897,-0.9725602980920193,0.5234375,0.8395620477324823,1.0,3/12,4.87%,SLCO2B1;SLC22A6;SLC39A8
prerank,cell-cell adhesion mediator activity (GO:0098632),0.387471278046921,0.9720584565281748,0.4979310344827586,0.8620815572531911,1.0,7/42,7.44%,BAIAP2L1;STXBP6;ANXA1;ANXA2;TMOD3;PDLIM5;EMB
prerank,P-type ion transporter activity (GO:0015662),0.4696478839912942,0.9710073354035431,0.4942339373970346,0.8613235065555441,1.0,2/12,5.13%,ATP2C2;ATP2B4
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3932840588398203,0.9702929563667596,0.4858757062146893,0.859843108443453,1.0,7/38,8.85%,SORBS1;SHC1;GAB2;IRS1;NCK2;SHANK1;G3BP2
prerank,platelet-derived growth factor binding (GO:0048407),0.47819073225865805,0.9689114569885672,0.4965986394557823,0.8598807437893049,1.0,3/11,7.96%,COL6A1;COL3A1;PDGFA
prerank,single-stranded DNA binding (GO:0003697),0.35287147471205216,0.9686907437548418,0.5301932367149759,0.8573282175526135,1.0,28/93,20.73%,CRY2;RNF138;STN1;ERCC5;MCM7;MCM2;RAD23B;TOP1;BRCA2;IGHMBP2;NABP1;DDX11;RAD52;CDC45;DHX9;MCM9;RBBP8;RPA1;TOP3A;RAD51;ERCC1;NEIL3;DHX36;WDR48;RTF1;SWSAP1;SMC6;POLA1
prerank,GABA receptor activity (GO:0016917),0.4306909024021525,0.9683967922105379,0.4896,0.8550001749043658,1.0,2/21,4.00%,GPR156;GABRA3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.4397604170164529,-0.9681619027934395,0.5048309178743962,0.8438581509281317,1.0,3/10,14.98%,CYBA;NCF2;NOX4
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4575792748083192,0.9659915354601919,0.48534201954397393,0.8572282785025842,1.0,4/15,13.01%,PIK3C2B;PI4KB;ATM;PIK3R3
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4504473342888784,0.9643577356474444,0.5113043478260869,0.8577664996662199,1.0,2/13,12.66%,EXO1;SLX4
prerank,protein kinase inhibitor activity (GO:0004860),0.3879338623202948,0.9618039324473397,0.5201668984700973,0.8602873069637084,1.0,7/42,10.91%,CIT;PARVA;SPRED2;DNAJC3;CDKN1B;IBTK;SMCR8
prerank,acyl-CoA hydrolase activity (GO:0047617),0.44049437785896894,0.961776290888671,0.5016181229773463,0.8574044047538641,1.0,6/17,19.02%,ACOT8;ACOT12;ACOT9;ACOT13;ABCD1;ACOT11
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.40307089942943447,-0.9617685597908884,0.49135802469135803,0.852932256001597,1.0,5/13,9.13%,PDGFD;PDGFRB;IL1R1;ERN1;PDGFRA
prerank,phosphatidylinositol binding (GO:0035091),0.3498684333211619,0.9614143280974917,0.5317073170731708,0.8553470908390649,1.0,14/91,9.53%,TNFAIP8L3;ESYT3;PITPNC1;PITPNA;EEA1;SNX2;ESYT2;SNX24;BCAS3;ZFYVE1;ITPR2;PHF12;PARD3;FCHO2
prerank,ion gated channel activity (GO:0022839),-0.33887626782265395,-0.9594316954324696,0.5222551928783383,0.8519908900400018,1.0,9/24,15.56%,KCNT2;ANO4;TTYH2;KCNT1;ANO2;TTYH1;TMEM63B;TMEM63A;ANO3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3159572845756299,0.955491264154123,0.5759493670886076,0.8652011435297048,1.0,53/269,17.26%,EGFR;SNCAIP;TANK;SMAD6;FHIT;USP2;USP13;MID1;GSK3B;HERC2;VCP;UBE2B;VCL;BECN1;SKI;ARIH1;CLU;IKBKE;CHEK2;GPI;NLK;HSPA1L;EGR2;USP25;JUN;SLC22A18;USP7;PER1;SMAD2;RB1;TRAF5;TNFRSF1B;DDRGK1;CKB;XRCC5;TRIOBP;FATE1;CUL3;NPLOC4;CXCR4;PSMD1;FANCL;SPOP;CASC3;SQSTM1;PML;UBE2K;IKBKG;CUL1;AMBRA1;BCL10;PRKAR2A;TSG101
prerank,adenylyltransferase activity (GO:0070566),0.4215356906948915,0.9546652844335348,0.526742301458671,0.864039680067607,1.0,3/21,8.13%,NMNAT2;ABL1;NMNAT1
prerank,aminopeptidase activity (GO:0004177),0.40505858315527477,0.9535195153008504,0.517557251908397,0.8634514204606091,1.0,8/26,17.76%,NPEPPS;MMP16;XPNPEP1;XPNPEP3;MMP14;ERAP1;LAP3;METAP1D
prerank,kinase activity (GO:0016301),0.33991437944149566,0.9533173126175962,0.548235294117647,0.8609486180381145,1.0,21/109,13.43%,STK39;GSK3B;PAPSS2;ABL1;PIK3C2B;IP6K2;RFK;ETNK1;TRRAP;DGKA;SHPK;PI4KB;HYKK;CCL3;NADK;MTOR;PPIP5K2;CHKB;CKB;PKN2;AGK
prerank,hydro-lyase activity (GO:0016836),0.37588544990576983,0.9516570978161571,0.5160390516039052,0.8615563705529982,1.0,7/41,11.33%,EHHADH;GMDS;AUH;CYP2S1;ECHDC1;UROC1;TGDS
prerank,voltage-gated calcium channel activity (GO:0005245),0.3872219453007979,0.9510485085822156,0.5148936170212766,0.8599831287532259,1.0,7/37,7.26%,CACNA1C;CACHD1;CACNA1G;TMC1;ITGAV;CACNG6;CACNA1F
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.39457272693299317,-0.9495324764553449,0.5378590078328982,0.868697521811798,1.0,4/14,14.98%,MICAL1;CYBA;NCF2;NOX4
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.40600924165816116,-0.9475364356046073,0.543640897755611,0.8669668818304711,1.0,2/11,13.25%,HCN1;HCN2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.31171739296661394,0.9465552798987114,0.6164102564102564,0.8667465795820793,1.0,97/346,22.08%,WWP1;NEDD4;TRAF3IP2;FBXO10;WWP2;RNF144A;RNF115;HERC2;RNF138;RNF185;UBR4;FBXW8;UBE2B;ARIH1;MKRN3;UBR5;RNF19A;TRIM44;BIRC6;RNF114;TRIP12;CBLC;BIRC7;RNF214;MYCBP2;RNF141;TRIM47;KLHL13;RNF126;UBE2D3;LRSAM1;FBXW11;KCMF1;FBXL6;TRIM41;TRIM7;TRIM26;TRIM55;FBXO17;RNF146;RNF111;UBE2Z;TRAF5;RNFT2;COP1;RNF122;FBXO4;RNF168;ARIH2;ANKIB1;SMURF1;CUL3;RNF2;ERCC8;UBE2S;RNF135;FANCL;ASB1;TRIM39;PML;UBE2K;SH3RF3;NSMCE1;CHFR;MKRN1;BFAR;CUL1;UHRF2;RNF14;UBE3C;BARD1;MKRN2;DTX3;FBXO25;BIRC3;TRIM25;TRAF3;TRIM45;TSPAN17;TRIM35;UBE2N;UBE2W;RNF123;RNF31;CNOT4;MIB1;NFX1;RNF8;HUWE1;RNF130;PPIL2;UBE2M;CDC42;RBCK1;CUL4A;RMND5A;ANAPC11
prerank,kinase inhibitor activity (GO:0019210),0.39303329520817865,0.944740840073584,0.5291545189504373,0.8676223435701406,1.0,5/33,10.91%,LRP6;PARVA;DNAJC3;CDKN1B;SMCR8
prerank,nuclear export signal receptor activity (GO:0005049),0.47185777859993927,0.9419954712198817,0.5347593582887701,0.8706850066174279,1.0,5/11,24.29%,XPO1;NUP214;XPO4;RAN;XPO7
prerank,water transmembrane transporter activity (GO:0005372),-0.41480202450129355,-0.9385227446976174,0.5504807692307693,0.8821801408691838,1.0,2/11,7.73%,AQP11;AQP4
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.3589265015904789,-0.938014384419145,0.5915119363395226,0.8765981310702422,1.0,4/18,12.92%,PIK3R1;PIK3R6;SOCS5;PIK3R5
prerank,AMP binding (GO:0016208),0.47291512653028056,0.9351633395948634,0.5469798657718121,0.8818594064055186,1.0,2/11,6.38%,MPPED2;PFKP
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.44768094612599246,0.9349491024415659,0.5331125827814569,0.8793536817166178,1.0,7/13,30.94%,TRMT10A;TARBP1;METTL1;TRMT1L;TRMT11;THUMPD2;FTSJ1
prerank,phosphatase activity (GO:0016791),0.3431143936157152,0.933411301694239,0.5822622107969152,0.8796111215499715,1.0,15/73,14.97%,PLPPR2;PLPP3;ALPL;ACP3;NANP;OCRL;DUSP16;DUSP11;DUSP5;LPIN2;DUSP10;PPP5C;PLPP1;SBF1;ACP4
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.26447175717579974,-0.9331388246073163,0.5829145728643216,0.8822418985122927,1.0,21/74,19.98%,NADK2;DGKB;DGKI;GK;DGKD;PIK3C2A;PANK1;SPHK1;DGKG;HK2;PGM2L1;FAM20C;PAPSS1;CHKA;IDNK;IPMK;IPPK;DGKE;PIK3CG;DGKZ;SPHK2
prerank,transferrin receptor binding (GO:1990459),0.4791661171833531,0.9297811055405828,0.5290102389078498,0.8843727709720274,1.0,6/10,26.46%,SNX2;CHUK;IKBKG;SNX4;HFE;IKBKB
prerank,cytokine receptor activity (GO:0004896),0.3404073225048413,0.9287696878824029,0.5823095823095823,0.8835721492009773,1.0,7/83,6.25%,F3;IL17RE;IL22RA1;CD44;CMKLR1;IL17RA;IL17RD
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3381961391138152,-0.9285635215522985,0.5342857142857143,0.8870688805064525,1.0,7/20,17.41%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;SLC30A4;SLC39A1;SLC39A7
prerank,pyridoxal phosphate binding (GO:0030170),0.41450668945892355,0.9284426625520972,0.5510204081632653,0.8813167371997493,1.0,2/20,5.65%,PYGB;PNPO
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.395502333702218,0.9278542344884452,0.5412979351032449,0.8795045285408352,1.0,15/28,35.69%,EXO1;APEX1;RPP38;RNASEH2A;AGO2;DROSHA;DBR1;EDC3;ELAC1;NUDT16L1;AGO3;DICER1;ELAC2;RNASEH1;POP1
prerank,RNA binding (GO:0003723),0.29649718371081196,0.9262316540666523,0.775,0.8800553918014625,1.0,350/1321,22.84%,STRBP;MSI2;RNMT;SLTM;MBNL1;SAMD4A;SPATS2L;TES;FNDC3A;DDX5;EZR;RBFOX2;RPSA;AHNAK;EIF4G3;ANXA2;ZCCHC24;DSP;GPATCH8;PURG;HOXB6;TCF20;CTNNA1;YBX3;RBM47;FLNB;LARP1B;GOLGB1;POLR1G;CAST;TDRD3;ERI3;DIAPH1;HDLBP;BMS1;SREK1;LUC7L2;SMG6;SON;EIF4G1;PNISR;VCP;DDX17;SIDT2;NUFIP2;ANKHD1;ALG13;RBM6;SNTB2;SRSF11;PRR3;FNDC3B;ZC3H7A;MKRN3;THOC2;STAT3;DUSP14;SRSF5;KDM1A;C1D;LRP1;CEBPZ;KMT2C;SRRM2;EWSR1;ZFR;FASTKD1;ZCCHC7;SRSF6;FAM120C;SYNCRIP;BZW1;NUDT4;SLPI;HNRNPH1;CELF1;CELF3;MOV10;RDX;MBNL2;YARS1;SCAF8;DXO;KTN1;MARK2;KIF1C;RBM39;FUS;ZC3H14;PABPC4;LARP4B;RBM27;ZC3H18;DDX18;CCDC9;DDX19B;TYW5;DUSP11;WDR43;G3BP2;RBM25;L1TD1;BCLAF1;ETF1;EBNA1BP2;DDX43;ELP5;PCBP4;RBMX;LBR;MTO1;TOP1;U2AF2;JUN;MRPS27;MTDH;GSPT1;USP10;APEX1;NUDT5;RBM33;CS;PRRC2C;ATXN2;IGHMBP2;TCERG1;CISD2;SERBP1;RBM28;KRT18;RPP38;DDX11;PLEC;ZBED4;MRPL14;MRPL32;EIF3E;MRPL40;PABPC1;EXOSC7;RBMS3;DDX42;SMC1A;ZCCHC8;ALKBH8;UTP6;ADD1;AATF;CKAP4;TDRD9;ARCN1;DGCR8;EIF3A;NCOA5;CPNE3;NOP56;ZC3H12A;SNRNP70;SCAF11;RRBP1;IFIH1;TRIP6;BRIX1;NELFE;ABCF1;SRRM1;PPRC1;GTPBP4;RPF1;SMG1;FARSA;MRPS31;PKN2;PRKDC;XRCC5;CSNK1E;CHD3;PUM2;ANXA7;TDRD7;ZC3H12D;NIP7;EIF2AK4;RBM34;PUS10;DHX9;STAU1;TUT7;DHX57;FYTTD1;PRPF3;GPKOW;RPUSD4;CDK11B;HNRNPM;TLR8;DCP1A;CASC3;BAZ2A;PUM1;U2SURP;KIN;TRMT10A;SCAF4;CHTOP;SF3B1;SF3B2;PDCD11;PPIG;EIF2S2;THRAP3;NOA1;NOL11;SEC23IP;AGO2;DDX56;DDX21;DDX49;SEC63;MKRN1;JMJD6;MRPL21;MEX3A;PRPF38B;ANKRD17;NAA15;MRPL42;TUT4;YY1;CDK13;ANXA11;NQO1;MRPS30;SRPK1;PSMC1;BARD1;YLPM1;PDAP1;ZC3H12C;MTIF2;WDR3;MKRN2;DIDO1;RBM14;EXOSC1;UTP4;MTHFSD;EIF2S1;ZC3H15;PUM3;DROSHA;KHDRBS1;DHX36;TRAP1;ZC3H11A;LSM8;DALRD3;KRI1;LSM2;FDPS;SNRNP35;CIRBP;EIF4B;WBP4;THOC5;RRP1B;TASOR;FXR2;USO1;KCTD12;MRPS28;MRPS35;LSM14B;SNRNP40;TRIM25;PNLDC1;ESF1;LARP4;RTF1;PCDHGA9;GANAB;NXF1;SRSF2;UBE2N;MATR3;CAPRIN1;DAZAP1;SEPSECS;HELB;SNW1;RAN;URB1;PNN;FMR1;IMMT;CNOT4;EIF4G2;FAM133B;MYEF2;TRA2B;ERH;ILF2;USP36;FBRSL1;NFX1;NUP98;PCDH20;YTHDF2;EPRS1;HUWE1;BYSL;DCAF13;HMGN2;DDX1;DBR1;LGALS3;NKAP;ALKBH5;NUDT1;MAZ;NOL3;MCAT;RBM3;SSB;SRPRA;LLPH;NOP58;UBAP2L;R3HDM2;SRSF12;STXBP1;LACTB2;NAF1;FLNA;NANOS2;ZCRB1;WDR75;UTP11;FASTKD5;TRMT1L;KNOP1;PRPF40B;FAM32A;TNRC6A;NCBP3;RBM5;FTSJ3;SRRT;NOC3L;FIP1L1
prerank,protein kinase C activity (GO:0004697),-0.38487570861965037,-0.9251986569746338,0.5584725536992841,0.8884683955833219,1.0,5/14,7.50%,PRKCH;PRKD1;PRKCB;PRKCQ;PRKCZ
prerank,syntaxin-1 binding (GO:0017075),-0.3418171834719081,-0.9220025506237738,0.5590778097982709,0.8895350220631197,1.0,4/22,10.47%,UNC13C;SNAP25;SYT1;SYP
prerank,actin monomer binding (GO:0003785),0.4114610466543283,0.9217128042883218,0.5576036866359447,0.8866306202580653,1.0,4/22,5.74%,COBL;PRKCE;ABL1;MRTFA
prerank,amino acid binding (GO:0016597),-0.30601619421741266,-0.9188602399256619,0.5642633228840125,0.8903173865273368,1.0,10/31,15.85%,GRM7;NOS3;GRIN2B;GRIN1;GLRA1;GLRA3;ASS1;GRIN3A;AGXT;DDAH2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3607056861010639,0.9184076630354682,0.5605858854860186,0.8904654294109695,1.0,14/49,16.38%,TAB3;VCP;IKBKE;RAD23B;OTUD7B;WDR81;UIMC1;ZRANB1;RNF168;TNIP1;ZBTB1;SQSTM1;ZFAND6;IKBKG
prerank,growth factor receptor binding (GO:0070851),0.32771944159706456,0.9182167920989752,0.6130952380952381,0.8880337795784242,1.0,20/95,13.32%,PGF;PDGFC;SHC1;FGF2;EFEMP1;SNX2;ITGA5;PLSCR1;AGR2;IL10;CBLC;PDGFA;VEGFA;ARF4;ATXN2;ITGB3;ERAP1;FGF22;TRIP6;PIBF1
prerank,endonuclease activity (GO:0004519),0.3544159843057453,0.9167192824787936,0.5906666666666667,0.8882790842414501,1.0,14/49,23.22%,N4BP2;SMG6;ERCC5;APLF;APEX1;ZC3H12A;ERN2;ZC3H12D;AGO2;ZC3H12C;LACTB2;MBD4;EXOG;YBEY
prerank,protein heterodimerization activity (GO:0046982),0.308948800581722,0.9156709116617606,0.6300768386388584,0.8875678755988675,1.0,29/178,12.33%,KCNB2;EXT1;ADRA1B;ATP1B1;KCNB1;ITGB1;BMP6;HEXA;MEF2A;AGTR1;NR4A2;SNX2;PAFAH1B1;BHLHE40;DDIT3;PDGFA;TLR4;SAE1;PAFAH1B2;ATP1A1;CHUK;AURKA;IRAK3;KATNB1;ATF6;ERBB2;SMC1A;ADD1;NR4A1
prerank,phospholipase activator activity (GO:0016004),-0.4082731690860098,-0.9154789933764089,0.5503875968992248,0.891450910348682,1.0,6/10,31.54%,ARHGAP6;BTK;CCL5;SRC;STX4;CCL8
prerank,lipase activator activity (GO:0060229),-0.40950842905890944,-0.9150782479422762,0.5894736842105263,0.8860154089861285,1.0,6/10,31.54%,ARHGAP6;BTK;CCL5;SRC;APOH;CCL8
prerank,voltage-gated chloride channel activity (GO:0005247),0.46827864350374093,0.9150410597772612,0.5791304347826087,0.8860099510189723,1.0,2/10,12.26%,ANO6;CLCN5
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.46233335903627315,0.9150249919728662,0.5612903225806452,0.8832441149931857,1.0,3/10,13.01%,PIK3C2B;ATM;PIK3R3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.40750957271369825,-0.914686891479891,0.5319148936170213,0.880583397006607,1.0,2/10,7.27%,KDM7A;KDM2B
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3725842138954896,-0.9135796611937206,0.5800524934383202,0.8766408817800083,1.0,4/15,12.71%,EPB41;PICALM;SNAP91;SCARB1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.45325848987474215,0.9131654786772598,0.5507487520798668,0.8840050399305491,1.0,4/10,20.12%,B4GALT1;B3GALT6;A3GALT2;B4GALT7
prerank,GTPase activity (GO:0003924),0.30672048999870377,0.9125372716004998,0.6543075245365322,0.8824697170761253,1.0,26/192,13.24%,RHOJ;ARHGDIB;ATL3;NRAS;KRAS;MRAS;RHOBTB1;RAB43;BMS1;RAP1A;RAB6A;ATL2;RHOQ;GNL1;GNG8;RRAGB;RAP2C;RHOA;RND3;GNA13;GSPT1;RIT1;GTPBP4;GPN1;GFM2;ENTPD7
prerank,exoribonuclease activity (GO:0004532),0.45581729707658875,0.9122953625866205,0.5813953488372093,0.8801451209686024,1.0,7/12,32.48%,EXOSC7;ZC3H12A;CNOT7;EXOSC1;EXOSC4;EXOSC2;EXOSC3
prerank,microtubule binding (GO:0008017),0.3038135988353432,0.9108343864303385,0.6518046709129511,0.8804768161755725,1.0,49/222,18.07%,EZR;NDRG1;CLIP4;MAPRE2;RP1;KIF13A;MTUS1;MID1;MAP7D3;FMN1;FGF13;NDEL1;CLIP1;HDGFL3;KIF1B;PAFAH1B1;ARL3;GAS2L2;KIF1C;TOGARAM1;KIF9;CAPN6;DYNC1I1;MAP1B;MACO1;FBXW11;KIF7;KATNB1;KIF16B;MAST2;CCDC66;CHP1;TUBGCP6;RMDN3;POLB;KRIT1;RMDN1;TUBGCP5;CEP44;HOOK3;KIF3B;KNSTRN;CEP57;FAM161A;TUBGCP4;EML6;MAP6;GAS2L1;WHAMM
prerank,histone demethylase activity (GO:0032452),0.39385353373132503,0.9108298269922342,0.5417298937784522,0.8777519812711396,1.0,9/27,18.21%,JMJD1C;KDM1A;RIOX2;KDM3B;KDM4D;KDM2A;JMJD6;HR;FBXL19
prerank,cGMP binding (GO:0030553),0.4567290541389287,0.9102737278214098,0.5682210708117443,0.8760738559029737,1.0,2/11,5.63%,PDE5A;PDE10A
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3802883914094117,0.9087652193282941,0.5925394548063128,0.8761773929486464,1.0,13/33,20.28%,RNF144A;RNF185;ARIH1;RNF19A;ZMYM2;DCUN1D5;TCERG1;ARIH2;ANKIB1;RNF14;DCUN1D4;DCUN1D2;DCUN1D1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.4147904705228347,0.9082160011674859,0.5689922480620155,0.8744354656250668,1.0,2/19,1.79%,EFNA5;ABI1
prerank,deoxyribonuclease activity (GO:0004536),0.4285254452363458,0.905818481895048,0.5647840531561462,0.8763384718006293,1.0,6/14,26.19%,ERCC5;APLF;APEX1;DFFB;MBD4;MAP1S
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.32677752893312645,-0.9050237862625691,0.622478386167147,0.8890720836321809,1.0,7/22,21.83%,CPEB2;HNRNPA0;ELAVL4;EXOSC9;CPEB3;RBM24;ELAVL3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.37018552825206014,0.9020930684586566,0.5740223463687151,0.8807572408775637,1.0,4/35,4.64%,PLCE1;MPPED2;PLCB3;APEX2
prerank,protein kinase activator activity (GO:0030295),0.3418022755846299,0.9019287856708852,0.6007653061224489,0.8783818811166276,1.0,10/60,10.52%,ABI1;WNK1;WNT11;FGF13;FAM20A;MARK2;IQGAP1;MLST8;CAB39;STRADA
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.4469116468378498,0.9002216167171403,0.555366269165247,0.8789480315238525,1.0,5/11,27.92%,NUDT4;NUDT5;NUDT1;NUDT7;NUDT16L1
prerank,nucleotide diphosphatase activity (GO:0004551),0.4221436206082017,0.8999353345169785,0.5704918032786885,0.8768538817126894,1.0,4/14,15.84%,FHIT;NUDT4;NUDT17;NUDT12
prerank,DNA replication origin binding (GO:0003688),0.4026976157123465,0.8998035011571146,0.578125,0.874477724941595,1.0,6/23,15.18%,MCM7;MCM2;DDX11;CDC45;DHX9;MCM9
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.3921099165645637,-0.8963809926615653,0.6030927835051546,0.9023392895477033,1.0,5/10,18.18%,CASP4;CFLAR;CASP3;CASP1;CASP12
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.413565613486182,0.8952491319122653,0.5852842809364549,0.8804064628881152,1.0,6/15,31.51%,KMT2C;KMT2D;WDR82;KMT2A;SETD1B;ASH2L
prerank,nuclear import signal receptor activity (GO:0061608),0.418802387266132,0.8950143190796087,0.5758998435054773,0.8782096433373887,1.0,5/15,25.36%,KPNA1;TNPO2;KPNA4;TNPO3;IPO4
prerank,epidermal growth factor receptor binding (GO:0005154),0.39568279026030123,0.8936037336350358,0.6055469953775039,0.8781838065560624,1.0,8/25,10.78%,SHC1;EFEMP1;SNX2;PLSCR1;AGR2;CBLC;ARF4;ATXN2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3165118576825531,0.8926772785253515,0.6429404900816803,0.8774042192189465,1.0,34/100,22.68%,CYTH3;ARAP1;PLEKHA4;GAB2;PLCZ1;WIPI2;SNX24;ZFYVE1;ARAP2;RLBP1;GOLPH3;GBF1;IQGAP1;PARD3;COMMD1;KIF16B;SNX12;FCHSD2;DAPP1;ARFIP1;ARFIP2;ANXA8;SNX20;ATG2A;SNX13;ZFYVE19;OSBPL5;WDR45B;PLA2G4A;RUBCN;PLEKHF1;FERMT2;ZFYVE26;MYO10
prerank,transcription coregulator binding (GO:0001221),0.3443789033737479,0.8923813397495881,0.6042780748663101,0.8753001155639306,1.0,14/50,18.96%,CIT;ZBTB16;ESR1;LCOR;EHMT1;RORA;PER3;PER1;EED;SUZ12;ZBTB7A;EHMT2;PER2;NEK6
prerank,lipoprotein particle receptor binding (GO:0070325),-0.31241673975260265,-0.8895631536443874,0.6467065868263473,0.9114108124709724,1.0,3/27,2.90%,APOE;PICALM;HSPG2
prerank,cAMP response element binding (GO:0035497),0.442696274336262,0.8876478722568121,0.5961871750433275,0.8817294640810596,1.0,5/10,15.02%,NR4A3;ATF7;JUN;CREB3L1;ATF2
prerank,death domain binding (GO:0070513),0.43697962108523547,0.8872787437112958,0.598939929328622,0.8798072613177946,1.0,2/11,3.12%,CRADD;DAPL1
prerank,glycine binding (GO:0016594),-0.3921993878510942,-0.8870943086666825,0.6286407766990292,0.9106582085827957,1.0,5/11,14.15%,GRIN2B;GRIN1;GLRA1;GLRA3;GRIN3A
prerank,chemokine binding (GO:0019956),0.37630764839425035,0.8860793276561103,0.625,0.8794469871819209,1.0,5/30,14.55%,ITGB1;FGF2;ITGAV;ITGB3;CXCR4
prerank,cytokine receptor binding (GO:0005126),-0.24928821018573263,-0.8855613839641019,0.7513812154696132,0.9075627225357827,1.0,14/83,13.42%,IL34;TGFBR3;CXCL12;CSF1;IL13RA1;IL6R;OSMR;SPRED1;IL18;IL6ST;SDCBP;MIF;LIFR;CCL19
prerank,guanyl ribonucleotide binding (GO:0032561),0.2958904857979522,0.8846481266866605,0.6885775862068966,0.8795296917511961,1.0,24/196,11.51%,RHOJ;MPPED2;ATL3;PDE5A;NRAS;KRAS;MRAS;RHOBTB1;BMS1;RAP1A;RAB6A;ATL2;PDE10A;ARL3;RHOQ;GNL1;ARF3;RRAGB;RAP2C;RHOA;RND3;ARF4;ARHGEF5;MIEF1
prerank,phosphatase inhibitor activity (GO:0019212),0.39598697366848296,0.8842706901044927,0.5930047694753577,0.8776248293476212,1.0,9/20,25.43%,CABIN1;STYXL1;BOD1L1;URI1;MGAT5;ARPP19;LGALS3;STYX;PPME1
prerank,carboxylic acid binding (GO:0031406),-0.27854671852223284,-0.8821689958723324,0.6884057971014492,0.9088434151133599,1.0,16/38,24.45%,GRM7;NOS3;GRIN2B;GRIN1;MAG;GLRA1;GLRA3;GRIN3A;PSAP;PHYH;GLDC;CASTOR1;SESN1;GLUD1;NOS2;SHMT2
prerank,C-C chemokine binding (GO:0019957),-0.32207156013126154,-0.8817687395353203,0.6438746438746439,0.9035188948668206,1.0,1/22,1.80%,CCR9
prerank,C-C chemokine receptor activity (GO:0016493),-0.326069363738269,-0.8809217793189976,0.6308539944903582,0.8994377546868103,1.0,1/21,1.80%,CCR9
prerank,ferrous iron binding (GO:0008198),0.3924220220521961,0.8802214484609262,0.6156351791530945,0.882473434195579,1.0,2/21,4.65%,EGLN3;FTO
prerank,nuclear receptor coactivator activity (GO:0030374),-0.2678101929959774,-0.8797635684138592,0.7022900763358778,0.8956501415793968,1.0,12/52,15.93%,TACC1;NCOA1;PPARGC1B;ETS1;PRKCB;PPARGC1A;ELK1;ACTN4;PKN1;CNOT9;MED1;NCOA7
prerank,lipase activity (GO:0016298),0.3490560159132035,0.8784260878890586,0.6225626740947076,0.8830644111942749,1.0,11/43,19.51%,MGLL;PNPLA3;PLA2G15;ABHD6;DAGLB;DDHD1;LCAT;PITPNM3;SEC23IP;LDAH;ABHD2
prerank,phospholipase A2 activity (GO:0004623),0.3728648551676041,0.8777939418744668,0.6108527131782946,0.8816344480001667,1.0,3/26,6.16%,PNPLA3;PLA2G4F;PLA2G15
prerank,semaphorin receptor binding (GO:0030215),0.3801869687114947,0.8741021927012592,0.5996932515337423,0.8858936208188833,1.0,3/23,2.43%,SEMA3E;SEMA3D;SEMA3C
prerank,MHC class II protein complex binding (GO:0023026),0.4309813706670148,0.8736918025467935,0.6313993174061433,0.8841017452573482,1.0,1/11,1.55%,ATP1B1
prerank,dynactin binding (GO:0034452),0.4177182816054574,0.8725290530223601,0.618657937806874,0.8838587066472366,1.0,2/12,5.11%,GSK3B;PAFAH1B1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3530141342426562,0.8723629416839833,0.6416107382550336,0.8815843980317156,1.0,15/38,22.64%,PLEKHA4;PLCZ1;WIPI2;ZFYVE1;PARD3;KIF16B;SNX12;SNX20;ATG2A;SNX13;ZFYVE19;WDR45B;PLA2G4A;PLEKHF1;ZFYVE26
prerank,exonuclease activity (GO:0004527),0.3452102823553818,0.8704814323932756,0.6358620689655172,0.8824325168144161,1.0,15/46,22.87%,REV3L;APEX2;EXO1;DXO;WRN;APLF;APEX1;EXOSC7;ZC3H12A;CNOT7;EXOSC1;REXO1;EXD2;RAD50;EXOG
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.43121651463510724,0.8687089100295863,0.6091370558375635,0.8829325917727019,1.0,3/11,22.07%,SLC25A25;SLC19A1;SLC25A17
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.269374110288642,-0.8678766165039158,0.6754716981132075,0.9150717094510387,1.0,6/49,10.61%,ATP1A2;ENPP6;SAMHD1;PXYLP1;DUSP23;PTPRO
prerank,motor activity (GO:0003774),-0.24977019415866475,-0.8677685311515217,0.7533632286995515,0.9092750472522715,1.0,14/60,15.18%,STARD9;MYO6;MYH9;KIF3C;KIF6;KIFC3;MYL6;KIF26A;KIF26B;KIF1A;KIF5C;KIF21B;DYNLRB1;GPR88
prerank,nucleoside-triphosphatase activity (GO:0017111),0.288462820842845,0.8676450928918419,0.7556029882604055,0.8822744603261561,1.0,37/248,14.40%,RHOJ;ARHGDIB;ATL3;NRAS;KRAS;MRAS;RHOBTB1;RAB43;BMS1;RAP1A;RAB6A;ATL2;VCP;RHOQ;CLU;GNL1;GNG8;RRAGB;RAP2C;KIF1C;CHD1L;KLC1;VWA8;DYNC1I1;RHOA;RND3;GNA13;GSPT1;TDRD9;RIT1;GTPBP4;GPN1;GFM2;ENTPD7;CHD3;RAB24;DHX9
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3021475047771199,-0.8671159515102841,0.6765578635014837,0.9046275708359662,1.0,2/26,2.55%,AEBP1;AGBL4
prerank,LRR domain binding (GO:0030275),0.4175447586768219,0.8668155443405957,0.6067226890756302,0.8811650716682092,1.0,6/14,14.16%,PAWR;ERC1;MRTFA;DDIT3;AATF;ZXDC
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3714852230316921,0.864834276014038,0.6176024279210925,0.8820803858752263,1.0,5/22,15.77%,ATP2C2;ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1
prerank,carboxypeptidase activity (GO:0004180),-0.2854314544508271,-0.8636248013474194,0.6771929824561403,0.9062123323213711,1.0,5/35,10.06%,AEBP1;AGBL4;CTSA;CTSZ;ACE2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.35643755808982874,0.8633624920473174,0.6464088397790055,0.8821755819959103,1.0,19/34,32.48%,ERI3;PAN3;EXOSC7;ANGEL1;ANGEL2;CNOT7;DIS3L2;PNLDC1;EXD2;ERI2;ERI1;PARN;EXOSC4;CNOT8;REXO2;EXOSC2;CNOT1;DIS3;EXOSC3
prerank,ephrin receptor binding (GO:0046875),0.3830713206947444,0.8625777157624562,0.6107594936708861,0.8810498190096804,1.0,3/21,3.61%,EFNA5;SHC1;ABL1
prerank,metalloexopeptidase activity (GO:0008235),0.3351507692605033,0.861605417651534,0.6234817813765182,0.8802677937396082,1.0,14/51,15.91%,NPEPPS;CPQ;MMP16;XPNPEP1;CPA5;XPNPEP3;CPA4;CPA3;MMP14;AGBL3;ERAP1;LAP3;CPB1;DPEP1
prerank,3'-5' DNA helicase activity (GO:0043138),0.3918287573546975,0.8610992007728274,0.6225490196078431,0.8786849268319311,1.0,7/16,18.10%,MCM7;WRN;MCM2;DHX9;ERCC3;RECQL5;FANCM
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.36399374926386646,-0.8606881668784556,0.6424870466321243,0.906510042495567,1.0,6/11,23.30%,CASP4;CFLAR;CASP3;CASP1;CASP12;PYCARD
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.42454772048332523,0.8582027418050291,0.6047700170357752,0.8813609268131503,1.0,5/11,27.52%,NAA40;NAA15;NAA50;NAA80;NAA60
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.37022421288466717,0.8572434594220244,0.6355555555555555,0.8806045883979134,1.0,11/27,20.28%,RNF144A;ARIH1;RNF19A;ZMYM2;DCUN1D5;ARIH2;ANKIB1;RNF14;DCUN1D4;DCUN1D2;DCUN1D1
prerank,phosphatidic acid binding (GO:0070300),0.39217704238681045,0.8531035456368783,0.6625954198473283,0.8853536329119027,1.0,4/19,9.74%,MARK1;PITPNC1;RAPGEF6;COMMD1
prerank,translation elongation factor activity (GO:0003746),-0.35170354304883755,-0.851314060514746,0.6666666666666666,0.9201692729491732,1.0,2/14,5.70%,EEF1A1;EEF1B2
prerank,mRNA binding (GO:0003729),0.2826805334836052,0.849676901182437,0.7710718002081165,0.8887340316395272,1.0,64/249,20.96%,SAMD4A;DDX5;RBFOX2;EIF4G3;YBX3;RBM47;HDLBP;LUC7L2;AUH;EIF4G1;THOC2;SRSF5;SRRM2;SRSF6;SYNCRIP;SLPI;CELF1;CELF3;SCAF8;DXO;PABPC4;LARP4B;G3BP2;RBM25;ETF1;PCBP4;RBMX;SERBP1;PABPC1;RBMS3;EIF3A;ZC3H12A;SNRNP70;ANGEL2;PUM2;TDRD7;ZC3H12D;DHX9;FYTTD1;HNRNPM;DCP1A;PUM1;SF3B1;EIF2S2;AGO2;ZC3H12C;RBM14;PUM3;KHDRBS1;DHX36;ZC3H11A;SNRNP35;CIRBP;THOC5;FXR2;LSM14B;LARP4;DAZAP1;FMR1;EIF4G2;MYEF2;TRA2B;NUP98;YTHDF2
prerank,miRNA binding (GO:0035198),0.3607370235404013,0.8477825987918979,0.6515373352855052,0.8893901390218973,1.0,11/30,22.93%,ZC3H7A;ZC3H12A;PUM2;TUT7;PUM1;AGO2;DDX21;TUT4;MATR3;FMR1;RBM4
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3246514622388422,0.8446639283036679,0.6826801517067004,0.892342008217482,1.0,11/60,13.20%,PPP3CA;PPP1R3C;PPM1H;PPTC7;PHLPP2;CDC14A;PPEF2;CDKN3;PPP5C;ILKAP;PPM1A
prerank,bHLH transcription factor binding (GO:0043425),0.38431158314481145,0.844494556423102,0.6416275430359938,0.8901359019627573,1.0,6/19,15.29%,BHLHE40;CREBBP;ISL1;KDM1A;TCF3;TWIST1
prerank,G protein-coupled receptor activity (GO:0004930),-0.20529160352060047,-0.8440069252947735,0.8955223880597015,0.9283340008410883,1.0,47/239,18.50%,ADGRL4;ADGRL3;PDGFRB;GRM3;ADGRV1;LGR4;GRM5;LPAR1;GRM1;NPR1;CALCRL;ADGRE5;RORB;P2RY14;ADGRB3;TAPT1;ADRA2A;P2RY1;GRM8;ADGRG1;ADORA2A;S1PR1;CYSLTR1;BDKRB2;PTH1R;CYSLTR2;LPAR2;S1PR3;ELOVL4;GPR37;ADGRB1;GABBR2;APLNR;HRH1;GPR176;GPR88;XPR1;GPR157;NTSR2;ADGRE1;ADGRA1;GPR37L1;ADGRB2;GPR63;VIPR2;LHCGR;LGR5
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.3909696855720555,0.8416139622962174,0.6750418760469011,0.8924254303134712,1.0,3/15,20.47%,PLA2G4F;PLA2G2C;PLA2G4A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.3699001112871555,-0.8408104388077345,0.6707317073170732,0.9288743456539932,1.0,9/11,45.47%,DDAH2;PADI2;ARG2;DDAH1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,steroid hydroxylase activity (GO:0008395),0.3953388139695916,0.8406413753144587,0.6565008025682183,0.8915607588899723,1.0,2/16,5.06%,CYP1B1;CYP2S1
prerank,ATPase activator activity (GO:0001671),0.3711222361965634,0.8403707454062602,0.6514913657770801,0.8896377739226281,1.0,4/20,14.63%,ATP1B1;TOR1AIP1;DNAJC1;DNAJA2
prerank,mannosyltransferase activity (GO:0000030),0.37027860149611097,0.8398268594213599,0.676056338028169,0.8881548744261409,1.0,1/21,0.79%,TMTC1
prerank,SH2 domain binding (GO:0042169),0.3518677489977404,0.8370439501456578,0.6661849710982659,0.8903442667433441,1.0,6/31,9.17%,ABL1;IRS1;NLK;RUFY1;ARHGAP5;AFAP1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.31057108222387386,-0.8339231184514686,0.7155963302752294,0.9366857276604333,1.0,4/21,10.19%,KL;FGF1;FRS2;FGF7
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3337893848900366,-0.833423760874601,0.6781914893617021,0.931816598498809,1.0,8/15,26.16%,PLEKHA5;JPH2;PHLDA3;RUBCNL;LANCL2;SNX3;SH3PXD2B;PLA2G4E
prerank,ribosomal large subunit binding (GO:0043023),-0.36667835825020595,-0.832437967607552,0.6778846153846154,0.9278052555366435,1.0,3/11,12.29%,CPEB2;CPSF6;NPM1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.41253724533491387,0.8297745070036164,0.6660899653979239,0.9001468485197754,1.0,5/10,27.63%,CDKN1B;KAT2B;CDKN1A;HEXIM1;CDKN2C
prerank,transaminase activity (GO:0008483),-0.36189790973436464,-0.8270525435408066,0.686046511627907,0.9320993203190154,1.0,6/11,33.52%,AGXT;GOT2;ABAT;BCAT1;GOT1L1;AADAT
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3423188728898511,0.826883010032668,0.6890756302521008,0.902402805798114,1.0,16/34,30.42%,UBE2B;BIRC6;UBE2F;UBE2D3;UBE2Z;UBE2S;UBE2K;UBE2N;UBE2W;UBE2Q2;UBE2O;UBE2R2;TAF1;UBE2H;UBE2A;UBE2G1
prerank,hyaluronic acid binding (GO:0005540),-0.3697266746553154,-0.8250675339794322,0.6964705882352941,0.9298784228807967,1.0,2/10,4.51%,CEMIP;LAYN
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.37556403239725394,0.8249315634794905,0.6821829855537721,0.9031425236674582,1.0,9/17,32.75%,AK4;AK3;AK9;AK1;NME6;CLP1;AK5;CMPK1;DTYMK
prerank,high voltage-gated calcium channel activity (GO:0008331),0.413679112422767,0.8229487396371518,0.6783333333333333,0.9039415812710228,1.0,2/10,7.26%,CACNA1C;CACNA1F
prerank,ribosomal small subunit binding (GO:0043024),-0.31747713675159317,-0.8220100690754785,0.6934097421203438,0.9297967899900133,1.0,7/17,25.47%,CPEB2;NPM1;PIM1;EIF4H;DDX3X;NME1;EIF1B
prerank,phosphate ion binding (GO:0042301),-0.37548240811643974,-0.8214554261557476,0.7060240963855422,0.9252428096870544,1.0,6/10,30.08%,PDE2A;RPH3A;ADSS1;CHST14;RELA;PNP
prerank,tRNA methyltransferase activity (GO:0008175),0.3831350898450765,0.821367527392038,0.7004909983633388,0.904118723403138,1.0,10/16,33.56%,ALKBH8;TRMT13;TARBP1;TRDMT1;THUMPD2;TRMT12;FTSJ1;METTL2B;METTL2A;TRMT44
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4025805514620177,0.8210494815794639,0.654485049833887,0.9021895854232922,1.0,3/12,22.07%,SLC25A25;SLC19A1;SLC25A17
prerank,retinoid X receptor binding (GO:0046965),0.3985337845729484,0.8200113865871783,0.6637931034482759,0.9014229696952356,1.0,6/11,18.79%,NR4A2;RARG;NSD1;NCOA6;PPARG;NRIP1
prerank,pyrophosphatase activity (GO:0016462),0.3185555004378555,0.8187426925759893,0.7190412782956058,0.9011751120021727,1.0,10/50,14.68%,ENTPD6;ALPL;NUDT4;DXO;NUDT5;ENTPD2;ENTPD7;PLPP1;DHX9;NUDT15
prerank,titin binding (GO:0031432),0.39704366399356417,0.8177438072289577,0.6737704918032786,0.9002984469847504,1.0,1/13,1.74%,CAMK2D
prerank,glutamate receptor binding (GO:0035254),-0.32069280317435217,-0.8152299125524207,0.7213930348258707,0.9312228463496667,1.0,4/17,10.40%,SHANK3;IGSF11;CAMK2A;HIP1
prerank,ubiquitin-specific protease binding (GO:1990381),0.3725523766255435,0.8150930351916739,0.6704,0.9020540050366825,1.0,2/19,7.53%,VCP;LCOR
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.36161578107308856,0.8150397482612913,0.717741935483871,0.8997288099226102,1.0,3/21,8.66%,GLRB;P2RX2;P2RX4
prerank,adenyl ribonucleotide binding (GO:0032559),0.26470458543895997,0.8131544241497421,0.8489968321013728,0.900382622499395,1.0,43/291,13.69%,ME1;MAP3K5;ABCD3;MARK1;MPPED2;WNK1;SMC4;GCLC;PRPS2;N4BP2;BMPR1A;TLK1;ABL1;TGFBR1;MKNK2;EIF4G1;PDE10A;PFKP;IDE;P2RX2;MARK2;CARS2;NLK;P2RX4;ATP1A3;ATP1A1;HSPA1L;SIK3;SIK2;IRAK3;ACVR1;TOP1;IGHMBP2;HACL1;MAST2;MIEF1;PPP5C;PDK3;ABCF1;PPIP5K2;ERN2;CDC42BPG;DYRK2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.34167632081825916,0.8128258811408766,0.6928471248246845,0.8985362418298134,1.0,15/31,30.42%,UBE2B;BIRC6;UBE2D3;UBE2Z;UBE2S;UBE2K;UBE2N;UBE2W;UBE2Q2;UBE2O;UBE2R2;TAF1;UBE2H;UBE2A;UBE2G1
prerank,GTP binding (GO:0005525),0.27313623204083315,0.812497185492097,0.7947882736156352,0.8966753776889381,1.0,18/172,9.35%,RHOJ;ATL3;NRAS;KRAS;MRAS;RHOBTB1;BMS1;RAP1A;RAB6A;ATL2;ARL3;RHOQ;GNL1;ARF3;RRAGB;RAP2C;RHOA;RND3
prerank,glycerophospholipid flippase activity (GO:0140333),-0.34992917914526106,-0.8105498817355694,0.6959459459459459,0.9340227361358904,1.0,6/11,17.26%,ABCA4;ATP8A1;ABCB4;ATP10B;ATP11C;ATP8A2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3086411097104549,-0.810520252561963,0.708994708994709,0.9285473504427164,1.0,13/18,44.33%,HSD17B7;HSD11B1;HSD17B10;HSD17B1;HSD17B14;SRD5A2;HSD17B8;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.39469416952530917,0.8102837912426128,0.696917808219178,0.8977250518932359,1.0,5/12,25.46%,TRAF5;TNFSF11;TRAP1;TRAF3;TRAF6
prerank,ATP hydrolysis activity (GO:0140603),-0.2534705451717611,-0.8101144779785362,0.7770034843205574,0.9237064307923154,1.0,11/41,18.85%,ABCA4;RHOBTB3;ATP2B1;RNF213;KIF26A;RUVBL1;MYO18A;RUVBL2;ABCD2;ABCB10;DDX3X
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3395905887678954,-0.8099324306201977,0.7251184834123223,0.9184727403478807,1.0,4/12,18.63%,SLC38A5;SLC6A6;SLC3A2;SLC36A2
prerank,double-stranded RNA binding (GO:0003725),0.3049716654175615,0.8094002165984041,0.7397260273972602,0.8967292885126016,1.0,13/70,18.70%,STRBP;MBNL1;SIDT2;ZFR;MTDH;DGCR8;IFIH1;DHX9;TLR8;AGO2;DROSHA;DHX36;EIF4B
prerank,peptide hormone receptor binding (GO:0051428),0.40396067993869356,0.8077128289604991,0.6751700680272109,0.8970100394337996,1.0,2/11,17.66%,PTHLH;GNRH1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.40550317320221085,0.8074719655280475,0.6927083333333334,0.8950741966794837,1.0,5/11,25.51%,ALDH3A1;RDH12;DHRS13;AKR1B10;AKR1B1
prerank,tRNA binding (GO:0000049),0.31394003401742737,0.8070006478078076,0.7164383561643836,0.8934764400060116,1.0,15/43,26.75%,TYW5;ELP5;MRPS27;IGHMBP2;ALKBH8;EIF2AK4;RPUSD4;TRMT10A;DALRD3;SEPSECS;SSB;PTCD1;NAT10;TRNAU1AP;FARS2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.29938252452626074,0.8069972354728003,0.7406947890818859,0.8911848638568071,1.0,21/69,21.77%,SOAT1;KAT6B;CREBBP;MOGAT3;PLA2G15;ELP3;ZDHHC15;HHAT;DGAT2L6;ZDHHC2;EP300;MOGAT1;ZDHHC20;KAT2B;NAA15;CERS6;CERS5;ZDHHC12;PLA2G4A;MCAT;NMT1
prerank,DNA secondary structure binding (GO:0000217),0.33669290857785383,0.8066711957799463,0.7052631578947368,0.889357822316137,1.0,13/31,28.08%,ABL1;ERCC5;WRN;CLSPN;RBBP8;YY1;FANCM;NEIL3;RAD51C;XPC;RAD51AP1;RAD51B;KMT2A
prerank,mRNA 3'-UTR binding (GO:0003730),0.2958793475581705,0.8060568636074869,0.7571606475716065,0.8880521428847102,1.0,20/79,20.06%,DDX5;YBX3;AUH;CELF1;PABPC4;LARP4B;PCBP4;SERBP1;PABPC1;RBMS3;ZC3H12A;ANGEL2;PUM2;PUM1;DHX36;CIRBP;FXR2;LARP4;DAZAP1;FMR1
prerank,phospholipase binding (GO:0043274),-0.3368145446680332,-0.8041976667324546,0.7161803713527851,0.922766487435272,1.0,4/13,20.93%,ARHGAP6;BLNK;BTK;SYK
prerank,Toll-like receptor binding (GO:0035325),-0.3463046436120308,-0.8028972727424594,0.7117117117117117,0.9198051231986387,1.0,2/11,6.34%,DAB2IP;UNC93B1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2561344248575754,0.799689511609707,0.908256880733945,0.8956840106216015,1.0,60/431,13.69%,MAP3K5;ABCD3;MARK1;RHOJ;WNK1;SMC4;ATL3;NRAS;KRAS;MRAS;PRPS2;N4BP2;BMPR1A;RHOBTB1;TLK1;ABL1;BMS1;TGFBR1;RAP1A;RAB6A;ATL2;MKNK2;EIF4G1;ARL3;RHOQ;GNL1;PFKP;IDE;ARF3;RRAGB;P2RX2;MARK2;RAP2C;CARS2;NLK;P2RX4;ATP1A3;ATP1A1;RHOA;HSPA1L;RND3;SIK3;SIK2;IRAK3;ACVR1;TOP1;ARF4;IGHMBP2;ARHGEF5;HACL1;MAST2;PPP5C;RIT1;PDK3;ABCF1;PPIP5K2;GTPBP4;ERN2;CDC42BPG;DYRK2
prerank,peptidase activator activity (GO:0016504),0.3522922400870878,0.7952939603051205,0.7216981132075472,0.8999332136425351,1.0,2/22,4.92%,TANK;VCP
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3505652384387119,0.7932717234262431,0.702660406885759,0.900531060397001,1.0,5/22,14.56%,DUSP16;DUSP5;DUSP10;CDKN3;SBF1
prerank,voltage-gated anion channel activity (GO:0008308),0.37330286485348546,0.7930297133248466,0.6941747572815534,0.8986592993840694,1.0,2/15,12.26%,ANO6;CLCN5
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3997423698978941,0.7919878662745164,0.7011884550084889,0.8979636496445103,1.0,4/11,26.01%,STN1;RPA1;RAD50;HNRNPA2B1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.36488459991273325,-0.7911643242728378,0.7505720823798627,0.9339384481006745,1.0,2/10,6.08%,SHANK3;IGSF11
prerank,alpha-actinin binding (GO:0051393),0.3465972173823405,0.7889247616864978,0.7042682926829268,0.9002764861452892,1.0,7/24,18.73%,CACNA1C;PDLIM7;PDLIM5;RARA;MAGI1;PDLIM4;PPARG
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.31217409428966125,-0.7855888102232669,0.7581521739130435,0.9374725869120812,1.0,5/15,25.64%,CCR9;CCR5;CX3CR1;GPR17;CCRL2
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.21931203181245748,-0.7850280428665318,0.915,0.9330109218391838,1.0,19/73,20.04%,LGR4;NPR1;CALCRL;CYSLTR1;BDKRB2;PTH1R;CYSLTR2;SORCS2;SORCS3;GPR37;APLNR;SORCS1;GPR37L1;VIPR2;LHCGR;LGR5;EDNRB;TSHR;RXFP1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.33529219736160276,-0.7845947695152788,0.7274826789838337,0.9283800804121942,1.0,1/11,4.08%,SLC22A4
prerank,FMN binding (GO:0010181),0.3862901088196179,0.7792910037474472,0.7086092715231788,0.912676619742541,1.0,3/11,13.21%,IYD;PNPO;PPCDC
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3517754824869199,0.7743564503440855,0.7300813008130081,0.9152382499839917,1.0,4/16,15.77%,ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3517754824869199,0.7743564503440855,0.7300813008130081,0.9152382499839917,1.0,4/16,15.77%,ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1
prerank,snRNA binding (GO:0017069),0.30612247345935545,0.7741042124716133,0.7575757575757576,0.9133322166185995,1.0,14/42,28.59%,SNRNP70;LSM11;SNRPB2;DDX21;RNPC3;LSM8;LSM2;SNRNP35;CCNT1;LSM4;SF3B3;HEXIM1;CCNT2;NCBP2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.3382639625563022,-0.7740850127068463,0.7518987341772152,0.9392606485456212,1.0,2/11,4.30%,KSR1;SH3RF1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3029291176285145,0.7732690943400098,0.7677852348993288,0.9123652776224743,1.0,12/44,20.84%,SMYD2;KMT2C;SETD2;EHMT1;EED;KMT2D;SETD5;NSD1;KMT5A;EHMT2;ASH1L;KMT5B
prerank,tubulin binding (GO:0015631),0.25256933816827054,0.7716193256977101,0.9061855670103093,0.9124272487728771,1.0,41/295,12.76%,EZR;NDRG1;UNC5C;MAPRE2;RP1;KIF13A;MTUS1;MID1;MAP7D3;FMN1;FGF13;NDEL1;CLIP1;HDGFL3;NLRP5;TBCE;KIF1B;BCAS3;PAFAH1B1;ARL3;TTLL2;SETD2;GAS2L2;KIF1C;NCALD;TOGARAM1;KIF9;CAPN6;DYNC1I1;MAP1B;MACO1;KIF7;EMD;BRCA2;KATNB1;KIF16B;MAST2;CCDC66;CHP1;TUBGCP6;RMDN3
prerank,Hsp70 protein binding (GO:0030544),-0.2577286704526946,-0.7702337431048483,0.8322784810126582,0.9396470792021456,1.0,11/31,28.44%,RPS3;ERN1;SACS;SNCA;GPR37;PACRG;DNAJC10;HIKESHI;FICD;CYP2E1;RNF207
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.31226187917910425,0.7689639547676725,0.7647058823529411,0.9140822675467265,1.0,8/38,17.96%,ANXA2;SERPINB9;SLPI;SERPING1;SERPINB7;SERPINE2;SERPINB8;SERPINA2
prerank,protein phosphatase regulator activity (GO:0019888),-0.23891118997405514,-0.7675005996752111,0.9,0.9385527590091928,1.0,11/53,13.75%,PPP2R2B;PPP1R16B;CALM1;PPP4R4;DMPK;PPP1R15B;PPP2R5A;LMTK2;SET;CALM3;PPP2R2C
prerank,hexosaminidase activity (GO:0015929),0.37214670864437294,0.7668138931710504,0.7296849087893864,0.9149001813208197,1.0,7/12,24.54%,HEXA;SPAM1;NAGA;OGA;CEMIP2;HEXD;HYAL3
prerank,peptidase inhibitor activity (GO:0030414),0.31629714455923935,0.7651657862145981,0.764367816091954,0.9149453360843247,1.0,6/33,12.25%,GPC3;CAST;TIMP2;SLPI;TIMP1;RENBP
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.32043725769572395,0.76440991094356,0.7727910238429172,0.9137794672084228,1.0,18/33,32.48%,ERI3;EXOSC7;ANGEL1;ANGEL2;CNOT7;DIS3L2;PNLDC1;EXD2;ERI2;ERI1;PARN;EXOSC4;CNOT8;REXO2;EXOSC2;DIS3;XRN1;EXOSC3
prerank,tau protein binding (GO:0048156),0.30938228251993616,0.7606118338292607,0.7838214783821479,0.9166982697755629,1.0,9/40,14.34%,MARK1;GSK3B;CLU;MARK2;MARK3;SMAD2;PPP5C;EP300;S100B
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3330607849370026,0.7599217201623452,0.7609682299546142,0.915345553418868,1.0,5/23,11.14%,PLEKHA4;WIPI2;GBF1;COMMD1;KIF16B
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.2820268562786784,-0.7595973692105074,0.784741144414169,0.9345744147532992,1.0,5/22,15.04%,CHRM2;HTR2C;CHRM3;HTR2A;HRH1
prerank,serotonin receptor activity (GO:0099589),-0.2820268562786784,-0.7595973692105074,0.784741144414169,0.9345744147532992,1.0,5/22,15.04%,CHRM2;HTR2C;CHRM3;HTR2A;HRH1
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.2820268562786784,-0.7595973692105074,0.784741144414169,0.9345744147532992,1.0,5/22,15.04%,CHRM2;HTR2C;CHRM3;HTR2A;HRH1
prerank,poly-pyrimidine tract binding (GO:0008187),0.331408406911768,0.7578971093818466,0.7647058823529411,0.9159525917920381,1.0,10/23,21.69%,HNRNPH1;PABPC4;U2AF2;PABPC1;RBMS3;DIS3L2;KHDRBS1;DAZAP1;FMR1;SSB
prerank,TBP-class protein binding (GO:0017025),-0.2853637566219564,-0.7576117438555081,0.8269794721407625,0.9322887232360415,1.0,9/21,23.83%,AHR;RUVBL1;HHEX;DRAP1;RUVBL2;GTF2A1;PSMC5;DR1;THRA
prerank,regulatory RNA binding (GO:0061980),0.3098546406537014,0.7562700903664413,0.7759562841530054,0.915977150941996,1.0,11/38,20.06%,ZC3H7A;ZC3H12A;PUM2;DHX9;TUT7;PUM1;AGO2;DDX21;TUT4;MATR3;FMR1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3266254815155057,0.7542811948004201,0.7716417910447761,0.9165822014139847,1.0,7/25,13.38%,PLEKHA4;GAB2;ZFYVE1;COMMD1;KIF16B;FCHSD2;DAPP1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.3106590110867468,0.7510852954176835,0.7852062588904695,0.9185888311215665,1.0,18/35,36.05%,FTO;TRMT13;PUS10;DUS1L;TRDMT1;MTFMT;QTRT1;ELAC1;TRMT12;FTSJ1;DUS4L;TRPT1;PTRH2;GATC;QRSL1;ELAC2;DUS2;ALKBH1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3537236895956495,0.7440392645143842,0.7647058823529411,0.9258752925942527,1.0,1/13,2.08%,ARHGDIB
prerank,muscle alpha-actinin binding (GO:0051371),0.35427897981818307,0.7437954501012998,0.7397034596375618,0.9239732934427086,1.0,2/15,6.45%,PDLIM7;PDLIM5
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3042711501851009,0.7401992896937416,0.7722772277227723,0.9265992188000255,1.0,7/35,13.02%,PTK2B;CLK1;ABL1;FRK;SRMS;CSK;YES1
prerank,ribonuclease activity (GO:0004540),0.2904126413463024,0.7400564116982511,0.8297055057618438,0.9245790433031048,1.0,30/56,34.99%,SMG6;EXOSC7;ZC3H12A;ERN2;ZC3H12D;RNASEH2A;CNOT7;DIS3L2;AGO2;ZC3H12C;EXOSC1;RNASE6;LACTB2;RNASE3;EXOG;YBEY;CPSF3;RNASE12;EXOSC4;RNASE7;AGO3;EXOSC2;PIWIL4;EXOSC3;ZC3H12B;DICER1;NYNRIN;ELAC2;RNASEH1;PIWIL2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.36495529742211413,0.7396655573426338,0.7590361445783133,0.9228902856954946,1.0,1/11,2.90%,SGMS2
prerank,ATP binding (GO:0005524),0.2412973007471618,0.7394760267828577,0.9329073482428115,0.9209253588115557,1.0,38/266,13.69%,MAP3K5;ABCD3;MARK1;WNK1;SMC4;PRPS2;N4BP2;BMPR1A;TLK1;ABL1;TGFBR1;MKNK2;EIF4G1;PFKP;IDE;P2RX2;MARK2;CARS2;NLK;P2RX4;ATP1A3;ATP1A1;HSPA1L;SIK3;SIK2;IRAK3;ACVR1;TOP1;IGHMBP2;HACL1;MAST2;PPP5C;PDK3;ABCF1;PPIP5K2;ERN2;CDC42BPG;DYRK2
prerank,chemokine receptor binding (GO:0042379),-0.23492220680701542,-0.7390570951859652,0.8859060402684564,0.952157351478425,1.0,14/35,31.54%,CXCL12;CCL19;CX3CL1;CCL2;CX3CR1;CCRL2;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8
prerank,signal sequence binding (GO:0005048),-0.2405308790411868,-0.7346409870365743,0.8858131487889274,0.9527655661414481,1.0,2/35,2.89%,CEMIP;PEX5L
prerank,adrenergic receptor binding (GO:0031690),0.33917275599332786,0.7336665559492025,0.7682333873581848,0.926395955364067,1.0,1/16,1.48%,NEDD4
prerank,intracellular chloride channel activity (GO:0061778),0.34619744760130283,0.7312019437706327,0.7880690737833596,0.9252216692608543,1.0,2/16,3.68%,ANO6;ANO9
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.34619744760130283,0.7312019437706327,0.7880690737833596,0.9252216692608543,1.0,2/16,3.68%,ANO6;ANO9
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3072228870294733,-0.7280604318561114,0.8044554455445545,0.9554883945490845,1.0,2/13,5.91%,PIP5K1B;PIK3C2A
prerank,transcription coactivator binding (GO:0001223),0.32158699661189044,0.721661491378202,0.8057784911717496,0.9350581868286933,1.0,3/20,8.80%,CIT;ESR1;RORA
prerank,myosin V binding (GO:0031489),0.344882972678355,0.7211652763933333,0.7704081632653061,0.9334460954700631,1.0,6/15,30.06%,RAB6A;RAB25;RAB27B;RAB11B;RAB8A;RAB10
prerank,ATPase regulator activity (GO:0060590),0.2813760471486323,0.7074473904912251,0.8591352859135286,0.9483550982024365,1.0,6/38,14.63%,ATP1B1;TOR1AIP1;KATNB1;DNAJC1;BAG3;DNAJA2
prerank,5'-3' exonuclease activity (GO:0008409),0.3354278595995401,0.7053463940133495,0.7828947368421053,0.948693149985124,1.0,2/14,7.56%,EXO1;DXO
prerank,G protein-coupled receptor binding (GO:0001664),0.2453417887306516,0.7046599584902248,0.9224719101123595,0.9472600141451971,1.0,14/132,12.29%,WNT9A;LRP6;WNT11;FZD7;AGTR1;PDCD6IP;WNT16;BAMBI;FZD1;GNA13;PROK2;HOMER2;USP4;USP33
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.34340785264548235,0.7032606264444647,0.8124006359300477,0.9466347530060001,1.0,3/12,13.01%,PIK3C2B;ATM;PIK3R3
prerank,thioesterase binding (GO:0031996),-0.30948253136888926,-0.7005648250242926,0.8689320388349514,0.9832777439014865,1.0,2/11,8.12%,ADRA2A;RAC1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.2988029850342022,0.7000176049408211,0.8531157270029673,0.9482787146615027,1.0,8/30,15.91%,CAST;SERPINB9;BIRC6;BIRC7;UBE2Z;CARD16;PRDX5;DPEP1
prerank,methyl-CpG binding (GO:0008327),-0.2533516711934612,-0.6975845429013426,0.8793103448275862,0.981125137825941,1.0,5/22,17.93%,CXXC4;CXXC5;MBD2;PRMT1;WDR77
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.24676048689076002,-0.6960031313769407,0.925414364640884,0.9775920016380262,1.0,4/24,10.54%,ZDHHC14;ZDHHC1;ZDHHC17;ZDHHC9
prerank,poly(U) RNA binding (GO:0008266),0.3084952048801064,0.6915219984105784,0.8019169329073482,0.9559890310350527,1.0,10/20,24.50%,HNRNPH1;PABPC4;PABPC1;RBMS3;DIS3L2;KHDRBS1;DAZAP1;FMR1;SSB;MCRS1
prerank,endopeptidase activator activity (GO:0061133),-0.3080741507985331,-0.687894680455634,0.8528138528138528,0.9807179979703404,1.0,3/10,16.57%,APH1B;PSME2;VSIR
prerank,gamma-tubulin binding (GO:0043015),0.30275317559820225,0.6867907730586331,0.840625,0.9590686146697673,1.0,5/21,16.89%,NDRG1;BRCA2;TUBGCP6;TUBGCP5;TUBGCP4
prerank,microtubule motor activity (GO:0003777),0.26851715658426323,0.6855542443453116,0.8785425101214575,0.9582530749570941,1.0,8/51,11.14%,KIF13A;KIF1B;KIF1C;KIF9;DYNC1I1;KIF7;DNAH8;KIF16B
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2450111680926247,0.6838682115030585,0.9178082191780822,0.9579842696242616,1.0,8/85,8.61%,MGLL;PNPLA3;PLA2G4F;PON3;PLA2G15;ABHD6;DAGLB;PAFAH1B2
prerank,endoribonuclease activity (GO:0004521),0.28335960409096955,0.6834522704449849,0.8546511627906976,0.9562429506149852,1.0,9/32,23.22%,SMG6;ZC3H12A;ERN2;ZC3H12D;AGO2;ZC3H12C;LACTB2;EXOG;YBEY
prerank,pentosyltransferase activity (GO:0016763),0.2751054260766415,0.6818526707647662,0.8569364161849711,0.9557038662799184,1.0,12/36,23.70%,LARGE1;QPRT;UPP2;TNKS2;LARGE2;SIRT6;PARP6;PARP3;UMPS;PARP4;QTRT1;PARP2
prerank,CXCR chemokine receptor binding (GO:0045236),0.34505815013895114,0.6812101043140842,0.8350515463917526,0.9541641430504161,1.0,2/11,8.55%,YARS1;CXCL2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.27203119042566304,0.6802791806770682,0.8693181818181818,0.9529392293705636,1.0,21/40,34.51%,NNMT;PRMT8;PCMT1;DNMT3A;CARNMT1;GNMT;TARBP1;LRTOMT;DPH5;TPMT;HNMT;ASMT;THUMPD2;RRP8;MEPCE;PCMTD2;METTL2B;METTL2A;METTL4;PCMTD1;ARMT1
prerank,general transcription initiation factor binding (GO:0140296),-0.2490489611426847,-0.6784384888194115,0.9084967320261438,0.9845722815002687,1.0,10/25,25.23%,AHR;RUVBL1;HHEX;DRAP1;RUVBL2;GTF2A1;PSMC5;DR1;THRA;RELA
prerank,NADPH binding (GO:0070402),0.3260019208535411,0.6748523390036812,0.8225039619651348,0.9564734806321292,1.0,4/13,15.12%,DECR1;LBR;CBR3;HMGCR
prerank,alpha-tubulin binding (GO:0043014),-0.22445164123287584,-0.6700446467200705,0.9354838709677419,0.9874032259876848,1.0,9/31,21.67%,TTLL7;EML4;SNCA;TRPV4;PACRG;DLEC1;ARL4C;EFHC2;CDK5R1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3017934917312422,0.6661023472996725,0.8560830860534124,0.9633873226463248,1.0,5/21,17.98%,EZR;AKAP9;PRRC1;ACBD3;ARFGEF1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.310097480730268,0.6623018188809295,0.8576214405360134,0.9649917776083172,1.0,7/14,32.75%,AK4;AK9;AK1;NME6;AK5;CMPK1;DTYMK
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.2724657279761958,-0.6612692386071622,0.8922305764411027,0.9902439581030248,1.0,2/13,6.96%,SLC38A5;SLC7A7
prerank,hormone activity (GO:0005179),-0.19867714380684473,-0.6603958822695373,0.9781659388646288,0.9857429014532333,1.0,8/54,17.72%,IGF1;EDN1;SST;PENK;AGT;VGF;METRNL;METRN
prerank,disordered domain specific binding (GO:0097718),0.2889146991876203,0.6570674334481174,0.8643815201192251,0.9679205863757497,1.0,4/23,15.94%,FN1;SMAD2;RB1;DFFB
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.32456362374305225,0.6570622848163331,0.8619528619528619,0.9657400118272319,1.0,3/14,17.56%,MTMR12;SYNJ1;MTMR11
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.26597762833593563,-0.6488820506577104,0.9125295508274232,0.990169998997362,1.0,3/15,10.70%,P2RY14;P2RY1;P2RX7
prerank,ubiquitin-dependent protein binding (GO:0140036),0.32329155687655053,0.6451423869290605,0.8578767123287672,0.9748903408447308,1.0,2/10,9.62%,IDE;USP15
prerank,retinoic acid receptor binding (GO:0042974),0.29460351876281715,0.6429373779975077,0.9024390243902439,0.9746531557490768,1.0,7/17,19.81%,NR4A2;RARG;NSD1;NCOA6;PPARG;NRIP1;SNW1
prerank,methyltransferase activity (GO:0008168),0.2501385887199232,0.6392435851117068,0.9380165289256198,0.9757805320668752,1.0,23/46,35.42%,EHMT1;NNMT;PRMT8;CARNMT1;LRTOMT;NDUFAF7;EEF1AKMT1;PRMT5;FTSJ3;TRMT11;EEF1AKMT4;MRM2;NSUN4;ASMT;FTSJ1;RRP8;COQ5;PRMT3;MEPCE;METTL4;ARMT1;NSUN3;COQ3
prerank,Tat protein binding (GO:0030957),0.31453292638057645,0.6363659081317896,0.8769771528998243,0.9761201980556048,1.0,2/10,12.63%,MDFIC;SMARCA4
prerank,chemokine activity (GO:0008009),-0.20984414853655653,-0.635825491023926,0.9567901234567902,0.9950960877856468,1.0,12/31,31.54%,CXCL12;CCL19;CX3CL1;CCL2;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8
prerank,MAP kinase kinase activity (GO:0004708),-0.2519185049948844,-0.6338450751598417,0.9192708333333334,0.9914342810821589,1.0,2/15,8.87%,MAP2K6;PAK3
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.21926358562961273,-0.6297194870134779,0.9271137026239067,0.989349197852951,1.0,7/26,22.80%,PPP1R1A;PPP1R14A;LMTK2;SET;BOD1;PABIR1;ENSA
prerank,heme binding (GO:0020037),0.23336534729080827,0.6285539183848916,0.9590570719602978,0.9806614448193299,1.0,5/65,6.93%,CYP1B1;PTGIS;CYP2S1;HMOX2;PTGES2
prerank,lysophospholipase activity (GO:0004622),0.27441404537248176,0.6235830756080029,0.905144694533762,0.9826913951371673,1.0,5/20,20.47%,MGLL;LYPLA2;LYPLAL1;GDPD3;PLA2G4A
prerank,chemokine receptor activity (GO:0004950),-0.22048343154066352,-0.6212011839066225,0.9660056657223796,0.9899601382344325,1.0,1/24,1.80%,CCR9
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.2574776546662184,0.6200449813448419,0.911504424778761,0.9832031832517997,1.0,3/29,8.47%,CIT;SPRED2;CDKN1B
prerank,syntaxin binding (GO:0019905),0.23289126341679547,0.613821960354986,0.9587096774193549,0.9857021337146841,1.0,8/61,11.08%,UNC13B;ABL1;PTPN2;VPS54;SYT8;NSF;STX8;SNAP23
prerank,NAD+ binding (GO:0070403),-0.26071436815608773,-0.5990734247430441,0.9402985074626866,0.9982432918333409,1.0,4/12,24.20%,UXS1;SIRT5;HADH;GLUD1
prerank,acetylcholine receptor activity (GO:0015464),0.2641561192725107,0.5980118051799345,0.9144634525660964,0.994868976759412,1.0,4/22,15.53%,CHRM5;CHRNG;CHRNE;CHRNB1
prerank,nucleosomal DNA binding (GO:0031492),-0.21749450706992557,-0.595592355194447,0.964769647696477,0.9950096700639908,1.0,2/21,8.83%,ACTB;MBD2
prerank,channel activity (GO:0015267),0.23933619806186104,0.5931814804732946,0.9605442176870749,0.9959205402251498,1.0,4/41,10.90%,TMEM120A;AQP6;MCUB;CHRNG
prerank,RNA stem-loop binding (GO:0035613),0.2870661295774101,0.592440211952384,0.8946459412780656,0.9942297037392932,1.0,6/12,29.41%,ZC3H12A;DHX9;FMR1;EPRS1;RC3H2;CSDE1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.2047207954839059,-0.5911571844959191,0.9583333333333334,0.9925369879789903,1.0,13/26,32.64%,CSGALNACT1;CHSY3;CHSY1;B3GNT3;GBGT1;B3GALT2;CHPF;B4GALNT1;B3GALT1;B3GALT4;B4GALNT4;EXTL2;B3GALT5
prerank,neuropeptide hormone activity (GO:0005184),-0.21104201997361974,-0.5843851179579226,0.9603658536585366,0.9909581368244369,1.0,22/22,78.93%,PENK;NPY;PNOC;PPY;GAL;CALCB;UCN;NPPA;GHRH;QRFP;NMB;NPFF;CCK;CORT;OXT;ADCYAP1;CRH;AGRP;SPX;VIP;GRP;HCRT
prerank,glutathione transferase activity (GO:0004364),-0.20914557987043497,-0.5733998933809723,0.9788519637462235,0.9909771225673064,1.0,12/23,35.58%,HPGDS;GSTA4;MGST1;GSTK1;GSTM1;ALOX5AP;GSTA3;MGST3;GSTM2;LTC4S;GSTP1;GSTZ1
prerank,DNA polymerase binding (GO:0070182),0.26339693208743387,0.5719591397003075,0.9245585874799358,1.0,1.0,4/18,17.86%,SMG6;SMARCA4;POLG2;RAD51
prerank,adenyl nucleotide binding (GO:0030554),0.28381434830089386,0.567437782117735,0.931740614334471,1.0,1.0,5/11,31.47%,BAG3;GRPEL2;SIL1;BAG2;BAG5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.28381434830089386,0.567437782117735,0.931740614334471,1.0,1.0,5/11,31.47%,BAG3;GRPEL2;SIL1;BAG2;BAG5
prerank,semaphorin receptor activity (GO:0017154),0.2856245828748235,0.5601156217318756,0.9333333333333333,1.0,1.0,3/11,18.62%,NRP1;PLXNA2;PLXNB1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.2607652885195147,0.5594675985200774,0.9440894568690096,1.0,1.0,6/18,21.53%,SERPINB9;BIRC7;PRDX5;DPEP1;BIRC3;NOL3
prerank,microtubule minus-end binding (GO:0051011),0.26673928558628957,0.5574018900318741,0.9450171821305842,1.0,1.0,4/13,21.72%,TUBGCP6;TUBGCP5;TUBGCP4;CAMSAP3
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.22629143803377721,0.5463039115947539,0.9683453237410072,1.0,1.0,8/34,19.01%,FAM20A;IQGAP1;MLST8;CAB39;STRADA;MAP2K2;CAB39L;CCNT1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.24893257840332372,0.5403189031427305,0.952076677316294,1.0,1.0,5/16,20.67%,SMUG1;MACROD2;DNPH1;NEIL3;TDG
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.270644797189627,0.5319980696936372,0.952054794520548,1.0,1.0,3/10,21.19%,IDE;PML;ANKRD13D
prerank,neuropeptide receptor activity (GO:0008188),-0.1796159644413009,-0.5290020005595109,0.9806451612903225,1.0,1.0,10/29,34.86%,SORCS2;SORCS3;GPR37;SORCS1;HCRTR2;GPR143;NMUR1;NPFFR1;NPY1R;GAL
prerank,palmitoyltransferase activity (GO:0016409),0.2225184603177187,0.5265135506887629,0.9704142011834319,1.0,1.0,8/28,20.27%,ZDHHC11;ZDHHC15;HHAT;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12
prerank,CCR chemokine receptor binding (GO:0048020),0.22074351970981734,0.524937940351934,0.9791976225854383,1.0,1.0,3/28,11.36%,DEFB130A;CCL3;CCL1
prerank,histone methyltransferase binding (GO:1990226),0.2608627238040805,0.5248045556600377,0.9630252100840336,1.0,1.0,2/11,12.49%,LCOR;NOP56
prerank,O-methyltransferase activity (GO:0008171),-0.23710670829000688,-0.5216273114453946,0.9516483516483516,0.9998391986200318,1.0,1/10,7.59%,COMT
prerank,peptide N-acetyltransferase activity (GO:0034212),0.2639018559935764,0.5203566704116263,0.9525483304042179,1.0,1.0,4/10,27.52%,NAA15;NAA50;NAA80;NAA60
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.21442126490865848,-0.5191368141134856,0.973404255319149,0.9956246201587956,1.0,8/14,41.96%,POP5;POP7;RPP21;PRORP;TSEN34;RPP25;RPP40;RPP14
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.2485077125256394,0.5182101714167615,0.9527687296416938,1.0,1.0,3/16,17.56%,MTMR12;SYNJ1;MTMR11
prerank,neuropeptide receptor binding (GO:0071855),0.24192410454644162,0.5104464984796189,0.9634920634920635,1.0,1.0,1/14,8.51%,SHANK1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.21447515849083443,-0.5056331266895178,0.9690949227373068,0.9945045066848294,1.0,2/12,15.20%,TENT5A;PAPOLB
prerank,ribonuclease P activity (GO:0004526),-0.22610493270611148,-0.5056178207424761,0.9723618090452262,0.9897506280052154,1.0,7/11,41.96%,POP5;POP7;RPP21;PRORP;RPP25;RPP40;RPP14
prerank,kinesin binding (GO:0019894),0.21032222694873384,0.49308545577180607,0.9780701754385965,1.0,1.0,8/27,25.15%,KIF1B;ARHGEF10;PLEKHM2;TOR1B;NEK6;SPAG9;MAPK8IP3;CROCC
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.22014718564805102,-0.4920101206928842,0.9751131221719457,0.9880129444019956,1.0,4/10,25.43%,STAMBPL1;TNFAIP3;ATXN3;CYLD
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.23858169528340603,0.48038009094862355,0.9657534246575342,1.0,1.0,6/12,30.98%,PAN3;CNOT7;PNLDC1;PARN;CNOT8;CNOT1
prerank,U6 snRNA binding (GO:0017070),0.2265185996839176,0.4691869383603285,0.9725557461406518,1.0,1.0,3/14,23.85%,LSM8;LSM2;LSM4
prerank,RNA methyltransferase activity (GO:0008173),0.21093946244662148,0.4687478393964755,0.9857369255150554,1.0,1.0,19/19,78.93%,TRMT13;TRDMT1;FTSJ3;MRM2;TGS1;TRMT12;FTSJ1;MEPCE;METTL4;BCDIN3D;TRMT5;HENMT1;FBLL1;METTL8;FBL;LCMT2;TRMT9B;TYW3;METTL3
prerank,antiporter activity (GO:0015297),0.20957106072976184,0.46166674138001224,0.97339593114241,1.0,1.0,20/20,79.07%,ATP1A3;SLC25A14;SLC35D2;SLC25A16;CLCN4;SLC35E3;SLC35E2B;SLC35E2A;SLC25A30;SLC35A1;SLC35D3;SLC35C2;TMEM241;SLC25A10;CLCN3;SLC35C1;SLC35D1;SLC35E4;SLC25A11;SLC35E1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.20627122924319463,0.4443924077009672,0.9747634069400631,1.0,1.0,6/16,33.60%,CDO1;TDO2;IDO2;ALOX5;PIR;HGD
prerank,carbohydrate kinase activity (GO:0019200),0.22226762404892686,0.44409133971200576,0.9898819561551433,1.0,1.0,3/11,25.30%,GALK2;GNE;POMK
prerank,telomerase RNA binding (GO:0070034),0.19472435994114978,0.44211382829943313,0.9924698795180723,1.0,1.0,1/22,4.46%,SMG6
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.19915892543309055,0.4107652252044217,0.9879931389365352,1.0,1.0,11/11,80.10%,CHRNB1;CHRNA4;CHRNB2;CHRNA3;CHRNA10;CHRNA2;CHRNA1;CHRNB4;CHRNA5;CHRNA9;CHRNA7
prerank,ribonuclease P RNA binding (GO:0033204),0.20674072679344765,0.40868942365117356,0.9898819561551433,1.0,1.0,10/10,79.34%,RPP38;POP1;RPP30;POP4;RPP14;RPP40;RPP25;RPP21;POP7;POP5
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.18140548420752978,0.3621139757708567,0.9932088285229203,1.0,1.0,3/12,22.50%,NQO1;AIFM2;CRYZL1
prerank,neuropeptide binding (GO:0042923),0.15324728947851787,0.34004037666531484,1.0,1.0,1.0,5/18,31.12%,SSTR3;OPRL1;SSTR2;SORL1;NMUR2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.14676726390831513,0.30330500751946043,1.0,0.9999252950844165,1.0,5/14,30.81%,NFU1;ETFDH;IREB2;RSAD1;NUBPL
